Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number: 811-21866

 

 

HIGHLAND FUNDS I

 

 

(Exact name of registrant as specified in charter)

200 Crescent Court

Suite 700

Dallas, Texas 75201

 

 

(Address of principal executive offices) (Zip code)

Highland Capital Management Fund Advisors, L.P.

200 Crescent Court

Suite 700

Dallas, Texas 75201

 

 

(Name and Address of Agent for Service)

Registrant’s telephone number, including area code: (877) 665-1287

Date of fiscal year end:    June 30

Date of reporting period:    December 31, 2013


Table of Contents

Item 1: Reports to Stockholders.

A copy of the Report to Shareholders transmitted to shareholders pursuant to Rule 30e-1 under the Investment Company Act of 1940 is attached herewith.

 

2


Table of Contents

LOGO

 

Highland Funds I

 

Highland Long/Short Equity Fund

Highland Long/Short Healthcare Fund

Highland Floating Rate Opportunities Fund

 

Semi-Annual Report

December 31, 2013

 

 


Table of Contents

Highland Funds I

Highland Long/Short Equity Fund

Highland Long/Short Healthcare Fund

Highland Floating Rate Opportunities Fund

 

TABLE OF CONTENTS

 

Fund Profile

     1   

Financial Statements

     4   

Investment Portfolio

     5   

Statements of Assets and Liabilities

     19   

Statements of Operations

     21   

Statements of Changes in Net Assets

     22   

Statement of Cash Flows

     28   

Financial Highlights

     31   

Notes to Financial Statements

     41   

Additional Information

     63   

Disclosure of Fund Expenses

     63   

Approval of Highland Funds I Advisory and Sub-Advisory Agreements

     64   

Important Information About This Report

     68   

Economic and market conditions change frequently.

There is no assurance that the trends described in this report will continue or commence.

 

A prospectus must precede or accompany this report. Please read the prospectus carefully before you invest.


Table of Contents

FUND PROFILE (unaudited)

 

 

 

  Highland Long/Short Equity Fund

 

Objective

Highland Long/Short Equity Fund seeks consistent, above average total returns primarily through capital appreciation, while also attempting to preserve capital and mitigate risk through hedging activities.

 

Net Assets of Common Shares as of December 31, 2013

$1,029.9 million

 

Portfolio Data as of December 31, 2013

The information below provides a snapshot of Highland Long/Short Equity Fund at the end of the reporting period. Highland Long/Short Equity Fund is actively managed and the composition of its portfolio will change over time.

 

Sectors as of 12/31/2013 (%) (1)(2)      Long Exposure        Short Exposure        Net Exposure  

Consumer Discretionary

       21.1           (4.8        16.3   

Energy

       11.2           (3.1        8.1   

Financial

       16.5           (3.7        12.8   

Healthcare

       4.8                     4.8   

Industrials

       11.7           (2.8        8.9   

Information Technology

       24.6           (6.5        18.1   

Materials

       1.7           (1.1        0.6   

Other

       0.9                     0.9   

Telecommunication Services

       2.3                     2.3   

Real Estate Investment Trust

                 (0.6        (0.6

Utilities

                 (0.6        (0.6

 

Top 5 Holdings as of 12/31/2013 (%) (1)(2)

Long Securities

                Short Securities           

Alliance Data Systems Corp.

       5.3         SPDR S&P Oil & Gas Exploration & Production, ETF        (1.7

CBS Corp.

       4.6         Potash Corp. of Saskatchewan, Inc.        (1.1

GNC Holdings, Inc.

       4.2         M&T Bank Corp.        (1.1

Melco Crown Entertainment, Ltd.

       3.2         Fastenal Co.        (1.1

Pioneer Natural Resources Co.

       3.1         Powershares QQQ Trust Series 1, ETF        (0.9

The Fund’s investment activities involve a significant degree of risk such as short sales which theoretically involve unlimited loss potential. The Fund is non-diversified and may invest a larger portion of its assets in the securities of fewer issuers than if the Fund was diversified.

Please refer to Note 9, Disclosure of Significant Risks and Contingencies, for more information.

 

(1)  

Long and short sectors and securities are calculated as a percentage of total net assets.

 

(2)  

Excludes the Fund’s investment in an investment company purchased with cash collateral from securities lending.

 

Semi-Annual Report       1


Table of Contents

FUND PROFILE (unaudited)

 

 

 

  Highland Long/Short Healthcare Fund

 

Objective

Highland Long/Short Healthcare Fund seeks long-term capital appreciation.

 

Net Assets as of December 31, 2013

$60.4 million

 

Portfolio Data as of December 31, 2013

The information below provides a snapshot of Highland Long/Short Healthcare Fund at the end of the reporting period. Highland Long/Short Healthcare Fund is actively managed and the composition of its portfolio will change over time.

 

Sectors as of 12/31/2013 (%) (1)(2)      Long Exposure        Short Exposure        Net Exposure  

Healthcare: Biotechnology

       23.1           (8.7        14.4   

Healthcare Distributors

       2.8                     2.8   

Healthcare Equipment

       14.4           (3.0        11.4   

Healthcare Facilities

       3.3           (2.0        1.3   

Healthcare Services

       8.2           (4.1        4.1   

Healthcare Supplies

       1.7                     1.7   

Healthcare Technology

       2.7           (0.7        2.0   

Life Sciences Tools & Services

       6.6           (0.6        6.0   

Managed Healthcare

       0.7           (7.4        (6.7

Pharmaceuticals

       10.7           (7.9        2.8   

Financial

       4.1                     4.1   

Consumer Discretionary

       1.1                     1.1   

Information Technology

       1.0                     1.0   

Consumer Staples

       -           (0.9        (0.9

 

Top 5 Holdings as of 12/31/2013 (%) (1)(2)

Long Securities

                Short Securities           

Cardinal Health, Inc.

       2.8         Chemed Corp.        (2.4

Aon PLC

       2.7         Bristol-Myers Squibb Co.        (2.4

Gilead Sciences, Inc.

       2.7         Horizon Pharma, Inc.        (2.4

Thoratec Corp.

       2.6         Cigna Corp.        (2.3

NuVasive, Inc.

       2.4         Eli Lilly & Co.        (2.2

The Fund’s investment activities involve a significant degree of risk such as short sales which theoretically involve unlimited loss potential. The Fund is non-diversified and may invest a larger portion of its assets in the securities of fewer issuers than if the Fund was diversified.

The Fund’s performance largely depends on the healthcare industry and is susceptible to economic, political and regulatory risks.

Please refer to Note 9, Disclosure of Significant Risks and Contingencies, for more information.

 

(1)  

Long and short sectors and securities are calculated as a percentage of total net assets.

 

(2)  

Excludes the Fund’s investment in an investment company purchased with cash collateral from securities lending.

 

2       Semi-Annual Report


Table of Contents

FUND PROFILE (unaudited)

 

 

 

  Highland Floating Rate Opportunities Fund

 

Objective

Highland Floating Rate Opportunities Fund seeks to provide a high level of current income, consistent with preservation of capital.

 

Net Assets of Common Shares as of December 31, 2013

$1,609.7 million

 

Portfolio Data as of December 31, 2013

The information below provides a snapshot of Highland Floating Rate Opportunities Fund at the end of the reporting period. Highland Floating Rate Opportunities Fund is actively managed and the composition of its portfolio will change over time.

Floating rate loan investments present special financial risks. Defaults on the loans, nonpayment and prepayment of principal could affect the valuation of the portfolio’s holdings.

Short sales theoretically involve unlimited loss potential since the market price of securities sold short may continuously increase.

The Fund’s ability to invest in high-yield debt securities (or junk securities) generally subjects the Fund to greater risk. The use of leverage involves certain risks, such as greater volatility of the NAV of the Fund’s shares and the nonpayment of dividends.

 

Quality Breakdown as of 12/31/2013 (%) (1)(2)  

AAA

       0.1   

AA

       0.4   

A

       0.3   

BBB

       4.9   

BB

       30.0   

B

       51.6   

CCC

       8.7   

D

       0.1   

Not Rated

       3.9   
Top 5 Sectors as of 12/31/2013 (%) (1)(2)  

Media & Telecommunications

       14.0   

Financial

       11.5 (3)  

Service

       10.8   

Information Technology

       8.0   

Chemicals

       7.2   
 

 

Top 10 Holdings as of 12/31/2013 (%) (1)(2)  

Media General, Inc. (Common Stocks & Exchange-Traded Funds)

     5.3   

Metro-Goldwyn-Mayer, Inc., Class A (Common Stocks & Exchange-Traded Funds)

     2.1   

CCS Medical, Inc. (U.S. Senior Loans)

     1.9   

Texas Competitive Electric Holdings Co. LLC (U.S. Senior Loans)

     1.8   

Dell, Inc. (U.S. Senior Loans)

     1.7   

SUPERVALU, Inc. (U.S. Senior Loans)

     1.5   

Highland/iBoxx Senior Loan, ETF (Common Stocks & Exchange-Traded Funds)

     1.4   

Tribune Co. (U.S. Senior Loans)

     1.4   

JC Penney Corp., Inc.(U.S. Senior Loans)

     1.4   

Arch Coal, Inc. (U.S. Senior Loans)

     1.3   

The Fund is non-diversified and may invest a larger portion of its assets in the securities of fewer issuers than if the Fund was diversified.

Please refer to Note 9, Disclosure of Significant Risks and Contingencies, for more information.

 

(1)  

Quality is calculated as a percentage of total senior loans, collateralized loan obligations and corporate notes and bonds. Sectors and holdings are calculated as a percentage of total assets. The quality ratings reflected were issued by Standard & Poors, a nationally recognized statistical rating organization. Quality ratings reflect the credit quality of the underlying loans and bonds in the Fund’s portfolio and not the Fund itself. Quality ratings are subject to change.

 

(2)  

Excludes the Fund’s investment in an investment company purchased with cash collateral from securities lending.

 

(3)  

Includes Collateralized Loan Obligations

 

Semi-Annual Report       3


Table of Contents

FINANCIAL STATEMENTS

 

 

 

December 31, 2013  

 

A guide to understanding each Fund’s financial statements

 

Investment Portfolio      The Investment Portfolio details each of the Fund’s holdings and their market value as of the last day of the reporting period. Portfolio holdings are organized by type of asset and industry to demonstrate areas of concentration and diversification.
Statement of Assets and Liabilities      This statement details each Fund’s assets, liabilities, net assets and share price for each share class as of the last day of the reporting period. Net assets are calculated by subtracting all of a Fund’s liabilities (including any unpaid expenses) from the total of the Fund’s investment and non-investment assets. The net asset value per share for each class is calculated by dividing net assets allocated to that share class by the number of shares outstanding in that class as of the last day of the reporting period.
Statement of Operations      This statement reports income earned by each Fund and the expenses incurred by each Fund during the reporting period. The Statement of Operations also shows any net gain or loss a Fund realized on the sales of its holdings during the period as well as any unrealized gains or losses recognized over the period. The total of these results represents a Fund’s net increase or decrease in net assets from operations.
Statement of Changes in Net Assets      This statement details how each Fund’s net assets were affected by its operating results, distributions to shareholders and shareholder transactions (e.g., subscriptions, redemptions and distribution reinvestments) during the reporting period. The Statement of Changes in Net Assets also details changes in the number of shares outstanding.
Statement of Cash Flows      This statement reports net cash and foreign currency, excluding restricted cash, provided or used by operating, investing and financing activities and the net effect of those flows on cash and foreign currency during the period.
Financial Highlights      The Financial Highlights demonstrate how each Fund’s net asset value per share was affected by the Fund’s operating results. The Financial Highlights also disclose the classes’ performance and certain key ratios (e.g., net expenses and net investment income as a percentage of average net assets).
Notes to Financial Statements      These notes disclose the organizational background of the Funds, certain of their significant accounting policies (including those surrounding security valuation, income recognition and distributions to shareholders), federal tax information, fees and compensation paid to affiliates and significant risks and contingencies.

 

4       Semi-Annual Report


Table of Contents

INVESTMENT PORTFOLIO (unaudited)

 

 

 

As of December 31, 2013   Highland Long/Short Equity Fund

 

    Shares    

 

    Value ($)    

 

 

Common Stocks & Exchange-Traded Funds - 93.8%

  

  CONSUMER DISCRETIONARY - 20.1%   
       745,487     

CBS Corp., Class B (a)

    47,517,341   
  205,700     

Dollar Tree, Inc. (b)

    11,605,594   
  745,140     

GNC Holdings, Inc., Class A (a)

    43,553,433   
  458,250     

H&R Block, Inc.

    13,307,580   
  384,992     

Life Time Fitness, Inc. (b)(c)

    18,094,624   
  847,107     

Melco Crown Entertainment, Ltd. ADR (b)(c)

    33,223,537   
  1,763,828     

News Corp., Class A (a)(b)

    31,784,181   
  419,380     

Service Corp. International (a)

    7,603,359   
   

 

 

 
      206,689,649   
   

 

 

 
  ENERGY - 11.2%   
  535,979     

Cabot Oil & Gas Corp.

    20,774,546   
  45,300     

Cimarex Energy Co.

    4,752,423   
  141,543     

Concho Resources, Inc. (b)

    15,286,644   
  286,000     

Marathon Petroleum Corp. (a)

    26,234,780   
  174,139     

Pioneer Natural Resources Co. (a)

    32,053,766   
  326,900     

Valero Energy Corp.

    16,475,760   
   

 

 

 
      115,577,919   
   

 

 

 
  FINANCIAL - 16.5%   
  109,832     

Affiliated Managers Group, Inc. (a)(b)

    23,820,364   
  416,100     

American International Group, Inc. (a)

    21,241,905   
  313,611     

Arthur J. Gallagher & Co. (a)

    14,717,764   
  932,347     

E*TRADE Financial Corp. (b)

    18,311,295   
  817,300     

Fidelity National Financial, Inc., Class A

    26,521,385   
  480,860     

Fifth Third Bancorp

    10,112,486   
  430,800     

Legg Mason, Inc.

    18,731,184   
  202,800     

MetLife, Inc.

    10,934,976   
  1,716,429     

Newcastle Investment Corp., REIT (c)

    9,852,302   
  350,000     

NMI Holdings, Inc., Class A (b)(c)

    4,455,500   
  153,000     

State Street Corp.

    11,228,670   
   

 

 

 
      169,927,831   
   

 

 

 
  HEALTHCARE - 4.8%   
  495,741     

Acadia Healthcare Co., Inc. (b)(c)

    23,463,422   
  92,400     

Actavis PLC (b)

    15,523,200   
  86,623     

Valeant Pharmaceuticals International, Inc. (b)

    10,169,540   
   

 

 

 
      49,156,162   
   

 

 

 
  INDUSTRIALS - 11.7%   
  341,285     

AerCap Holdings NV (a)(b)

    13,088,280   
  173,650     

B/E Aerospace, Inc. (b)

    15,112,760   
  162,941     

Colfax Corp. (b)

    10,377,712   
  52,400     

Dover Corp.

    5,058,696   
  107,150     

FedEx Corp.

    15,404,955   
  100,000     

Ingersoll-Rand PLC

    6,160,000   
  158,700     

Kirby Corp. (b)(c)

    15,750,975   
  645,500     

MasTec, Inc. (b)(c)

    21,120,760   
  333,199     

Pendrell Corp. (b)

    669,730   
  78,500     

Pentair, Ltd.

    6,097,095   
  123,150     

Watsco, Inc.

    11,829,789   
   

 

 

 
      120,670,752   
   

 

 

 

    Shares    

 

    Value ($)    

 
  INFORMATION TECHNOLOGY - 24.6%   
       206,605     

Alliance Data Systems Corp. (a)(b)(c)

    54,322,653   
  36,050     

Apple, Inc.

    20,228,015   
  337,050     

Ciena Corp. (b)

    8,065,606   
  84,092     

Cognizant Technology Solutions Corp., Class A (b)

    8,491,610   
  1,922,119     

Compuware Corp. (a)

    21,546,954   
  567,310     

Facebook, Inc., Class A (b)

    31,009,165   
  94,500     

FleetCor Technologies, Inc. (b)

    11,072,565   
  11,100     

Google, Inc., Class A (b)

    12,439,881   
  280,000     

Micron Technology, Inc. (b)

    6,092,800   
  437,394     

Monolithic Power Systems, Inc. (a)(b)

    15,160,076   
  480,900     

NXP Semiconductor NV (b)

    22,087,737   
  440,754     

Rackspace Hosting, Inc. (a)(b)(c)

    17,246,704   
  148,500     

SolarWinds, Inc. (b)

    5,617,755   
  238,100     

Western Digital Corp.

    19,976,590   
   

 

 

 
    253,358,111   
   

 

 

 
  MATERIALS - 1.7%   
  164,700     

Freeport-McMoRan Copper & Gold, Inc.

    6,215,778   
  98,000     

Monsanto Co.

    11,421,900   
   

 

 

 
    17,637,678   
   

 

 

 
  OTHER - 0.9%   
  480,654     

Highland/iBoxx Senior Loan, ETF (d)

    9,579,434   
   

 

 

 
  TELECOMMUNICATION SERVICES - 2.3%   
  264,907     

SBA Communications Corp., Class A (a)(b)

    23,799,245   
   

 

 

 
 

Total Common Stocks & Exchange-Traded Funds
(Cost $861,921,419)

    966,396,781   
   

 

 

 

 

Master Limited Partnerships (a) - 1.0%

  

  CONSUMER DISCRETIONARY - 1.0%   
  197,115     

Cedar Fair LP

    9,772,962   
   

 

 

 
 

Total Master Limited Partnerships (Cost $8,199,937)

    9,772,962   
   

 

 

 

 

Investment Companies (e) - 6.6%

  

  68,431,932     

State Street Navigator Prime Securities Lending Portfolio

    68,431,932   
   

 

 

 
 

Total Investment Companies
(Cost $68,431,932)

    68,431,932   
   

 

 

 

 

Total Investments - 101.4%

    1,044,601,675   
   

 

 

 

 


(Cost $938,553,288) (f)


  


 

Securities Sold Short (g) - (23.2)%

  

 

Common Stocks & Exchange-Traded Funds - (23.2)%

  

  CONSUMER DISCRETIONARY - (4.8)%   
  81,100     

Consumer Discretionary Select Sector SPDR Fund, ETF

    (5,419,913
  118,100     

DSW, Inc., Class A

    (5,046,413
  31,225     

Harman International Industries, Inc.

    (2,555,766
  149,298     

REA Group, Ltd.

    (5,043,581
  83,400     

Sinclair Broadcast Group, Inc., Class A

    (2,979,882
  95,150     

SPDR S&P Retail, ETF

    (8,382,715
 

 

See accompanying Notes to Financial Statements.       5


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland Long/Short Equity Fund

 

    Shares    

 

    Value ($)    

 

 

Securities Sold Short (g) (continued)

  

 

Common Stocks & Exchange-Traded Funds (continued)

  

  CONSUMER DISCRETIONARY (continued)   
       117,295     

Starz, Class A (h)

    (3,429,706
  68,886     

Time Warner, Inc.

    (4,802,732
  69,800     

Under Armour, Inc., Class A (h)

    (6,093,540
  61,500     

Viacom, Inc., Class B

    (5,371,410
   

 

 

 
    (49,125,658
   

 

 

 
  ENERGY - (3.1)%   
  23,200     

CARBO Ceramics, Inc.

    (2,703,496
  54,100     

Continental Resources, Inc. (h)

    (6,087,332
  93,810     

Energen Corp.

    (6,637,058
  248,065     

SPDR S&P Oil & Gas Exploration & Production, ETF

    (16,999,894
   

 

 

 
    (32,427,780
   

 

 

 
  FINANCIAL - (3.7)%   
  288,508     

Federated Investors, Inc., Class B

    (8,309,030
  320,800     

Financial Select Sector SPDR Fund, ETF

    (7,012,688
  78,800     

iShares US Real Estate, ETF

    (4,971,492
  96,575     

M&T Bank Corp.

    (11,243,262
  253,600     

New York Community Bancorp, Inc.

    (4,273,160
  197,909     

People’s United Financial, Inc.

    (2,992,384
   

 

 

 
    (38,802,016
   

 

 

 
  INDUSTRIALS - (2.8)%   
  80,259     

Air Lease Corp.

    (2,494,449
  30,600     

Armstrong World Industries, Inc. (h)

    (1,762,866
  41,865     

Boeing Co. (The)

    (5,714,154
  78,700     

Deere & Co.

    (7,187,671
  236,235     

Fastenal Co.

    (11,223,525
   

 

 

 
    (28,382,665
   

 

 

 
  INFORMATION TECHNOLOGY - (6.5)%   
  71,800     

Analog Devices, Inc.

    (3,656,774
  68,870     

AOL, Inc. (h)

    (3,210,719
  68,206     

Cognex Corp. (h)

    (2,604,105
  104,800     

Computer Sciences Corp.

    (5,856,224
  64,600     

Dolby Laboratories, Inc., Class A (h)

    (2,490,976
  94,400     

Linear Technology Corp.

    (4,299,920
  269,800     

Marvell Technology Group, Ltd.

    (3,879,724
  81,466     

Mellanox Technologies, Ltd. (h)

    (3,256,196
  413,102     

NVIDIA Corp.

    (6,617,894
  105,000     

Powershares QQQ Trust Series 1, ETF

    (9,235,800
  48,400     

SanDisk Corp.

    (3,414,136
  60,400     

SAP AG ADR

    (5,263,256
  19,565     

ServiceNow, Inc. (h)

    (1,095,836
  72,100     

Texas Instruments, Inc.

    (3,165,911
  65,000     

Twitter, Inc. (h)

    (4,137,250
  80,500     

Xilinx, Inc.

    (3,696,560
  16,700     

Yelp, Inc. (h)

    (1,151,466
   

 

 

 
    (67,032,747
   

 

 

 
  MATERIALS - (1.1)%   
  360,900     

Potash Corp. of Saskatchewan, Inc.

    (11,895,264
   

 

 

 

    Shares    

 

    Value ($)    

 
  REAL ESTATE INVESTMENT TRUST - (0.6)%   
       75,000     

American Tower Corp., REIT

    (5,986,500
   

 

 

 
  UTILITIES - (0.6)%   
  279,005     

United States Natural Gas Fund LP, ETF (h)

    (5,772,613
   

 

 

 
 

Total Common Stocks & Exchange-Traded Funds
(Proceeds $227,703,048)

    (239,425,243
   

 

 

 
 

Total Securities Sold Short
(Proceeds $227,703,048)

    (239,425,243
   

 

 

 

 

Other Assets & Liabilities, Net - 21.8%

    224,674,548   
   

 

 

 

 

Net Assets - 100.0%

    1,029,850,980   
   

 

 

 

 

(a) All or part of this security is pledged as collateral for short sales. The market value of the securities pledged as collateral was $328,634,465.
(b) Non-income producing security.
(c) Securities (or a portion of securities) on loan. As of December 31, 2013, the market value of securities loaned was $67,673,953. The loaned securities were secured with cash collateral of $68,431,932. Collateral is calculated based on prior day’s prices. See Note 4.
(d) Affiliated issuer. Assets with a total aggregate market value of $9,579,434, or 0.9% of net assets, were affiliated with the Fund as of December 31, 2013.
(e) Represents investments of cash collateral received in connection with securities lending.
(f) Cost for U.S. federal income tax purposes is $938,553,288.
(g) As of December 31, 2013, $154,731,920 in cash was segregated or on deposit with the brokers to cover investments sold short and is included in “Other Assets & Liabilities, Net.”
(h) No dividend payable on security sold short.

Currency Abbreviations:

AUD   Australian Dollar
USD   United States Dollar

Glossary:

ADR   American Depositary Receipt
ETF   Exchange-Traded Fund
PLC   Public Limited Company
REIT   Real Estate Investment Trust
SPDR   Standard & Poor’s Depositary Receipt

The Fund had the following futures contracts, brokered by Bank of America, for which $3,589,750 was pledged as collateral, open at December 31, 2013:

 

Description    Expiration
Date
     Numberof
Contracts
     Notional
Value
     Unrealized
Appreciation
(Depreciation)
 

Short Futures:

           

AUD v.USD

     March 2014         239       $ 21,227,980       $ (24,443

S&P 500 Emini Index

     March 2014         701         64,530,555         (1,599,634

WTI Crude

     March 2014         102         10,052,100         (77,076
           

 

 

 
            $ (1,701,153
           

 

 

 

Written options contracts outstanding as of December 31, 2013 were as follows:

 

Description    Exercise
Price
    Expiration
Date
    Number of
Contracts
    Premium     Value  

SPDR S&P 500 ETF Trust

   $ 179.00        January 2014        1,200      $ 538,270      $ (753,600
        

 

 

   

 

 

 
 

 

6       See accompanying Notes to Financial Statements.


Table of Contents

INVESTMENT PORTFOLIO (unaudited)

 

 

 

As of December 31, 2013   Highland Long/Short Healthcare Fund

 

 

    Shares    

 

    Value ($)    

 

 


Common Stocks - 76.4%


  


 
CONSUMER DISCRETIONARY - 1.1%
 
  36,255     

Service Corp. International (a)

    657,303   
   

 

 

 
 
FINANCIAL - 4.1%
 
  19,548     

Aon PLC (a)

    1,639,882   
  17,382     

eHealth, Inc. (b)(c)

    808,089   
   

 

 

 
      2,447,971   
   

 

 

 
 
HEALTHCARE - 70.2%
 

 


Biotechnology - 21.5%


 
  35,000     

ACADIA Pharmaceuticals, Inc. (a)(c)

    874,650   
  3,579     

Biogen Idec, Inc. (c)

    1,001,225   
  6,923     

Celgene Corp. (a)(c)

    1,169,710   
  17,848     

Cepheid, Inc. (a)(c)

    833,859   
  80,000     

Chelsea Therapeutics International, Ltd. (a)(b)(c)

    354,400   
  14,109     

Chimerix, Inc. (c)

    213,187   
  36,107     

Foundation Medicine, Inc. (b)(c)

    860,069   
  214,890     

Galena Biopharma, Inc. (b)(c)

    1,065,854   
  21,298     

Gilead Sciences, Inc. (a)(b)(c)

    1,600,545   
  16,351     

Intercept Pharmaceuticals, Inc. (a)(c)

    1,116,446   
  25,956     

Karyopharm Therapeutics, Inc. (b)(c)

    594,912   
  26,105     

Keryx Biopharmaceuticals, Inc. (b)(c)

    338,060   
  56,655     

MiMedx Group, Inc. (c)

    495,165   
  12,171     

Nanosphere, Inc. (c)

    27,872   
  8,834     

Portola Pharmaceuticals, Inc. (b)(c)

    227,475   
  17,762     

Repligen Corp. (b)(c)

    242,274   
  57,512     

Sarepta Therapeutics, Inc. (b)(c)

    1,171,519   
  15,416     

Swedish Orphan Biovitrum AB (c)

    160,218   
  8,254     

Vertex Pharmaceuticals, Inc. (c)

    613,272   
   

 

 

 
      12,960,712   
   

 

 

 

 


Healthcare Distributors - 2.8%


 
  25,000     

Cardinal Health, Inc. (a)

    1,670,250   
   

 

 

 

 


Healthcare Equipment - 14.4%


 
  5,124     

Becton Dickinson and Co. (b)

    566,151   
  24,611     

Cardiovascular Systems, Inc. (a)(c)

    843,911   
  1,068,076     

Genesys Ventures IA, LP (c)(d)

    622,688   
  36,569     

GenMark Diagnostics, Inc. (a)(c)

    486,733   
  7,223     

HeartWare International, Inc. (b)(c)

    678,673   
  14,750     

Natus Medical, Inc. (a)(c)

    331,875   
  31,718     

Novadaq Technologies, Inc. (a)(c)

    523,030   
  44,643     

NuVasive, Inc. (a)(c)

    1,443,308   
  54,397     

Rockwell Medical Technologies, Inc. (b)(c)

    567,905   
  13,190     

St Jude Medical, Inc. (b)

    817,121   
  42,230     

Thoratec Corp. (a)(c)

    1,545,618   
  21,000     

Veracyte, Inc. (b)(c)

    304,500   
   

 

 

 
      8,731,513   
   

 

 

 

 


Healthcare Facilities - 3.3%


 
  7,000     

Acadia Healthcare Co., Inc. (a)(c)

    331,310   
  75,804     

Adcare Health Systems, Inc. (a)(c)

    325,957   
  23,573     

HCA Holdings, Inc. (c)

    1,124,668   
  17,134     

Select Medical Holdings Corp. (b)

    198,926   
   

 

 

 
      1,980,861   
   

 

 

 

    Shares    

 

    Value ($)    

 

 


Healthcare Services - 8.2%


 
  88,450     

BioScrip, Inc. (b)(c)

    654,530   
  3,982,699     

CNS Response, Inc. (c)(d)

    934,341   
  25,645     

ExamWorks Group, Inc. (a)(b)(c)

    766,016   
  11,463     

Express Scripts Holding Co. (a)(b)(c)

    805,161   
  35,513     

Premier, Inc., Class A (a)(c)

    1,305,458   
  10,729     

Team Health Holdings, Inc. (a)(c)

    488,706   
   

 

 

 
      4,954,212   
   

 

 

 

 

Healthcare Supplies - 1.7%

 
  21,193     

DENTSPLY International, Inc. (b)

    1,027,437   
   

 

 

 

 

Healthcare Technology - 2.7%

 
  42,200     

Quality Systems, Inc. (a)

    888,732   
  106,535     

Streamline Health Solutions, Inc. (c)

    743,614   
   

 

 

 
      1,632,346   
   

 

 

 

 

Life Sciences Tools & Services - 6.4%

 
  10,295     

Agilent Technologies, Inc. (a)

    588,771   
  5,270     

Bio-Rad Laboratories, Inc., Class A (b)(c)

    651,425   
  23,467     

ICON PLC (a)(b)(c)

    948,301   
  74,508     

NanoString Technologies, Inc. (b)(c)

    1,284,518   
  8,765     

PAREXEL International Corp. (a)(c)

    396,003   
   

 

 

 
      3,869,018   
   

 

 

 

 

Managed Healthcare - 0.7%

 
  7,082     

Health Net, Inc. (a)(c)

    210,123   
  3,500     

WellCare Health Plans, Inc. (a)(c)

    246,470   
   

 

 

 
      456,593   
   

 

 

 

 

Pharmaceuticals - 8.5%

 
  4,318     

Actavis PLC (a)(c)

    725,424   
  73,388     

Endocyte, Inc. (a)(b)(c)

    784,518   
  13,082     

GlaxoSmithKline PLC ADR (a)(b)

    698,448   
  15,177     

Merck & Co., Inc. (a)

    759,609   
  245,627     

NuPathe, Inc. (c)

    803,200   
  10,522     

Stada Arzneimittel AG

    520,869   
  145,326     

Trimel Pharmaceuticals Corp. (c)

    54,711   
  23,885     

Zoetis, Inc.

    780,800   
   

 

 

 
      5,127,579   
   

 

 

 
      42,410,521   
   

 

 

 
  INFORMATION TECHNOLOGY - 1.0%  
  15,252     

WebMD Health Corp. (b)(c)

    602,454   
   

 

 

 
 

Total Common Stocks
(Cost $41,039,424)

    46,118,249   
   

 

 

 

    Units    

     

 

Rights (c) - 0.0%

 
  HEALTHCARE - 0.0%  

 

Healthcare Equipment - 0.0%

 
  69,326     

Wright Medical Group, Inc.

    22,392   
   

 

 

 
 

Total Rights
(Cost $188,241)

    22,392   
   

 

 

 
 

 

See accompanying Notes to Financial Statements.       7


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland Long/Short Healthcare Fund

 

    Units    

 

    Value ($)    

 

 

Warrants (c) - 4.0%

 
  HEALTHCARE - 4.0%  

 

Biotechnology - 1.6%

 
  94,204     

Discovery Laboratories, Inc., expires 02/16/2016

    109,887   
  121,816     

MediciNova, Inc., expires 03/24/2016 (d)

    73,872   
  271,081     

Threshold Pharmaceuticals, Inc., expires 03/11/2016 (d)

    765,295   
   

 

 

 
      949,054   
   

 

 

 

 

Life Sciences Tools & Services - 0.2%

 
  177,478     

Delcath Systems, Inc., expires 05/25/2017 (d)

    5,852   
  40,000     

Pluristem Therapeutics, Inc., expires 01/27/2016

    42,931   
  30,000     

pSivida Corp., expires 01/19/2016 (d)

    41,122   
   

 

 

 
      89,905   
   

 

 

 

 

Pharmaceuticals - 2.2%

 
  37,955     

ADVENTRX Pharmaceuticals, Inc., expires 01/07/2016

    370   
  252,549     

Horizon Pharmaceuticals, expires 09/20/2017 (d)

    1,263,791   
  521,727     

Neostem, Inc., expires 07/19/2016 (d)

    91,919   
   

 

 

 
      1,356,080   
   

 

 

 
 

Total Warrants
(Cost $—)

    2,395,039   
   

 

 

 

    Contracts    

     

 

Purchased Put Options (e) - 0.0%

 
  157     

Raptor Pharmaceutical Corp., Strike price $12.50, expires 01/18/2014

    9,813   
   

 

 

 
 

Total Purchased Put Options
(Cost $16,613)

    9,813   
   

 

 

 

    Shares    

     

 

Investment Companies (f) - 16.4%

 
  9,908,413     

State Street Navigator Prime Securities Lending Portfolio

    9,908,413   
   

 

 

 
 

Total Investment Companies
(Cost $9,908,413)

    9,908,413   
   

 

 

 

 

Total Investments - 96.8%

    58,453,906   
   

 

 

 

 

(Cost $51,152,691) (g)

 

 

Securities Sold Short (h) - (35.3)%

 

 

Common Stocks - (35.3)%

 
  CONSUMER STAPLES - (0.9)%  
  9,560     

Walgreen Co.

    (549,127
   

 

 

 

    Shares    

 

    Value ($)    

 
  HEALTHCARE - (34.4)%  

 

Biotechnology - (8.7)%

 
  38,431     

Galectin Therapeutics, Inc. (i)

    (310,522
  78,391     

Geron Corp. (i)

    (371,573
  43,187     

Halozyme Therapeutics, Inc. (i)

    (647,373
  25,949     

ImmunoGen, Inc. (i)

    (380,672
  24,190     

Intrexon Corp. (i)

    (575,722
  16,500     

MacroGenics, Inc. (i)

    (452,595
  17,400     

Organovo Holdings, Inc. (i)

    (192,618
  60,000     

Raptor Pharmaceutical Corp. (i)

    (781,200
  21,203     

Seattle Genetics, Inc. (i)

    (845,788
  155,000     

Threshold Pharmaceuticals, Inc. (i)

    (723,850
   

 

 

 
      (5,281,913
   

 

 

 

 

Healthcare Equipment - (3.0)%

 
  15,962     

Abaxis, Inc. (i)

    (638,799
  8,747     

DexCom, Inc. (i)

    (309,731
  18,747     

ResMed, Inc.

    (882,609
   

 

 

 
      (1,831,139
   

 

 

 

 

Healthcare Facilities - (2.0)%

 
  30,832     

Community Health Systems, Inc. (i)

    (1,210,773
   

 

 

 

 

Healthcare Services - (4.1)%

 
  18,858     

Chemed Corp.

    (1,444,900
  18,664     

Fresenius Medical Care AG & Co. KGaA, ADR

    (664,065
  29,329     

Gentiva Health Services, Inc. (i)

    (363,973
   

 

 

 
      (2,472,938
   

 

 

 

 

Healthcare Technology - (0.7)%

 
  17,947     

HMS Holdings Corp. (i)

    (407,935
   

 

 

 

 

Life Sciences Tools & Services - (0.6)%

 
  8,747     

Fluidigm Corp. (i)

    (335,185
   

 

 

 

 

Managed Healthcare - (7.4)%

 
  15,692     

Cigna Corp.

    (1,372,736
  11,764     

Humana, Inc.

    (1,214,280
  10,000     

Magellan Health Services, Inc. (i)

    (599,100
  13,966     

WellPoint, Inc.

    (1,290,319
   

 

 

 
      (4,476,435
   

 

 

 

 

Pharmaceuticals - (7.9)%

 
  27,029     

Bristol-Myers Squibb Co.

    (1,436,591
  26,026     

Eli Lilly & Co.

    (1,327,326
     187,111     

Horizon Pharma, Inc. (i)

    (1,425,786
  2,624     

Jazz Pharmaceuticals PLC (i)

    (332,094
  46,725     

Sciclone Pharmaceuticals, Inc. (i)

    (235,494
   

 

 

 
      (4,757,291
   

 

 

 
      (20,773,609
   

 

 

 
 

Total Common Stocks (Proceeds $20,134,594)

    (21,322,736
   

 

 

 
 

Total Securities Sold Short (Proceeds $20,134,594)

    (21,322,736
   

 

 

 

 

Other Assets & Liabilities, Net - 38.5%

    23,258,686   
   

 

 

 

 

Net Assets - 100.0%

    60,389,856   
   

 

 

 

 

 

 

8       See accompanying Notes to Financial Statements.


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland Long/Short Healthcare Fund

 

 

(a) All or part of this security is pledged as collateral for short sales. The market value of the securities pledged as collateral was $19,005,618.
(b) Securities (or a portion of securities) on loan. As of December 31, 2013, the market value of securities loaned was $9,744,486. The loaned securities were secured with cash collateral of $9,908,413. Collateral is calculated based on prior day’s prices. See Note 4.
(c) Non-income producing security.
(d) Represents fair value as determined by the Fund’s Board of Trustees (the “Board”), or its designee in good faith, pursuant to the policies and procedures approved by the Board. Securities with a total aggregate value of $3,798,880, or 6.3% of net assets, were fair valued under the Fund’s valuation procedures as of December 31, 2013.
(e) Options are shown at market value.
(f) Represents investments of cash collateral received in connection with securities lending.
(g) Cost for U.S. federal income tax purposes is $51,152,691.
(h) As of December 31, 2013, $21,038,845, in cash was segregated or on deposit with the brokers to cover investments sold short and is included in “Other Assets & Liabilities, Net.”
(i) No dividend payable on security sold short.

Glossary:

ADR   American Depositary Receipt
PLC   Public Limited Company
 

 

See accompanying Notes to Financial Statements.       9


Table of Contents

INVESTMENT PORTFOLIO (unaudited)

 

 

 

As of December 31, 2013   Highland Floating Rate Opportunities Fund

 

    Principal Amount ($)    

 

    Value ($)    

 

 

U.S. Senior Loans (a) - 68.7%

  

  AEROSPACE - 2.5%   
  8,436,250     

Continental Airlines, Inc.
Class B Term Loan
4.00%, 04/01/2019

    8,499,522   
  12,382,695     

Delta Air Lines, Inc.
Term Loan B-1
4.00%, 10/18/2018

    12,455,443   
  8,720,930     

Hawker Beechcraft Acquisition Co. LLC
Term Loan
5.75%, 02/14/2020

    8,808,139   
  10,630,667     

TransDigm, Inc.
Tranche C Term Loan
3.75%, 02/28/2020

    10,672,977   
   

 

 

 
      40,436,081   
   

 

 

 
  BROADCASTING - 1.5%   
  1,970,100     

Charter Communications Operating LLC
Term Loan F
3.00%, 01/04/2021

    1,958,713   
  18,000,000     

Clear Channel Communications, Inc.
Tranche D Term Loan
01/30/2019 (b)

    17,223,750   
  5,448,553     

ComCorp Broadcasting, Inc.
Term Loan
9.00%, 04/03/2014 (c)

    5,427,304   
   

 

 

 
      24,609,767   
   

 

 

 
  CHEMICALS - 6.0%   
  11,044,500     

Arysta LifeScience SPC LLC
First Lien Initial Term Loan
4.50%, 05/29/2020

    11,129,101   
  5,750,000     

Second Lien Initial Term Loan
11/30/2020 (b)

    5,855,944   
  17,954,774     

Axalta Coatings Systems Dutch Holdings B BV and Axalta Coatings Systems U.S. Holdings, Inc.
Initial Term Loan B
02/01/2020 (b)

    18,110,980   
  9,837,802     

Ineos U.S. Finance LLC
Dollar Term Loan
4.00%, 05/04/2018

    9,889,057   
  13,865,285     

MacDermid, Inc.
Tranche B First Lien Term Loan
06/08/2020 (b)

    13,990,904   
  6,639,699     

PQ Corp.
2013 Term Loan
4.50%, 08/07/2017

    6,696,967   
  19,376,913     

Univar, Inc.
New Term Loan B
6/30/2017 (b)

    19,257,163   
 
2,885,262
  
 

W.R. Grace & Co.
5-Year Revolver (d)

    6,059,051   
  2,885,262     

Revolver Credit Loan (d)

    6,059,051   
   

 

 

 
      97,048,218   
   

 

 

 

    Principal Amount ($)    

 

    Value ($)    

 
  CONSUMER DISCRETIONARY - 0.9%   
  3,000,000     

Aramark Corp.
U.S. Term Loan D
09/09/2019 (b)

    3,023,100   
  3,229,248     

FGI Operating Company, LLC
Term Loan B
04/19/2019 (b)

    3,253,467   
  7,735,294     

Maxim Crane Works, L.P.
Second Lien Term Loan
11/06/2018 (b)

    7,793,309   
   

 

 

 
      14,069,876   
   

 

 

 
  CONSUMER PRODUCTS - 1.1%   
  153,188     

Spectrum Brands, Inc.
Tranche C Term Loan
3.50%, 09/04/2019

    153,704   
  14,251,234     

SRAM LLC
First Lien Term Loan
04/10/2020 (b)

    14,274,962   
  3,389,673     

Tempur-Pedic International, Inc.
New Term Loan B
3.50%, 03/18/2020

    3,391,486   
   

 

 

 
      17,820,152   
   

 

 

 
  ENERGY - 2.0%   
  21,507,863     

Arch Coal, Inc.
Term Loan
05/16/2018 (b)

    21,261,491   
  1,333,333     

Fieldwood Energy LLC
Second Lien Term Loan
8.38%, 09/30/2020

    1,364,720   
  8,750,000     

TGGT Holdings, LLC
Term Loan
11/15/2018 (b)

    8,815,625   
   

 

 

 
      31,441,836   
   

 

 

 
  FINANCIAL - 3.5%   
  9,168,045     

Cunningham Lindsey U.S., Inc.
First Lien Initial Term Loan
5.00%, 12/10/2019

    9,179,505   
  6,000,000     

Kasima, LLC
Term Loan
3.00%, 05/17/2021

    5,985,000   
  3,930,300     

LPL Holdings, Inc.
Incremental Tranche B Term Loan
3.25%, 03/29/2019

    3,933,582   
  13,773,457     

National Financial Partners Corp.
Term Loan B
07/01/2020 (b)

    13,939,909   
  7,750,000     

Nuveen Investments, Inc.
Tranche B First Lien Term Loan
4.17%, 05/15/2017

    7,730,625   
  3,000,000     

Tranche B Second Lien Term Loan
6.50%, 02/28/2019

    2,976,000   
  12,354,306     

Ocwen Loan Servicing
Initial Term Loan
02/15/2018 (b)

    12,528,810   
   

 

 

 
      56,273,431   
   

 

 

 
 

 

10       See accompanying Notes to Financial Statements.


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland Floating Rate Opportunities Fund

 

    Principal Amount ($)    

 

    Value ($)    

 

 

U.S. Senior Loans (continued)

  

  FOOD & DRUG - 1.5%   
  23,804,528     

SUPERVALU, Inc.
New Term Loan
03/21/2019 (b)

    24,064,830   
   

 

 

 
  FOOD & TOBACCO - 0.7%   
  11,940,000     

US Foods, Inc.
Incremental Term Loan
4.50%, 03/29/2019

    12,071,818   
   

 

 

 
  FOREST PRODUCTS & CONTAINERS - 0.2%   
  3,316,335     

Berlin Packaging LLC
First Lien Term Loan
4.75%, 04/02/2019

    3,347,442   
  400,000     

Second Lien Term Loan
8.75%, 04/02/2020

    410,500   
   

 

 

 
      3,757,942   
   

 

 

 
  GAMING & LEISURE - 2.0%   
  49,819,311     

Ginn LA Conduit Lender, Inc.
First Lien Tranche B Term Loan (d)

    1,494,579   
  23,243,312     

First Lien Tranche A Credit-Linked Deposit (d)

    697,299   
  7,000,000     

Second Lien Term Loan (c)(d)

      
  15,250,526     

Hilton Worldwide Finance, LLC
Initial Term Loan
10/26/2020 (b)

    15,405,777   
  7,536,385     

Las Vegas Sands LLC
Term Loan B
03/31/2016 (b)

    7,542,678   
  10,180,509     

LLV Holdco LLC
Exit Revolving Loan
5.00%, 02/28/2017 (c)

    4,547,633   
  1,990,000     

Pinnacle Entertainment, Inc.
Tranche B-2 Term Loan
3.75%, 08/13/2020

    2,001,691   
  613,197     

Tamarack Resort LLC
Term Loan
0.00%, 07/02/2015

    521,218   
  18,000,000     

WAICCS Las Vegas 3 LLC
Second Lien Term Loan
0.00%, 02/03/2014 (c)

      
   

 

 

 
      32,210,875   
   

 

 

 
  HEALTHCARE - 5.1%   
  6,446,000     

Akorn, Inc.
Term Loan B
08/27/2020 (b)

    6,490,316   
  5,852,590     

Biomet Inc.
Dollar Term Loan B-2
3.67%, 07/25/2017

    5,897,099   
  9,601,000     

Catalent Pharma Solutions, Inc.
Term Loan
6.50%, 12/29/2017

    9,775,019   
  31,146,760     

CCS Medical, Inc.
First Lien Term Loan
03/31/2015 (b)

    30,562,758   
  9,329,512     

Kinetic Concepts, Inc.
Dollar Term Loan D-1
4.50%, 05/04/2018

    9,393,652   

    Principal Amount ($)    

 

    Value ($)    

 
  HEALTHCARE (continued)   
  7,623,729     

Onex Carestream Finance LP
First Lien Term Loan
5.00%, 06/07/2019

    7,731,414   
  7,000,000     

Second Lien Term Loan
9.00%, 06/07/2019

    7,148,750   
  2,109,062     

Select Medical Corp.
Series C Tranche B Term Loan
4.01%, 06/01/2018

    2,118,300   
  2,977,500     

United Surgical Partners International, Inc.
Tranche B Term Loan
4.75%, 04/03/2019

    2,998,417   
   

 

 

 
      82,115,725   
   

 

 

 
  HOUSING - 0.7%   
  2,977,500     

CBRE Services, Inc.
Tranche B Term Loan
2.92%, 03/29/2021

    2,994,249   
  8,000,000     

EH/Transeastern LLC/TE TOUSA
Term Loan
0.00%, 08/01/2016 (c)

    4,000,000   
  166,449     

Las Vegas Land Holdings LLC
Term Loan
2.25%, 03/31/2016

    151,468   
  7,591,233     

LBREP/L-Suncal Master I LLC
First Lien Term Loan (c)(d)

    575,416   
  2,156,713     

Nevada Land Group LLC
Second Lien Initial Term Loan
10.00%, 11/12/2014 (c)

    1,168,938   
  2,001,165     

First Lien Initial Term Loan
40.17%, 11/10/2014

    1,951,136   
   

 

 

 
      10,841,207   
   

 

 

 
  INFORMATION TECHNOLOGY - 7.2%   
  4,259,786     

Activision Blizzard, Inc.
Term Loan
3.25%, 10/12/2020

    4,294,908   
  17,738,915     

Avaya, Inc.
Term Loan B-5
03/30/2018 (b)

    18,031,607   
  1,153,547     

Dealer Computer Services, Inc.
Tranche B Term Loan
2.17%, 04/21/2016

    1,158,219   
  26,901,408     

Dell Inc.
Term Loan B
04/29/2020 (b)

    27,026,365   
  10,745,091     

Freescale Semiconductor, Inc.
Tranche B-5 Term Loan
01/15/2021 (b)

    10,882,252   
  8,477,261     

Infor (US), Inc.
Tranche B-5 Term Loan
06/03/2020 (b)

    8,479,042   
  11,822,367     

Kronos, Inc.
First Lien Incremental Term Loan
4.50%, 10/30/2019

    11,948,038   
  4,926,500     

Second Lien Initial Term Loan
9.75%, 04/30/2020

    5,108,165   
  2,835,691     

Novell, Inc.
First Lien Term Facility
11/22/2017 (b)

    2,894,177   
 

 

See accompanying Notes to Financial Statements.       11


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland Floating Rate Opportunities Fund

 

    Principal Amount ($)    

 

    Value ($)    

 

 

U.S. Senior Loans (continued)

  

  INFORMATION TECHNOLOGY (continued)   
  5,704,712     

RP Crown Parent, LLC
First Lien New Term Loan
6.25%, 12/21/2018

    5,737,200   
  12,000,000     

Scientific Games International, Inc.
Initial Term Loan
4.25%, 10/18/2020

    12,040,500   
  1,237,500     

SunGard Data Systems, Inc.
Tranche D Term Loan
4.50%, 01/31/2020

    1,246,268   
  2,275,687     

Verint Systems, Inc.
Term Loan
4.00%, 09/06/2019

    2,290,479   
  4,916,983     

Vertafore, Inc.
Term Loan
4.25%, 10/03/2019

    4,957,966   
   

 

 

 
      116,095,186   
   

 

 

 
  MANUFACTURING - 3.7%   
  9,099,858     

Doncasters U.S. Finance LLC
Term Loan B
04/09/2020 (b)

    9,211,695   
  8,000,000     

Second Lien Term Loan
10/09/2020 (b)

    8,140,000   
  480,000     

Filtration Group Corp.
Second Lien Term Loan
11/21/2020 (b)

    492,000   
  1,533,546     

First Lien Term Loan
4.50%, 11/20/2020

    1,551,765   
  10,779,435     

Quikrete Holdings, Inc.
First Lien Initial Term Loan
09/28/2020 (b)

    10,847,723   
  9,788,916     

Silver II US Holdings, LLC
Refincing Term Loan
12/13/2019 (b)

    9,820,534   
  17,000,680     

Veyance Technologies, Inc.
Term Loan
09/08/2017 (b)

    17,088,318   
  3,000,000     

WTG Holdings III Corp.
First Lien Term Loan
12/11/2020 (b)

    3,019,995   
   

 

 

 
      60,172,030   
   

 

 

 
  MEDIA & TELECOMMUNICATIONS - 8.4%   
  6,301,667     

Aufinco Pty, Ltd.
Term Loan B
4.00%, 05/30/2020

    6,341,052   
  59,425,403     

Broadstripe LLC
First Lien Term Loan (c)(d)

    766,588   
  1,713,726     

Revolver (c)(d)

    22,107   
  7,012,516     

Cequel Communications, LLC
Term Loan
02/14/2019 (b)

    7,035,166   
  3,043,478     

Crown Castle Operating Co.
Term Loan B-2
01/29/2021 (b)

    3,056,093   
  7,720,579     

Cumulus Media Holdings, Inc.
Term Loan
12/12/2020 (b)

    7,778,484   

    Principal Amount ($)    

 

    Value ($)    

 
  MEDIA & TELECOMMUNICATIONS (continued)   
  2,945,251     

Endurance Business Media, Inc.
Term Loan
6.50%, 12/15/2014

    677,408   
  14,924,623     

Getty Images, Inc.
Initial Term Loan
4.75%, 10/18/2019

    13,961,239   
  10,290,721     

Integra Telecom Holdings, Inc.
Term Loan B
02/22/2019 (b)

    10,445,082   
  2,000,000     

Knowledgepoint360 Group LLC
Second Lien Term Loan
7.24%, 04/13/2015 (c)

    1,737,600   
  12,000,000     

Level 3 Financing Inc.
Tranche B Term Loan
01/15/2020 (b)

    12,110,040   
  5,500,000     

Tranche B-III Term Loan
4.00%, 08/01/2019

    5,540,673   
  5,000,000     

Media General Inc.
Term Loan B
07/31/2020 (b)

    5,059,400   
  8,088,795     

Nielsen Finance LLC
Dollar Term Loan E
05/02/2016 (b)

    8,123,172   
  22,500,000     

Tribune Co.
Initial Term Loan
12/27/2020 (b)

    22,412,137   
  7,223,000     

TWCC Holding Corp.
Second Lien Term Loan
7.00%, 06/26/2020

    7,439,726   
  15,241,732     

Univision Communications, Inc.
Incremental Term Loan
03/02/2020 (b)

    15,333,792   
  6,658,938     

Extended First Lien Term Loan
4.50%, 03/02/2020

    6,701,089   
   

 

 

 
      134,540,848   
   

 

 

 
  METALS & MINERALS - 1.4%   
  3,117,188     

Fairmount Minerals, Ltd.
Tranche B-2 Term Loan
5.00%, 09/05/2019

    3,171,738   
  6,816,033     

Walter Energy, Inc.
Term Loan A
04/01/2016 (b)

    6,758,097   
  13,000,000     

Term Loan B
04/02/2018 (b)

    12,775,165   
   

 

 

 
      22,705,000   
   

 

 

 
  RETAIL - 5.3%   
  11,970,000     

American Builders & Contractors Supply Co., Inc.
Term Loan B
3.50%, 04/16/2020

    12,011,536   
  3,606,637     

Bass Pro Group LLC
New Term Loan
3.75%, 11/20/2019

    3,632,929   
  5,681,871     

Burlington Coat Factory Warehouse Corp.
Term Loan B-2
02/23/2017 (b)

    5,742,241   
 

 

12       See accompanying Notes to Financial Statements.


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

December 31, 2013   Highland Floating Rate Opportunities Fund

 

    Principal Amount ($)    

 

    Value ($)    

 

 

U.S. Senior Loans (continued)

  

  RETAIL (continued)   
  17,765,590     

Guitar Center, Inc.
Extended Term Loan
04/10/2017 (b)

    17,376,968   
  2,390,010     

Harbor Freight Tools USA, Inc.
Initial Term Loan
4.75%, 07/26/2019

    2,421,965   
  22,648,769     

JC Penney Corp., Inc.
Term Loan
05/22/2018 (b)

    22,195,793   
  11,452,740     

Michaels Stores, Inc.
Term Loan B
01/28/2020 (b)

    11,513,554   
  10,000,000     

Neiman Marcus Group, Inc. (The)
Term Loan
10/26/2020 (b)

    10,139,600   
   

 

 

 
      85,034,586   
   

 

 

 
  SERVICE - 8.9%   
  4,605,567     

ADS Waste Holdings, Inc.
Tranche B Term Loan
3.25%, 10/09/2019

    4,637,230   
  7,587,929     

Advantage Sales & Marketing, Inc.
First Lien Term Loan
12/18/2017 (b)

    7,633,456   
  650,220     

Second Lien Term Loan
8.25%, 06/18/2018

    660,584   
  12,343,750     

AlixPartners LLP
First Lien Term Loan B-2
07/10/2020 (b)

    12,451,758   
  10,085,653     

Cenveo Corp.
Term Loan B
02/13/2017 (b)

    10,169,717   
  10,243,000     

Ceridian Corp.
Term Loan
4.41%, 05/09/2017

    10,300,617   
  7,722,960     

EnergySolutions LLC
Term Loan
7.25%, 08/12/2016

    7,819,497   
  12,523,155     

First Data Corp.
Dollar Term Loan
03/24/2017 (b)

    12,564,669   
  5,500,000     

Dollar Term Loan
03/23/2018 (b)

    5,517,930   
  1,000,000     

Term Loan
4.16%, 09/24/2018

    1,002,640   
  9,100,307     

Moneygram International, Inc.
Term Loan
03/27/2020 (b)

    9,202,686   
  5,940,000     

Sabre, Inc.
Term Loan B
5.25%, 02/19/2019

    5,993,846   
  9,664,504     

ServiceMaster Co. (The)
Tranche B Term Loan
01/31/2017 (b)

    9,619,226   
  13,202,910     

Spin Holdco, Inc.
First Lien Initial Term Loan
11/14/2019 (b)

    13,293,746   
  1,750,000     

Incremental Term Loan B
11/14/2019 (b)

    1,765,312   

    Principal Amount ($)    

 

    Value ($)    

 
  SERVICE (continued)   
  1,250,503     

TransUnion, LLC
Replacement Term Loan
02/28/2020 (b)

    1,259,882   
  1,039,361     

Travelport LLC
Tranche 2 Term Loan
4.00%, 12/21/2016

    1,061,448   
  683,905     

Tranche 1 Term Loan
9.50%, 01/29/2016

    709,767   
  11,940,000     

Term Loan
6.25%, 06/26/2019

    12,268,350   
  17,193,327     

Weight Watchers International, Inc.
Tranche B-2 Initial Term Loan
04/02/2020 (b)

    15,381,580   
   

 

 

 
      143,313,941   
   

 

 

 
  TRANSPORTATION - 2.0%   
  10,342,200     

Affinia Group, Inc.
Tranche B-2 Term Loan
4.75%, 04/27/2020

    10,497,333   
  7,960,000     

Allison Transmission, Inc.
Term Loan B-3
08/23/2019 (b)

    8,017,232   
  2,193,562     

Fram Group Holdings, Inc.
First Lien Term Loan
07/28/2017 (b)

    2,179,853   
  26,586     

JHT Holdings, Inc.
Second Lien Term Loan
7.75%, 04/24/2014 (c)

    22,928   
  8,630,644     

Pilot Travel Centers LLC
Tranche B Term Loan
3.75%, 03/30/2018

    8,660,247   
  2,977,387     

Tranche B Term Loan
4.25%, 08/07/2019

    2,996,011   
   

 

 

 
      32,373,604   
   

 

 

 
  UTILITY - 4.1%   
  246,827     

Calpine Corp.
Term Loan
4.00%, 04/02/2018

    248,964   
  512,821     

Delayed Draw Term Loan
4.00%, 10/30/2020

    517,079   
  2,739,726     

EFS Cogen Holdings I Inc.
Term Loan B
12/17/2020 (b)

    2,763,698   
  589,695     

Equipower Resources Holdings LLC
First Lien Term B Advance
4.25%, 12/21/2018

    593,012   
  8,938,634     

First Lien Term C Advance
12/31/2019 (b)

    8,987,797   
  13,000,000     

Texas Competitive Electric Holdings Co. LLC
Non Extended Term Loan
10/10/2014 (b)

    9,239,750   
  40,877,210     

Extended Term Loan
4.73%, 10/10/2017

    28,375,733   
  14,558,989     

Topaz Power Holdings LLC
Term Loan B Advance
02/26/2020 (b)

    14,568,089   
   

 

 

 
    65,294,122   
   

 

 

 
 

Total U.S. Senior Loans
(Cost $1,271,968,989)

    1,106,291,075   
   

 

 

 
 

 

See accompanying Notes to Financial Statements.       13


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland Floating Rate Opportunities Fund

 

    Principal Amount    

 

    Value ($)    

 

 

Foreign Denominated or Domiciled

  

 

Senior Loans (a) - 5.9%

  

  CANADA - 3.0%   
  USD   
  11,666,667     

Hudson’s Bay Co.
First Lien Initial Term Loan
11/04/2020 (b)

    11,873,050   
  375,000     

2nd Lien Initial Term Loan 8.25%, 11/04/2021

    388,594   
  10,479,452     

Husky Injection Molding Systems, Ltd.
New Term Loan
06/30/2018 (b)

    10,573,610   
  15,944,925     

Tervita Corp.
Term Loan
05/15/2018 (b)

    16,042,109   
  606,976     

Valeant Pharmaceuticals International, Inc.
Tranche B Term Loan E
08/05/2020 (b)

    611,972   
  2,962,500     

Tranche B Term Loan C-2
3.75%, 12/11/2019

    2,988,111   
  5,881,555     

Tranche B Term Loan E
4.50%, 08/05/2020

    5,929,960   
   

 

 

 
      48,407,406   
   

 

 

 
  CAYMAN ISLANDS - 0.2%   
  USD       
  3,488,325     

Edwards (Cayman Islands II), Ltd.
First Lien Initial Term Loan
5.50%, 03/26/2020

    3,497,586   
   

 

 

 
  FRANCE - 0.1%   
  EUR       
  1,269,011     

Vivarte
Acquisition/Capex Facility 1
2.59%, 03/08/2016

    1,508,196   
   

 

 

 
  GERMANY - 0.0%   
  EUR       
  334,902     

Schieder Mobel Holding GmbH
Delayed Draw Term Loan
0.00%, 07/20/2016 (c)

    336,233   
   

 

 

 
  GERMANY - 0.1%   
  USD       
  1,655,000     

Ina Beteiligungsgesellschaft Mit Beschrankter Haftung
Term Loan Facility C
4.25%, 01/27/2017

    1,671,889   
   

 

 

 
  IRELAND - 0.2%   
  USD       
  3,956,474     

SSI Investments II, Ltd.
New Term Loan
5.00%, 05/26/2017

    3,993,566   
   

 

 

 
  LUXEMBOURG - 0.4%   
  USD       
  3,394,609     

AI Chem & Cy SCA
Tranche B-1 Term Loan
4.50%, 10/03/2019

    3,430,694   

    Principal Amount    

 

    Value ($)    

 
  LUXEMBOURG (continued)   
  USD       
  1,761,300     

Tranche B-2 Term Loan
4.50%, 10/03/2019

    1,780,022   
  592,592     

Second Lien Term Loan
8.25%, 04/03/2020

    610,003   
   

 

 

 
      5,820,719   
   

 

 

 
  NETHERLANDS - 0.3%   
  USD       
  3,989,744     

NXP B.V.
Tranche A-1 Term Loan
1.00%, 03/04/2017 (b)

    4,051,585   
   

 

 

 
  NEW ZEALAND - 0.9%   
  USD       
  9,351,563     

Pacific Industrial Services US Finco LLC
Term Loan B
5.00%, 10/02/2018 (b)

    9,505,489   
  4,149,213     

Second Lien Initial Term Loan
8.75%, 04/02/2019

    4,252,943   
   

 

 

 
      13,758,432   
   

 

 

 
  UNITED KINGDOM - 0.0%   
  GBP       
  1,030,670     

Henson No. 4, Ltd.
Term Loan Facility C (c)(d)

    89,211   
  1,026,435     

Term Loan Facility B (c)(d)

    89,865   
   

 

 

 
      179,076   
   

 

 

 
  UNITED KINGDOM - 0.4%   
  USD       
  7,000,000     

Virgin Media Investment Holdings, Ltd.
Term Loan Facility B
3.50%, 06/08/2020

    7,024,500   
   

 

 

 
  UNITED STATES - 0.3%   
  GBP       
  2,637,656     

Knowledgepoint360 Group LLC
First Lien Term Loan
3.78%, 04/14/2014 (c)

    4,353,762   
   

 

 

 
 

Total Foreign Denominated or Domiciled Senior Loans
(Cost $97,909,435)

    94,602,950   
   

 

 

 

    Principal Amount ($)    

     

 

Collateralized Loan Obligations (e) - 7.2%

  

  2,000,000     

ABCLO, Ltd.
Series 2007-1A, Class C
2.09%, 04/15/2021 (f)

    1,884,400   
  3,000,000     

ACA CLO, Ltd.
Series 2007-1A, Class D
2.59%, 06/15/2022 (f)

    2,797,500   
  1,500,000     

ACAS CLO, Ltd.
Series 2007-1A, Class D
4.49%, 04/20/2021 (f)

    1,355,250   
  1,000,000     

Apidos CDO
Series 2007-5A, Class C
1.69%, 04/15/2021 (f)

    898,600   
  1,500,000     

Apidos CLO
Series 2013-12A, Class D
3.29%, 04/15/2025 (f)

    1,408,650   
 

 

14       See accompanying Notes to Financial Statements.


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland Floating Rate Opportunities Fund

 

    Principal Amount ($)    

 

    Value ($)    

 

 

Collateralized Loan Obligations (continued)

  

  1,000,000     

Series 2013-12A, Class F
5.14%, 04/15/2025 (f)

    870,100   
  1,000,000     

ARES XI CLO, Ltd.
Series 2007-11A, Class E
6.25%, 10/11/2021 (f)

    1,002,500   
  5,028,988     

ARES XII CLO, Ltd.
Series 2007-12A, Class E
5.99%, 11/25/2020 (f)

    4,932,934   
  2,000,000     

Babson CLO, Inc.
Series 2005-2A, Class C1
1.94%, 07/20/2019 (f)

    1,915,000   
  2,000,000     

Babson Mid-Market CLO, Inc.
Series 2007-2A, Class D
1.94%, 04/15/2021 (f)

    1,892,000   
  1,000,000     

Series 2007-2A, Class E
3.89%, 04/15/2021 (f)

    927,600   
  750,000     

BlueMountain CLO, Ltd.
Series 2013-2A, Class D
3.82%, 01/22/2025 (f)

    720,225   
  250,000     

Series 2013-2A, Class E
5.32%, 01/22/2025 (f)

    236,450   
  2,250,000     

Brentwood CLO Corp.
Series 2006-1A, Class B
1.06%, 02/01/2022 (f)

    1,992,375   
  1,410,000     

Callidus Debt Partners CLO Fund V, Ltd.
Series 5A, Class C
1.69%, 11/20/2020 (f)

    1,318,491   
  2,000,000     

Carlyle Global Market Strategies CLO
Series 2013-2A, Class D
4.00%, 04/18/2025 (f)

    1,942,600   
  3,000,000     

Carlyle High Yield Partners X, Ltd.
3.44%, 04/19/2022 (f)

    2,700,000   
  1,700,000     

Catamaran CLO, Ltd.
Series 2013-1A, Class E
5.28%, 01/27/2025 (f)

    1,580,150   
  1,500,000     

Series 2012-1A, Class E
5.50%, 12/20/2023 (f)

    1,417,500   
  750,000     

Series 2013-1A, Class F
5.97%, 01/27/2025 (f)

    670,875   
  1,000,000     

Cent CDO, Ltd.
Series 2007-14A, Class D
1.54%, 04/15/2021 (f)

    883,800   
  3,000,000     

Series 2007-15A, Class C
2.49%, 03/11/2021 (f)

    2,760,300   
  1,500,000     

CIFC Funding, Ltd.
Series 2006-1BA, Class B1L
1.85%, 12/22/2020 (f)

    1,433,250   
  2,000,000     

ColumbusNova CLO, Ltd.
Series 2007-1A, Class D
1.59%, 05/16/2019 (f)

    1,832,600   
  742,733     

CSAM Funding II
Series 2A, Class B1
7.05%, 10/15/2016

    747,189   
  1,500,000     

Diamond Lake CLO, Ltd.
Series 2006-1A, Class B2L
4.24%, 12/01/2019 (f)

    1,422,450   
  1,000,000     

Dryden Senior Loan Fund
Series 2012-25A, Class E
5.74%, 01/15/2025 (f)

    977,500   

    Principal Amount ($)    

 

    Value ($)    

 
  2,500,000     

Duane Street CLO II, Ltd.
Series 2006-2A, Class E
3.99%, 08/20/2018 (f)

    2,398,250   
  3,000,000     

Eastland CLO, Ltd.
Series 2007-1A, Class C
1.74%, 05/01/2022 (f)

    2,580,000   
  1,000,000     

Eaton Vance CDO IX, Ltd.
Series 2007-9A, Class D
1.74%, 04/20/2019 (f)

    947,500   
  4,000,000     

Flagship CLO
Series 2013-7A, Class D
3.99%, 01/20/2026 (b)(f)

    3,854,400   
  2,000,000     

Series 2013-7A, Class E
4.99%, 01/20/2026 (b)(f)

    1,809,000   
  3,000,000     

Fraser Sullivan CLO II, Ltd.
Series 2006-2A, Class D
1.75%, 12/20/2020 (f)

    2,859,300   
  2,500,000     

Series 2006-2A, Class E
3.75%, 12/20/2020 (f)

    2,337,000   
  4,275,000     

Gannett Peak CLO, Ltd.
Series 2006-1A, Class B1
0.94%, 10/27/2020 (f)

    4,125,375   
  750,000     

Series 2006-1A, Class C
1.76%, 10/27/2020 (f)

    717,000   
  2,000,000     

Series 2006-1A, Class D1
3.79%, 10/27/2020 (f)

    1,925,000   
  1,695,322     

Goldman Sachs Asset Management CLO PLC
Series 2007-1A, Class E
5.24%, 08/01/2022 (f)

    1,661,415   
  1,000,000     

Grayson CLO, Ltd.
Series 2006-1A, Class B
0.94%, 11/01/2021 (f)

    889,000   
  3,000,000     

Greenbriar CLO, Ltd.
Series 2007-1A, Class C
1.99%, 11/01/2021 (f)

    2,725,200   
  814,466     

Greywolf CLO, Ltd.
Series 2007-1A, Class E
4.19%, 02/18/2021 (f)

    773,743   
  1,250,000     

Series 2013-1A, Class E
5.29%, 04/15/2025 (f)

    1,108,875   
  1,000,000     

Gulf Stream - Sextant CLO, Ltd.
Series 2006-1A, Class D
1.84%, 08/21/2020 (f)

    963,800   
  1,315,000     

Halcyon Loan Investors CLO I, Inc.
Series 2006-1A, Class C
1.69%, 11/20/2020 (f)

    1,221,372   
  1,500,000     

Series 2006-1A, Class D
3.74%, 11/20/2020 (f)

    1,398,750   
  1,250,000     

HarbourView CLO
Series 6A, Class D
3.95%, 12/27/2019 (f)

    1,168,750   
  1,004,938     

Hewett’s Island CDO, Ltd.
Series 2007-1RA, Class E
6.99%, 11/12/2019 (f)

    994,889   
  1,683,283     

Hillmark Funding
Series 2006-1A, Class D
3.84%, 05/21/2021 (f)

    1,503,172   
  1,000,000     

ING Investment Management
Series 2006-3A, Class C
1.70%, 12/13/2020 (f)

    949,000   
 

 

See accompanying Notes to Financial Statements.       15


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland Floating Rate Opportunities Fund

 

    Principal Amount ($)    

 

    Value ($)    

 

 

Collateralized Loan Obligations (continued)

  

  1,000,000     

Inwood Park CDO, Ltd.
Series 2006-1A, Class E
3.74%, 01/20/2021 (f)

    914,700   
  1,000,000     

Jersey Street CLO, Ltd.
Series 2006-1A, Class D
1.79%, 10/20/2018 (f)

    944,800   
  2,500,000     

Katonah CLO, Ltd.
Series 2006-9A, Class B1L
1.64%, 01/25/2019 (f)

    2,325,000   
  636,115     

Series 7A, Class D
2.09%, 11/15/2017 (f)

    609,080   
  1,000,000     

Landmark CDO, Ltd.
Series 2007-9A, Class E
3.74%, 04/15/2021 (f)

    915,000   
  918,075     

Mountain Capital Clo VI, Ltd.
Series 2007-6A, Class E
3.54%, 04/25/2019 (f)

    832,052   
  835,038     

Navigator CDO, Ltd.
Series 2006-2A, Class D
3.75%, 09/20/2020 (f)

    781,846   
  3,000,000     

Newmark Capital Funding CLO, Ltd.
Series 2013-1A, Class E
4.89%, 06/02/2025 (f)

    2,670,000   
  1,000,000     

OHA Credit Partners, Ltd.
Series 2012-7A, Class D
4.24%, 11/20/2023 (f)

    990,800   
  1,000,000     

Palmer Square CLO, Ltd.
Series 2013-2A, Class C
3.88%, 10/17/2025 (f)

    952,000   
  1,000,000     

Series 2013-1A, Class C
4.29%, 05/15/2025 (f)

    994,300   
  1,500,000     

Series 2013-2A, Class D
5.60%, 10/17/2025 (f)

    1,420,800   
  1,500,000     

Rockwall CDO, Ltd.
Series 2006-1A, Class A1LB
0.74%, 08/01/2021 (f)

    1,387,500   
  3,422,643     

San Gabriel CLO, Ltd.
Series 2007-1A, Class B2L
4.49%, 09/10/2021 (f)

    3,260,067   
  3,000,000     

Stanfield Azure CLO, Ltd.
Series 2006-1A, Class B1L
1.94%, 05/27/2020 (f)

    2,898,300   
  2,000,000     

Stanfield Daytona CLO, Ltd.
Series 2007-1A, Class B1L
1.59%, 04/27/2021 (f)

    1,851,600   
  3,000,000     

Stanfield McLaren CLO Delaware Corp.
Series 2007-1A, Class B1L
2.64%, 02/27/2021 (f)

    2,755,200   
  4,000,000     

Stone Tower CLO VI, Ltd.
Series 2007-6A, Class D
3.84%, 04/17/2021 (f)

    3,685,200   
  750,000     

Venture V CDO, Ltd.
Series 2005-1A, Class D
4.89%, 11/22/2018 (f)

    716,250   
  3,500,000     

Vibrant CLO, Ltd. 2012-1
Series 2012-1A, Class D
5.74%, 07/17/2024 (f)

    3,338,300   
   

 

 

 
 

Total Collateralized Loan Obligations
(Cost $108,082,387)

    115,673,875   
   

 

 

 

    Principal Amount ($)    

 

    Value ($)    

 

 

Corporate Bonds & Notes - 3.4%

  

  BROADCASTING - 0.0%   
  500,000     

Clear Channel Communications, Inc.
9.00%, 12/15/2019 (g)

    512,500   
   

 

 

 
  CHEMICALS - 0.4%  
  6,500,000     

TPC Group, Inc.
8.75%, 12/15/2020 (e)

    6,938,750   
   

 

 

 
  ENERGY - 0.3%  
  1,000,000     

Arch Coal, Inc.
8.00%, 01/15/2019 (e)(g)

    1,000,000   
  3,000,000     

Venoco, Inc.
8.88%, 02/15/2019

    2,970,000   
   

 

 

 
      3,970,000   
   

 

 

 
  FOOD & DRUG - 0.1%  
  2,000,000     

SUPERVALU, Inc.
6.75%, 06/01/2021 (g)

    1,985,000   
   

 

 

 
  GAMING & LEISURE - 0.3%  
  5,000,000     

Caesars Entertainment Operating Co., Inc.
11.25%, 06/01/2017

    5,100,000   
   

 

 

 
  INFORMATION TECHNOLOGY - 0.3%  
  4,571,000     

Avaya, Inc.
10.50%, 03/01/2021 (e)(g)

    4,388,160   
   

 

 

 
  MEDIA & TELECOMMUNICATIONS - 0.1%  
  2,000,000     

Univision Communications, Inc.
6.75%, 09/15/2022 (e)(g)

    2,200,000   
   

 

 

 
  SERVICE - 0.7%  
  2,000,000     

Cenveo Corp.
8.88%, 02/01/2018

    2,010,000   
  3,500,000     

Sabre, Inc.
8.50%, 05/15/2019 (e)

    3,898,125   
  4,660,000     

ServiceMaster Co.
8.00%, 02/15/2020 (g)

    4,776,500   
  581,628     

Travelport LLC PIK
13.88%, 03/01/2016 (e)

    619,434   
   

 

 

 
      11,304,059   
   

 

 

 
  UTILITY - 1.2%   
  17,000,000     

Edison Mission Energy (d)

    12,962,500   
  8,000,000     

Texas Competitive Electric Holdings Co. LLC
11.50%, 10/01/2020 (e)

    5,920,000   
   

 

 

 
      18,882,500   
   

 

 

 
 

Total Corporate Bonds & Notes
(Cost $54,295,146)

    55,280,969   
   

 

 

 

    Principal Amount    

     

 

Foreign Corporate Bonds & Notes - 1.0%

  

  CANADA - 0.2%   
  USD       
  3,207,000     

Tervita Corp.
8.00%, 11/15/2018 (e)

    3,327,263   
   

 

 

 
 

 

16       See accompanying Notes to Financial Statements.


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland Floating Rate Opportunities Fund

 

    Principal Amount    

 

    Value ($)    

 

 

Foreign Corporate Bonds & Notes (continued)

  

  FINLAND - 0.4%   
  USD       
  6,000,000     

Nokia OYJ
5.38%, 05/15/2019 (g)

    6,255,000   
   

 

 

 
  UNITED KINGDOM - 0.4%   
  USD       
  5,325,000     

Ineos Finance PLC
8.38%, 02/15/2019 (e)(g)

    5,944,031   
   

 

 

 
 

Total Foreign Corporate Bonds & Notes
(Cost $14,593,580)

    15,526,294   
   

 

 

 

    Shares    

     

 

Claims (h)(i) - 0.1%

  

  TELECOMMUNICATIONS - 0.1%   
  3,414,269     

Wind Telecomunicazione SpA Trade Claim Facility 3692

    1,143,780   
   

 

 

 
 

Total Claims
(Cost $2,497,729)

    1,143,780   
   

 

 

 

 

Common Stocks & Exchange-Traded Funds - 11.0%

  

  BROADCASTING - 0.1%   
  304,726     

Communications Corp. of America (c)(i)

    2,437,808   
   

 

 

 
  ENERGY - 0.1%   
  1,118,286     

Value Creation, Inc. (i)

    1,677,429   
   

 

 

 
  GAMING & LEISURE - 0.0%   
  44     

LLV Holdco LLC - Litigation Trust Units (c)(i)(j)

      
  34,512     

LLV Holdco LLC—Series A, Membership Interest (c)(i)(j)

      
  436     

LLV Holdco LLC—Series B, Membership Interest (c)(i)(j)

      
   

 

 

 
        
   

 

 

 
  HEALTHCARE - 0.8%   
  207,031     

CCS Medical, Inc. (c)(i)(j)

    12,465,336   
   

 

 

 
  HOUSING - 0.4%   
  1,648,350     

CCD Equity Partners LLC (c)(i)(j)

    5,043,951   
  5,000,000     

KAG Property LLC (i)

    975,000   
  880,996     

Las Vegas Land Holdings LLC (i)

    264,299   
  8     

Nevada Land Group LLC (c)(i)(j)

      
   

 

 

 
      6,283,250   
   

 

 

 
  MEDIA & TELECOMMUNICATIONS - 7.4%   
  4,921     

Endurance Business Media, Inc., Class A (c)(i)(j)

      
  3,776,559     

Media General, Inc. (i)

    85,350,233   
  501,736     

Metro-Goldwyn-Mayer, Inc., Class A (i)

    33,741,746   
   

 

 

 
      119,091,979   
   

 

 

 
  OTHER - 1.4%   
  1,150,000     

Highland/iBoxx Senior Loan, ETF (g)(j)

    22,919,500   
   

 

 

 

    Shares    

 

    Value ($)    

 
  REAL ESTATE INVESTMENT TRUST - 0.7%   
  1,101,402     

Spirit Realty Capital, Inc., REIT (g)

    10,826,782   
   

 

 

 
  TELECOMMUNICATIONS - 0.1%   
  180,540     

Fairpoint Communications, Inc. (i)

    2,041,911   
   

 

 

 
  TRANSPORTATION - 0.0%   
  2,023     

JHT Holdings, Inc. (c)(i)

      
   

 

 

 
  UTILITY - 0.0%   
  286,159     

Entegra TC LLC (i)

    28,616   
   

 

 

 
 

Total Common Stocks & Exchange-Traded Funds
(Cost $394,740,813)

    177,772,611   
   

 

 

 

 

Preferred Stocks (c)(i) - 0.0%

  

  REAL ESTATE - 0.0%   
  105,366     

Allenby

      
  142,367     

Claymore

      
   

 

 

 
 

Total Preferred Stocks
(Cost $247,732)

      
   

 

 

 

    Units    

     

 

Rights (i) - 0.7%

  

  TRANSPORTATION - 0.7%   
  402,947     

AAL, expires 04/11/14

    10,488,715   
   

 

 

 
 

Total Rights
(Cost $7,080,843)

    10,488,715   
   

 

 

 

 

Warrants (c)(i) - 0.0%

  

  GAMING & LEISURE - 0.0%   
  1,834     

LLV Holdco LLC - Series C, Membership Interest, expires 07/15/15

      
  2,522     

LLV Holdco LLC - Series D, Membership Interest, expires 07/15/15

      
  2,819     

LLV Holdco LLC - Series E, Membership Interest, expires 07/15/15

      
  3,172     

LLV Holdco LLC - Series F, Membership Interest, expires 07/15/15

      
  3,594     

LLV Holdco LLC - Series G, Membership Interest, expires 07/15/15

      
   

 

 

 
      
   

 

 

 
 

Total Warrants
(Cost $—)

      
   

 

 

 

    Shares    

     

 

Investment Companies (k) - 1.5%

  

  24,801,660     

State Street Navigator Prime Securities Lending Portfolio

    24,801,660   
   

 

 

 
 

Total Investment Companies
(Cost $24,801,660)

    24,801,660   
   

 

 

 

 

Total Investments - 99.5%

    1,601,581,929   
   

 

 

 

 


(Cost $1,976,218,314) (l)


  


 

 

See accompanying Notes to Financial Statements.       17


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland Floating Rate Opportunities Fund

 

    Shares    

 

    Value ($)    

 

 

Securities Sold Short (m) - (2.6)%

  

 

Common Stocks & Exchange-Traded Funds - (2.6)%

  

  MEDIA & TELECOMMUNICATIONS - (2.6)%   
  496,763     

LIN Media LLC, Class A (n)

    (14,262,066
  375,936     

Sinclair Broadcast Group, Inc., Class A

    (13,432,193
  495,997     

Gannett Co., Inc.

    (14,671,591
   

 

 

 
 

Total Media & Telecommunications
(Proceeds $38,036,395)

    (42,365,850
   

 

 

 
 

Total Common Stocks & Exchange-Traded Funds
(Proceeds $38,036,395)

    (42,365,850
   

 

 

 
 

Total Securities Sold Short
(Proceeds $38,036,395)

    (42,365,850
   

 

 

 

 

Other Assets & Liabilities, Net - 3.1%

    50,458,385   
   

 

 

 

 

Net Assets - 100.0%

    1,609,674,464   
   

 

 

 

 

(a) Senior loans (also called bank loans, leveraged loans, or floating rate loans) in which the Fund invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread (unless otherwise identified, all senior loans carry a variable rate of interest). These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by one or more European banks such as the London Interbank Offered Rate (“LIBOR”) or (iii) the Certificate of Deposit rate. Rate shown represents the weighted average rate at December 31, 2013. Senior loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturity shown.
(b) All or a portion of this position has not settled. Full contract rates do not take effect until settlement date.
(c) Represents fair value as determined by the Fund’s Board of Trustees (the “Board”), or its designee in good faith, pursuant to the policies and procedures approved by the Board. Securities with a total aggregate value of $43,084,680, or 2.7% of net assets, were fair valued under the Fund’s valuation procedures as of December 31, 2013.
(d) The issuer is, or is in danger of being, in default of its payment obligation. Income is not being accrued.
(e) Securities exempt from registration under Rule 144A of the 1933 Act. These securities may only be resold in transaction exempt from registration to qualified institutional buyers. At December 31, 2013, these securities amounted to $149,909,638 or 9.3% of net assets.
(f) Variable or floating rate security. The interest rate shown reflects the rate in effect December 31, 2013.
(g) Securities (or a portion of securities) on loan. As of December 31, 2013, the market value of securities loaned was $24,286,219. The loaned securities were secured with cash collateral of $24,801,660. Collateral is calculated based on prior day’s prices. See Note 4.
(h) These positions represent claims that have been filed with the United State Bankruptcy Court Southern District of New York against Lehman Commercial Paper, Inc. UK Branch.
(i) Non-income producing security.
(j) Affiliated issuer. Assets with a total aggregate market value of $40,428,787, or 2.5% of net assets, were affiliated with the Fund as of December 31, 2013.
(k) Represents investments of cash collateral received in connection with securities lending.
(l) Cost for U.S. federal income tax purposes is $1,976,218,314.
(m) As of December 31, 2013, $58,983,363 in cash was segregated or on deposit with the brokers to cover investments sold short and is included in “Other Assets & Liabilities, Net.”
(n) No dividend payable on security sold short.

Currency Abbreviations:

EUR   Euro Currency
GBP   British Pound

Glossary:

CDO   Collateralized Debt Obligation
CLO   Collateralized Loan Obligation
CSF   Credit Suisse First Boston
ETF   Exchange-Traded Fund
PIK   Payment-in-Kind
PLC   Public Limited Company
PNC   PNC Capital Markets LLC
REIT   Real Estate Investment Trust

Forward foreign currency exchange contracts outstanding as of December 31, 2013 were as follows:

 

Contracts
to Buy or
to Sell
  Currency     Counter-
party
    Principal
Amount
Covered
by
Contracts
    Expiration     Unrealized
Appreciation/
(Depreciation)
 

Sell

    EUR        PNC        1,485,000        01/31/2014      $ (77,341

Buy

    GBP        PNC        600,000        01/31/2014        28,951   

Sell

    GBP        CSF        3,420,000        01/31/2014        (417,961
         

 

 

 
          $ (466,351
         

 

 

 
 

 

18       See accompanying Notes to Financial Statements.


Table of Contents

STATEMENTS OF ASSETS AND LIABILITIES

 

 

 

As of December 31, 2013 (unaudited)   Highland Funds I

 

 

       Highland
Long/Short
Equity
Fund
($)
       Highland
Long/Short
Healthcare
Fund
($)
       Highland
Floating Rate
Opportunities
Fund
($)
 

Assets

              

Unaffiliated investments, at value  (a)

       1,035,022,241           58,453,906           1,561,153,142   

Affiliated investments, at value (Note 11)

       9,579,434                     40,428,787   
    

 

 

      

 

 

      

 

 

 

Total Investments, at value

       1,044,601,675           58,453,906           1,601,581,929   

Cash

       108,620,650           9,700,694           355,232,844   

Restricted Cash—Futures (Note 3)

       3,589,750                       

Restricted Cash—Securities Sold Short (Note 2)

       154,731,920           21,038,845           58,983,363   

Foreign currency

       15,152,141           567,569           173,905   

Unrealized appreciation on forward foreign currency exchange contracts

                           28,951   

Receivable for:

              

Investments sold

       23,458,730           6,785,982           6,756,285   

Dividend and interest

       592,168           77,062           7,945,980   

Fund shares sold

       10,925,409           1,428,615           7,616,409   

Prepaid expenses and other assets

       181,125           112,301           457,563   

Prepaid litigation fee

                           322,188   
    

 

 

      

 

 

      

 

 

 

Total assets

       1,361,853,568           98,164,974           2,039,099,417   
    

 

 

      

 

 

      

 

 

 

Liabilities

              

Securities sold short, at value (Note 2 and 9)

       239,425,243           21,322,736           42,365,850   

Written options contracts, at value (Note 3 and 9)

       753,600                       

Unrealized depreciation on forward foreign currency exchange contracts

                           495,302   

Payable for:

              

Upon receipt of securities loaned (Note 4)

       68,431,932           9,908,413           24,801,660   

Distributions to shareholders

       283,179           11,557           1,249,816   

Investments purchased

       20,753,038           5,440,771           354,522,772   

Fund shares redeemed

       833,610           977,058           4,647,769   

Variation margin

       170,410                       

Investment advisory and administration fees (Note 7)

       939,217           59,471           1,015,119   

Trustees’ fees

       28,897           1,078           19,672   

Distribution and shareholder service fees (Note 7)

       6,014           1,059           30,085   

Transfer agent fees

       356,102           8,187           120,882   

Commitment fee payable (Note 6)

       1,444           52             

Accrued expenses and other liabilities

       19,902           44,736           156,026   
    

 

 

      

 

 

      

 

 

 

Total liabilities

       332,002,588           37,775,118           429,424,953   
    

 

 

      

 

 

      

 

 

 

Net Assets

       1,029,850,980           60,389,856           1,609,674,464   
    

 

 

      

 

 

      

 

 

 

 

See accompanying Notes to Financial Statements.       19


Table of Contents

STATEMENTS OF ASSETS AND LIABILITIES (continued)

 

 

 

As of December 31, 2013 (unaudited)   Highland Funds I

 

       Highland
Long/Short
Equity
Fund
($)
       Highland
Long/Short
Healthcare
Fund
($)
       Highland
Floating Rate
Opportunities
Fund
($)
 

Net Assets Consist of:

              

Par value (Note 1)

       82,829           4,544           196,992   

Paid-in capital

       930,514,238           60,168,151           2,901,667,979 (c)  

Accumulated net investment loss

       (5,988,953        (765,970        (28,539,270 ) (c)  

Accumulated net realized gain (loss) from investments, securities sold short, written options, futures contracts and foreign currency transactions

       12,679,025           (5,132,505        (884,222,548 ) (c)  

Net unrealized appreciation (depreciation) on investments, securities sold short, written options, futures contracts and foreign currency translations

       92,563,841           6,115,636           (379,428,689
    

 

 

      

 

 

      

 

 

 

Net Assets

       1,029,850,980           60,389,856           1,609,674,464   
    

 

 

      

 

 

      

 

 

 

Investments, at cost

       928,935,401           51,152,691           1,634,446,897   

Affiliated investments, at cost

       9,617,887                     341,771,417   

Foreign currency, at cost

       14,996,535           564,697           170,185   

Proceeds from securities sold short

       227,703,048           20,134,594           38,036,395   

Written option premiums received

       538,270                       

(a) Includes market value of securities on loan

       67,673,953           9,744,486           24,286,219   

(b) See Note 5.

              

Class A:

  

    

Net assets

       171,763,558           22,436,600           642,583,913   

Shares outstanding ($0.001 par value; unlimited shares authorized)

       14,051,623           1,690,580           78,611,925   

Net asset value per share

       12.22 (a)          13.27 (a)          8.17 (a)  

Maximum offering price per share

       12.93 (b)          14.04 (b)          8.47 (b)  

Class B:

              

Net assets

                           135,443   

Shares outstanding ($0.001 par value; unlimited shares authorized)

                           16,589   

Net asset value and offering price per share

                           8.16 (a)  

Class C:

              

Net assets

       51,134,824           11,859,951           381,511,274   

Shares outstanding ($0.001 par value; unlimited shares authorized)

       4,372,664           925,978           46,681,473   

Net asset value and offering price per share

       11.69 (a)          12.81 (a)          8.17 (a)  

Class Z

              

Net assets

       806,952,598           26,093,305           585,443,834   

Shares outstanding ($0.001 par value; unlimited authorization)

       64,404,297           1,927,528           71,681,923   

Net asset value, offering and redemption price per share

       12.53           13.54           8.17   

 

 

(a)

Redemption price per share is equal to net asset value per share less any applicable contingent deferred sales charge (“CDSC”).

(b)

On sales of $1,000,000 or more, there is no sales charge and therefore the offering price will be lower.

(c)

See Note 5.

 

20       See accompanying Notes to Financial Statements.


Table of Contents

STATEMENTS OF OPERATIONS

 

 

 

For the six months ended December 31, 2013 (unaudited)   Highland Funds I

 

 

     Highland
Long/Short
Equity
Fund
($)
     Highland
Long/Short
Healthcare
Fund
($)
     Highland
Floating Rate
Opportunities
Fund
($)
 

Investment Income

        

Income:

        

Dividends from unaffiliated issuers

     3,996,343         99,150         363,812   

Dividends from affiliated issuers (Note11)

     393,880                 610,482   

Less: Foreign taxes withheld

     (188                

Interest from unaffiliated issuers

             8,600         21,194,006   

Securities lending income (Note 4)

     104,724         68,264         27,672   

Other income

             7,035         383,820   
  

 

 

    

 

 

    

 

 

 

Total Income

     4,494,759         183,049         22,579,792   
  

 

 

    

 

 

    

 

 

 

Expenses:

        

Investment advisory and administration fees (Note 7)

     11,913,448         239,283         4,694,585   

Distribution and shareholder service fees: (Note 7)

        

Class A

     278,197         25,704         753,995   

Class B

                     509   

Class C

     241,671         33,888         1,528,865   

Transfer agent fees

     552,373         14,056         279,646   

Trustees’ fees (Note 7)

     71,570         2,489         61,021   

Accounting services fees

     160,170         44,543         96,627   

Audit fees

     84,211         6,391         68,392   

Legal fees

     333,074         16,673         266,626   

Registration fees

     51,370                 17,995   

Insurance

     111,034         4,690         97,853   

Reports to shareholders

     108,959         6,412         71,497   

Commitment fees-credit agreement (Note 6)

     5,480         195         191,708   

Dividends and fees on securities sold short (Note 2)

     2,595,065         223,700         137,247   

Other

     212,697         26,279         26,063   
  

 

 

    

 

 

    

 

 

 

Total operating expenses before waiver and reimbursement

     16,719,319         644,303         8,292,629   

Less: Expenses waived or borne by the Adviser (Note 7)

     (6,235,607              (584,315
  

 

 

    

 

 

    

 

 

 

Net operating expenses

     10,483,712         644,303         7,708,314   
  

 

 

    

 

 

    

 

 

 

Net investment income (loss)

     (5,988,953      (461,254      14,871,478   
  

 

 

    

 

 

    

 

 

 

Net Realized and Unrealized Gain (Loss) on Investments

        

Realized gain (loss) on:

        

Investments from unaffiliated issuers

     117,199,749         8,030,180         (1,250,851

Investments from affiliated issuers

     (7,398                

Securities sold short (Note 2)

     (27,731,620      (1,634,537        

Written options contracts (Note 3)

     (5,126,548      (1,333,816        

Futures contracts (Note 3)

     (674,315                

Foreign currency related transactions

     (103,141      16,730         265,715   

Change in unrealized appreciation (depreciation) on:

        

Investments

     81,364,806         3,488,892         73,267,460   

Securities sold short (Note 2)

     (14,381,552      (1,039,645      (4,329,455

Written options contracts (Note 3)

     (281,320      (28,623        

Futures contracts (Note 3)

     (1,701,153                

Foreign currency related translations

     154,132         2,692         (846,394
  

 

 

    

 

 

    

 

 

 

Net realized and unrealized gain on investments

     148,711,640         7,501,873         67,106,475   
  

 

 

    

 

 

    

 

 

 

Total increase in net assets resulting from operations

     142,722,687         7,040,619         81,977,953   
  

 

 

    

 

 

    

 

 

 

 

See accompanying Notes to Financial Statements.       21


Table of Contents

STATEMENTS OF CHANGES IN NET ASSETS

 

 

 

  Highland Funds I

 

 

     Highland Long/Short
Equity Fund
 
     Six Months Ended
December 31,  2013
(unaudited)
($)
     Year Ended
June 30, 2013
($)
 

Increase (Decrease) in Net Assets

     

Operations:

     

Net investment loss

     (5,988,953      (10,073,645

Net realized gain on investments, securities sold short, written options contracts, futures contracts and foreign currency related transactions

     83,556,727         36,916,291   

Net increase in unrealized appreciation (depreciation) on investments, securities sold short, written options contracts, futures contracts and foreign currency related translations

     65,154,913         3,098,751   
  

 

 

    

 

 

 

Net increase from operations

     142,722,687         29,941,397   
  

 

 

    

 

 

 

Distributions to shareholders from:

     

Net realized gains

     

Class A

     (12,186,421      (6,734,680

Class C

     (3,835,029      (1,461,758

Class Z

     (57,915,273      (15,891,663
  

 

 

    

 

 

 

Total distributions

     (73,936,723      (24,088,101
  

 

 

    

 

 

 

Share transactions:

     

Proceeds from sale of shares

     

Class A

     55,401,028         113,098,248   

Class C

     7,652,581         9,352,984   

Class Z

     153,195,286         484,118,868   

Value of distributions reinvested

     

Class A

     10,380,103         4,101,890   

Class C

     2,516,828         884,764   

Class Z

     35,127,021         9,195,206   

Cost of shares redeemed

     

Class A

     (46,206,738      (242,284,369

Class C

     (8,058,278      (21,854,014

Class Z

     (128,945,428      (205,639,005

Redemption fees (Note 8)

     21,571         74,812   
  

 

 

    

 

 

 

Net increase from share transactions

     81,083,974         151,049,384   
  

 

 

    

 

 

 

Total increase in net assets

     149,869,938         156,902,680   
  

 

 

    

 

 

 

Net Assets

     

Beginning of period

     879,981,042         723,078,362   
  

 

 

    

 

 

 

End of period

     1,029,850,980         879,981,042   
  

 

 

    

 

 

 

Accumulated net investment loss

     (5,988,953        
  

 

 

    

 

 

 

 

22       See accompanying Notes to Financial Statements.


Table of Contents

STATEMENTS OF CHANGES IN NET ASSETS (continued)

 

 

 

  Highland Funds I

 

 

     Highland Long/Short
Equity Fund
 
     Six Months Ended
December 31, 2013
(unaudited)
($)
     Year Ended
June 30, 2013
($)
 

CAPITAL STOCK ACTIVITY - SHARES

     

Class A:

     

Shares sold

     4,491,734         10,026,831   

Issued for distributions reinvested

     863,568         376,666   

Shares redeemed

     (3,736,509      (21,484,575
  

 

 

    

 

 

 

Net increase (decrease) in fund shares

     1,618,793         (11,081,078
  

 

 

    

 

 

 

Class C:

     

Shares sold

     641,873         857,610   

Issued for distributions reinvested

     218,855         84,023   

Shares redeemed

     (682,838      (2,008,135
  

 

 

    

 

 

 

Net increase (decrease) in fund shares

     177,890         (1,066,502
  

 

 

    

 

 

 

Class Z

     

Shares sold

     12,202,476         41,975,607   

Issued for distributions reinvested

     2,851,219         828,397   

Shares redeemed

     (10,302,362      (17,917,404
  

 

 

    

 

 

 

Net increase in fund shares

     4,751,333         24,886,600   
  

 

 

    

 

 

 

 

See accompanying Notes to Financial Statements.       23


Table of Contents

STATEMENTS OF CHANGES IN NET ASSETS (continued)

 

 

 

  Highland Funds I

 

     Highland Long/Short
Healthcare Fund
 
     Six Months Ended
December 31, 2013
(unaudited)
($)
     Year Ended
June 30, 2013
($)
 

Increase (Decrease) in Net Assets

     

Operations:

     

Net investment loss

     (461,254      (961,333

Net realized gain (loss) on investments, securities sold short, written options contracts and foreign currency related transactions

     5,078,557         (518,118

Net increase in unrealized appreciation (depreciation) on investments, securities sold short, written options contracts and foreign currency related translations

     2,423,316         796,101   
  

 

 

    

 

 

 

Net increase (decrease) from operations

     7,040,619         (683,350
  

 

 

    

 

 

 

Share transactions:

     

Proceeds from sale of shares

     

Class A

     11,441,656         5,604,225   

Class C

     6,148,947         701,692   

Class Z

     12,173,891         4,412,515   

Cost of shares redeemed

     

Class A

     (3,209,023      (23,020,947

Class C

     (929,736      (4,251,333

Class Z

     (3,189,962      (5,113,810

Redemption fees (Note 8)

     62         12,549   
  

 

 

    

 

 

 

Net increase (decrease) from share transactions

     22,435,835         (21,655,109
  

 

 

    

 

 

 

Total increase (decrease) in net assets

     29,476,454         (22,338,459
  

 

 

    

 

 

 

Net Assets

     

Beginning of period

     30,913,402         53,251,861   
  

 

 

    

 

 

 

End of period

     60,389,856         30,913,402   
  

 

 

    

 

 

 

Accumulated net investment loss

     (765,970      (304,716
  

 

 

    

 

 

 

 

24       See accompanying Notes to Financial Statements.


Table of Contents

STATEMENTS OF CHANGES IN NET ASSETS (continued)

 

 

 

  Highland Funds I

 

     Highland Long/Short
Healthcare Fund
 
     Six Months Ended
December 31, 2013
(unaudited)
($)
     Year Ended
June 30, 2013
($)
 

CAPITAL STOCK ACTIVITY - SHARES

     

Class A:

     

Shares sold

     896,232         534,383   

Shares redeemed

     (262,291      (2,224,834
  

 

 

    

 

 

 

Net increase (decrease) in fund shares

     633,941         (1,690,451
  

 

 

    

 

 

 

Class C:

     

Shares sold

     493,406         66,897   

Shares redeemed

     (78,831      (422,264
  

 

 

    

 

 

 

Net increase (decrease) in fund shares

     414,575         (355,367
  

 

 

    

 

 

 

Class Z

     

Shares sold

     944,927         424,605   

Shares redeemed

     (246,656      (484,200
  

 

 

    

 

 

 

Net increase (decrease) in fund shares

     698,271         (59,595
  

 

 

    

 

 

 

 

See accompanying Notes to Financial Statements.       25


Table of Contents

STATEMENTS OF CHANGES IN NET ASSETS (continued)

 

 

 

  Highland Funds I

 

 

     Highland Floating
Rate Opportunities Fund
 
     Six Months Ended
December 31, 2013
(unaudited)
($)
     Year Ended
June 30, 2013
($)
 

Increase (Decrease) in Net Assets

  

Operations:

     

Net investment income

     14,871,478         21,277,495   

Net realized loss on investments and foreign currency related transactions

     (985,136      (26,386,322

Net increase in unrealized appreciation (depreciation) on investments, securities sold short and foreign currency related translations

     68,091,611         103,578,610   
  

 

 

    

 

 

 

Net increase from operations

     81,977,953         98,469,783   
  

 

 

    

 

 

 

Distributions to shareholders from:

     

Net investment income

     

Class A

     (7,356,374      (8,158,527 ) (a)  

Class B

     (2,261      (71,663 ) (a)  

Class C

     (5,301,378      (11,460,980 ) (a)  

Class Z

     (6,021,626      (2,095,539 ) (a)  

Return of capital

     

Class A

             (2,386,722 ) (a)  

Class B

             (19,874 ) (a)  

Class C

             (3,810,817 ) (a)  

Class Z

             (639,915 ) (a)  
  

 

 

    

 

 

 

Total distributions

     (18,681,639      (28,644,037 ) (a)  
  

 

 

    

 

 

 

Share transactions:

     

Proceeds from sale of shares

     

Class A

     415,086,745         75,608,962   

Class B

     11         45,054   

Class C

     63,910,391         27,432,448   

Class Z

     463,780,008         149,727,562   

Value of distributions reinvested

     

Class A

     4,971,008         6,063,436   

Class B

     1,964         51,514   

Class C

     3,544,408         9,576,862   

Class Z

     5,295,384         2,401,103   

Cost of shares redeemed

     

Class A

     (51,759,372      (60,232,565

Class B

     (28,257      (4,217,699

Class C

     (32,197,384      (69,284,485

Class Z

     (72,585,441      (11,263,189

Redemption fees (Note 8)

     108,589         11,876   
  

 

 

    

 

 

 

Net increase from share transactions

     800,128,054         125,920,879   
  

 

 

    

 

 

 

Total increase in net assets

     863,424,368         195,746,625   
  

 

 

    

 

 

 

Net Assets

     

Beginning of period

     746,250,096         550,503,471   
  

 

 

    

 

 

 

End of period

     1,609,674,464         746,250,096   
  

 

 

    

 

 

 

Accumulated net investment loss

     (28,539,270      (24,729,109 ) (a)  
  

 

 

    

 

 

 

 

(a)  

See Note 5.

 

26       See accompanying Notes to Financial Statements.


Table of Contents

STATEMENTS OF CHANGES IN NET ASSETS (continued)

 

 

 

  Highland Funds I

 

     Highland Floating
Rate Opportunities Fund
 
     Six Months Ended
December 31, 2013
(unaudited)
($)
     Year Ended
June 30, 2013
($)
 

CAPITAL STOCK ACTIVITY - SHARES

     

Class A:

     

Shares sold

     52,283,276         9,948,491   

Issued for distributions reinvested

     626,002         831,555   

Shares redeemed

     (6,518,938      (8,299,242
  

 

 

    

 

 

 

Net increase in fund shares

     46,390,340         2,480,804   
  

 

 

    

 

 

 

Class B:

     

Shares sold

     1         6,034   

Issued for distributions reinvested

     249         7,196   

Shares redeemed

     (3,600      (588,467
  

 

 

    

 

 

 

Net decrease in fund shares

     (3,350      (575,237
  

 

 

    

 

 

 

Class C:

     

Shares sold

     8,111,503         3,641,813   

Issued for distributions reinvested

     447,311         1,313,814   

Shares redeemed

     (4,055,797      (9,538,411
  

 

 

    

 

 

 

Net increase (decrease) in fund shares

     4,503,017         (4,582,784
  

 

 

    

 

 

 

Class Z

     

Shares sold

     58,115,984         19,905,110   

Issued for distributions reinvested

     666,149         322,354   

Shares redeemed

     (9,099,099      (1,526,742
  

 

 

    

 

 

 

Net increase in fund shares

     49,683,034         18,700,722   
  

 

 

    

 

 

 

 

See accompanying Notes to Financial Statements.       27


Table of Contents

STATEMENT OF CASH FLOWS

 

 

 

For the Six Months Ended December 31, 2013 (unaudited)   Highland Long/Short Equity Fund

 

       ($)  

Cash Flows Provided by Operating Activities

  

Net increase from operations

     142,722,687   

Adjustments to Reconcile Net Investment Loss to Net Cash Provided by Operating Activities

  

Purchases of investment securities from unaffiliated issuers

     (1,435,120,121

Proceeds from disposition of investment securities from unaffiliated issuers

     1,440,464,377   

Proceeds from disposition of investment securities from affiliated issuers

     5,382,216   

Purchases of purchased options

     (6,153,503

Proceeds from the disposition of purchased options

     6,205,610   

Proceeds from disposition of securities sold short

     1,016,617,979   

Purchases of securities sold short

     (1,074,309,787

Net premium received on written options

     (4,776,768

Net realized gain on investments from unaffiliated issuers

     (117,199,749

Net realized loss on investments from affiliated issuers

     7,398   

Net realized loss on securities sold short, written options contracts, and foreign currency related transactions

     32,961,309   

Net change in unrealized appreciation on investments, securities sold short, written options contracts and foreign currency related translations

     (66,856,066

Net change in short-term investments

     1,732,154   

Decrease in restricted cash

     100,045,597   

Decrease in receivable for investments sold

     104,760,643   

Decrease in dividends and interest receivable

     96,505   

Increase in receivable for fund shares sold

     (6,640,900

Increase in receivable for other assets

     (131,364

Decrease in payable for investments purchased

     (19,791,512

Decrease in payable for distributions

     (348,321

Increase in payables to related parties

     8,879   

Decrease in payable for securities on loan

     (1,732,154

Decrease in payable for distribution and shareholder fees

     (12,087

Increase in payable for transfer agent fees

     196,595   

Increase in payable for commitment fee

     71   

Decrease in accrued expenses and other liabilities

     (354,759
  

 

 

 

Net cash flow provided by operating activities

     117,774,929   
  

 

 

 

Cash Flows Provided by Financing Activities

  

Proceeds from shares sold

     216,248,895   

Payment of shares redeemed

     (183,188,873

Distributions paid in cash

     (25,912,771
  

 

 

 

Net cash flow provided by financing activities

     7,147,251   
  

 

 

 

Effect of exchange rate changes on cash

     50,991   
  

 

 

 

Net increase in cash

     124,973,171   
  

 

 

 

Cash & Foreign Currency

  

Beginning of the period

     (1,200,380
  

 

 

 

End of the period

     123,772,791   
  

 

 

 

Supplemental disclosure of cash flow information:

  

Reinvestment of distributions

     48,023,952   
  

 

 

 

Cash paid during the year for commitment fees

     5,480   
  

 

 

 

 

28       See accompanying Notes to Financial Statements.


Table of Contents

STATEMENT OF CASH FLOWS

 

 

 

For the Six Months Ended December 31, 2013 (unaudited)   Highland Long/Short Healthcare Fund

 

      

($)

 

Cash Flows Used in Operating Activities

  

Net increase from operations

     7,040,619   

Adjustments to Reconcile Net Investment Loss to Net Cash Used in Operating Activities

  

Purchases of investment securities from unaffiliated issuers

     (138,153,854

Proceeds from disposition of investment securities from unaffiliated issuers

     136,008,725   

Purchases of purchased options

     (2,119,279

Proceeds from the disposition of purchased options

     1,251,475   

Purchases of securities sold short

     (82,081,381

Proceeds from disposition of securities sold short

     92,787,577   

Net premium received on written options

     1,254,555   

Net realized gain on investments from unaffiliated issuers

     (8,030,180

Net realized loss on securities sold short, written options contracts and foreign currency related transactions

     2,951,623   

Net change in unrealized appreciation on investments, securities sold short, written options contracts and foreign currency related translations

     (2,423,316

Net change in short-term investments

     (9,908,413

Increase in restricted cash

     (18,055,542

Increase in receivable for investments sold

     (5,136,909

Decrease in dividends and interest receivable

     130,492   

Increase in receivable for fund shares sold

     (1,419,854

Increase in receivable for other assets

     (2,376

Increase in payable for investments purchased

     481,742   

Increase in payable for distributions

     10,399   

Increase in payables to related parties

     26,252   

Increase in payable upon receipt of securities loaned

     9,908,413   

Decrease in payable for distribution and shareholder service fees

     (755

Increase in payable for commitment fees

     5   

Increase in payable for transfer agent fees

     2,004   

Decrease in accrued expenses and other liabilities

     (30,366
  

 

 

 

Net cash flow used in operating activities

     (15,508,344
  

 

 

 

Cash Flows Provided by Financing Activities

  

Proceeds from shares sold

     29,764,494   

Payment of shares redeemed

     (7,328,659
  

 

 

 

Net cash flow provided by financing activities

     22,435,835   
  

 

 

 

Effect of exchange rate changes on cash

     19,134   
  

 

 

 

Net increase in cash

     6,946,625   
  

 

 

 

Cash & Foreign Currency/Due to Custodian

  

Beginning of the period

     3,321,638   
  

 

 

 

End of the period

     10,268,263   
  

 

 

 

Supplemental disclosure of cash flow information:

  

Cash paid during the year for commitment fees

     195   
  

 

 

 

 

See accompanying Notes to Financial Statements.       29


Table of Contents

STATEMENT OF CASH FLOWS

 

 

 

For the Six Months Ended December 31, 2013 (unaudited)   Highland Floating Rate Opportunities Fund

 

       ($)  

Cash Flows Used in Operating Activities

  

Net increase from operations

     81,977,953   

Adjustments to Reconcile Net Investment Income to Net Cash Used in Operating Activities

  

Purchases of investments securities from unaffiliated issuers

     (917,523,179

Proceeds from disposition of investment securities from unaffiliated issuers

     183,072,276   

Proceeds of securities sold short

     38,036,395   

Paydowns at cost

     1,107,267   

Net amortization of premium

     (1,989,233

Net realized loss on investments from unaffiliated issuers

     1,250,851   

Net realized gain on investments from foreign currency related transactions

     (265,715

Net change in unrealized appreciation on investments, securities sold short, written options contracts and foreign currency related translations

     (68,091,611

Net change in short-term investments

     (14,281,932

Increase in restricted cash

     (58,983,363

Decrease in receivable for investments sold

     20,216,988   

Increase in dividends and interest receivable

     (3,789,935

Decrease in receivable for fund shares sold

     25,777,772   

Increase in prepaid expenses and other assets

     (422,039

Increase in payable upon receipt of securities on loan

     14,281,932   

Increase in payable for investments purchased

     199,639,648   

Decrease in payable for distribution and shareholder service fees

     (37,538

Increase in payables to related parties

     458,744   

Increase in payable for distributions to shareholders

     557,805   

Decrease in payable for commitment fees

     (93,042

Increase in payable for transfer agent fees

     37,585   

Decrease in payable for interest expense

     (22,185

Decrease in accrued expenses and other liabilities

     (219,341
  

 

 

 

Net cash flow used in operating activities

     (499,303,897
  

 

 

 

Cash Flows Provided by Financing Activities

  

Proceeds from shares sold

     942,777,155   

Payment of shares redeemed

     (156,461,865

Distributions paid in cash

     (4,868,875
  

 

 

 

Net cash flow provided by financing activities

     781,446,415   
  

 

 

 

Effect of exchange rate changes on cash

     277,395   
  

 

 

 

Net increase in cash

     282,419,913   
  

 

 

 

Cash and Foreign Currency

  

Beginning of the period

     72,986,836   
  

 

 

 

End of the period

     355,406,749   
  

 

 

 

Supplemental disclosure of cash flow information:

  

Reinvestment of distributions

     13,812,764   
  

 

 

 

Cash paid during the year for commitment fees

     191,708   
  

 

 

 

 

30       See accompanying Notes to Financial Statements.


Table of Contents

FINANCIAL HIGHLIGHTS

 

 

 

  Highland Long/Short Equity Fund, Class A

 

Selected data for a share outstanding throughout each period is as follows:

 

     For the
Six Months
Ended
12/31/13
(unaudited)
    For the Years Ended June 30,     For the
Ten Months
Ended
06/30/10
    For the
Year
Ended
08/31/09
 
       2013     2012     2011      

Net Asset Value, Beginning of Period

   $ 11.37      $ 11.30      $ 11.10      $ 10.68      $ 10.37      $ 10.50   

Income from Investment Operations:

  

   

Net investment (loss) (a)

     (0.09     (0.16     (0.22     (0.21     (0.19     (0.23

Redemption fees added to paid-in capital (a)

     (b)       (b)       (b)       (b)       0.01        0.01   

Net realized and unrealized gain (a)

     1.89        0.53        0.48        0.93        0.59        0.10   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total from investment operations

     1.80        0.37        0.26        0.72        0.41        (0.12

Less Distributions Declared to Shareholders:

  

   

From net investment income

                                        (0.01

From net realized gains

     (0.95     (0.30     (0.06     (0.30     (0.10       
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions declared to shareholders

     (0.95     (0.30     (0.06     (0.30     (0.10     (0.01

Net Asset Value, End of Period (i)

   $ 12.22      $ 11.37      $ 11.30      $ 11.10      $ 10.68      $ 10.37   

Total Return (c)(i)

     15.98 % (d)       3.38     2.42     6.62     3.90 % (d)       (1.16 )% 

Ratios to Average Net Assets (e) /Supplemental Data:

  

   

Net assets, end of period (in 000’s)

   $ 171,764      $ 141,351      $ 265,712      $ 286,581      $ 207,323      $   56,364   

Gross operating expenses (excluding interest expense and commitment fee) (f)

     3.69     3.79     3.66     3.64     4.19     4.94

Interest expense and commitment fee

     (g)       (g)                            0.01

Waiver/reimbursement

     (1.28 )%      (1.25 )%      (1.25 )%      (1.25 )%      (1.25 )%      (1.86 )% 

Net operating expenses (including interest expense and commitment fee) (f)(h)

     2.41     2.54     2.41     2.39     2.94     3.09

Dividends and fees on securities sold short

     0.54     0.66     0.53     0.41     0.70     0.59

Net operating expenses (excluding dividends and fees on securities sold short)

     1.87     1.88     1.88     1.98     2.24     2.50

Net investment loss

     (1.47 )%      (1.40 )%      (1.99 )%      (1.89 )%      (2.10 )%      (2.30 )% 

Portfolio turnover rate

     146 % (d)       706     650     684     496 % (d)       443

 

(a) Per share data was calculated using average shares outstanding during the period.
(b) Represents less than $0.005 per share.
(c) Total return is at net asset value assuming all distributions are reinvested and no initial sales charge or CDSC. For periods with waivers/reimbursements, had the Fund’s investment adviser not waived or reimbursed a portion of expenses, total return would have been reduced.
(d) Not annualized.
(e) All ratios for the period have been annualized, unless otherwise indicated.
(f) Includes dividends and fees on securities sold short.
(g) Represents less than 0.005%.
(h) Net expense ratio has been calculated after applying any waiver/reimbursement, if applicable.
(i) The Net Asset Value per share and total return have been calculated based on net assets which include adjustments made in accordance with U.S. generally accepted accounting principles required at period end for financial reporting purposes. These figures do not necessarily reflect the Net Asset Value per share or total return experienced by the shareholder at period end.

 

See accompanying Notes to Financial Statements.       31


Table of Contents

FINANCIAL HIGHLIGHTS

 

 

 

  Highland Long/Short Equity Fund, Class C

 

Selected data for a share outstanding throughout each period is as follows:

 

     For the
Six Months
Ended
12/31/13
(unaudited)
    For the Years Ended June 30,     For the
Ten Months
Ended
06/30/10
    For the
Year
Ended
08/31/09
 
       2013     2012     2011      

Net Asset Value, Beginning of Period

   $ 10.95      $ 10.96      $ 10.83      $ 10.48      $ 10.22      $ 10.42   

Income from Investment Operations:

  

   

Net investment (loss) (a)

     (0.13     (0.22     (0.28     (0.27     (0.24     (0.29

Redemption fees added to paid-in capital (a)

     (b)       (b)       (b)       (b)       0.01        0.01   

Net realized and unrealized gain (a)

     1.82        0.51        0.47        0.92        0.59        0.09   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total from investment operations

     1.69        0.29        0.19        0.65        0.36        (0.19

Less Distributions Declared to Shareholders:

  

   

From net investment income

                                        (0.01

From net realized gains

     (0.95     (0.30     (0.06     (0.30     (0.10       
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions declared to shareholders

     (0.95     (0.30     (0.06     (0.30     (0.10     (0.01

Net Asset Value, End of Period (i)

   $ 11.69      $ 10.95      $ 10.96      $ 10.83      $ 10.48      $ 10.22   

Total return (c)(i)

     15.59 % (d)       2.75     1.83     6.18     3.46 % (d)       (1.84 )% 

Ratios to Average Net Assets (e) /Supplemental Data:

  

   

Net assets, end of period (in 000’s)

   $   51,135      $   45,925      $   57,677      $   79,243      $   59,290      $   19,585   

Gross operating expenses (excluding interest expense and commitment fee) (f)

     4.33     4.48     4.31     4.29     4.84     5.59

Interest expense and commitment fee

     (g)       (g)                            0.01

Waiver/reimbursement

     (1.28 )%      (1.26 )%      (1.25 )%      (1.25 )%      (1.25 )%      (1.86 )% 

Net operating expenses (including interest expense and commitment fee) (f)(h)

     3.05     3.22     3.06     3.04     3.59     3.74

Dividends and fees on securities sold short

     0.53     0.67     0.53     0.41     0.70     0.59

Net operating expenses (excluding dividends and fees on securities sold short)

     2.52     2.55     2.53     2.63     2.89     3.15

Net investment (loss)

     (2.13 )%      (2.02 )%      (2.64 )%      (2.54 )%      (2.75 )%      (2.95 )% 

Portfolio turnover rate

     146 % (d)       706     650     684     496 % (d)       443

 

(a) Per share data was calculated using average shares outstanding during the period.
(b) Represents less than $0.005 per share.
(c) Total return is at net asset value assuming all distributions are reinvested and no initial sales charge or CDSC. For periods with waivers/reimbursements, had the Fund’s investment adviser not waived or reimbursed a portion of expenses, total return would have been reduced.
(d) Not annualized.
(e) All ratios for the period have been annualized, unless otherwise indicated.
(f) Includes dividends and fees on securities sold short.
(g) Represents less than 0.005%.
(h) Net expense ratio has been calculated after applying any waiver/reimbursement, if applicable.
(i) The Net Asset Value per share and total return have been calculated based on net assets which include adjustments made in accordance with U.S. generally accepted accounting principles required at period end for financial reporting purposes. These figures do not necessarily reflect the Net Asset Value per share or total return experienced by the shareholder at period end.

 

32       See accompanying Notes to Financial Statements.


Table of Contents

FINANCIAL HIGHLIGHTS

 

 

 

  Highland Long/Short Equity Fund, Class Z

 

Selected data for a share outstanding throughout each period is as follows:

 

     For the
Six Months
Ended
12/31/13
(unaudited)
    For the Years Ended June 30,     For the
Ten Months
Ended
06/30/10
    For the
Year

Ended
08/31/09
 
       2013     2012     2011      

Net Asset Value, Beginning of Year

   $ 11.61      $ 11.50      $ 11.27      $ 10.81      $ 10.46      $ 10.54   

Income from Investment Operations:

  

   

Net investment (loss) (a)

     (0.07     (0.11     (0.18     (0.17     (0.16     (0.20

Redemption fees added to paid-in capital (a)

     (b)       (b)       (b)       (b)       0.01        0.01   

Net realized and unrealized gain (a)

     1.94        0.52        0.47        0.93        0.60        0.12   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total from investment operations

     1.87        0.41        0.29        0.76        0.45        (0.07

Less Distributions Declared to Shareholders:

  

   

From net investment income

                                        (0.01

From net realized gains

     (0.95     (0.30     (0.06     (0.30     (0.10       
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions declared to shareholders

     (0.95     (0.30     (0.06     (0.30     (0.10     (0.01

Net Asset Value, End of Year (i)

   $ 12.53      $ 11.61      $ 11.50      $ 11.27      $ 10.81      $ 10.46   

Total return (c)(i)

     16.25 % (d)       3.68     2.56     7.02     4.25 % (d)       (0.68 )% 

Ratios to Average Net Assets (e) /Supplemental Data:

  

   

Net assets, end of period (in 000’s)

   $ 806,953      $ 692,705      $ 399,689      $ 163,490      $     3,827      $        975   

Gross operating expenses (excluding interest expense and commitment fee) (f)

     3.33     3.54     3.31     3.29     3.84     4.59

Interest expense and commitment fee

     (g)       (g)                            0.01

Waiver/reimbursement

     (1.28 )%      (1.26 )%      (1.25 )%      (1.25 )%      (1.25 )%      (1.86 )% 

Net operating expenses (including interest expense and commitment fee) (f)(h)

     2.05     2.28     2.06     2.04     2.59     2.74

Dividends and fees on securities sold short

     0.53     0.71     0.53     0.41     0.70     0.59

Net operating expenses (excluding dividends and fees on securities sold short)

     1.52     1.57     1.53     1.63     1.89     2.15

Net investment (loss)

     (1.13 )%      (0.96 )%      (1.64 )%      (1.54 )%      (1.75 )%      (1.95 )% 

Portfolio turnover rate

     146 % (d)       706     650     684     496 % (d)       443

 

(a) Per share data was calculated using average shares outstanding during the period.
(b) Represents less than $0.005 per share.
(c) Total return is at net asset value assuming all distributions are reinvested and no initial sales charge or CDSC. For periods with waivers/reimbursements, had the Fund’s investment adviser not waived or reimbursed a portion of expenses, total return would have been reduced.
(d) Not annualized.
(e) All ratios for the period have been annualized, unless otherwise indicated.
(f) Includes dividends and fees on securities sold short.
(g) Represents less than 0.005%.
(h) Net expense ratio has been calculated after applying any waiver/reimbursement, if applicable.
(i) The Net Asset Value per share and total return have been calculated based on net assets which include adjustments made in accordance with U.S. generally accepted accounting principles required at period end for financial reporting purposes. These figures do not necessarily reflect the Net Asset Value per share or total return experienced by the shareholder at period end.

 

See accompanying Notes to Financial Statements.       33


Table of Contents

FINANCIAL HIGHLIGHTS

 

 

 

  Highland Long/Short Healthcare Fund, Class A

 

Selected data for a share outstanding throughout each period is as follows:

 

     For the
Six Months
Ended
12/31/13
(unaudited)
    For the Years Ended June 30,     For the
Ten Months
Ended
6/30/10
    For the
Year

Ended
08/31/09
 
       2013     2012     2011      

Net Asset Value, Beginning of Period

   $ 11.03      $ 10.87      $ 13.75      $ 11.19      $ 9.42      $ 10.30   

Income from Investment Operations:

  

   

Net investment (loss) (a)

     (0.15     (0.26     (0.28     (0.15     (0.51     (1.37

Redemption fees added to paid-in capital

     (a)(b)       (a)(b)       0.01 (a)       (a)(b)              0.02 (a)  

Capital contributions (Note 1)

            (0.03 ) (a)                              

Net realized and unrealized gain/(loss) (a)

     2.39        0.45        (1.36     3.06        2.28        0.82   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total from investment operations

     2.24        0.16        (1.63     2.91        1.77        (0.53

Less Distributions Declared to Shareholders:

  

   

From net realized gains

                   (1.25     (0.35            (0.35
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions declared to shareholders

                   (1.25     (0.35            (0.35

Net Asset Value, End of Period (i)

   $ 13.27      $ 11.03      $ 10.87      $ 13.75      $ 11.19      $ 9.42   

Total Return (c)(i)

     20.31 % (d)       1.47     (12.37 )%      26.63     18.79 % (d)       (5.61 )% 

Ratios to Average Net Assets (e) /Supplemental Data:

  

   

Net assets, end of period (in 000’s)

   $   22,437      $   11,652      $   29,861      $   23,767      $      2,042      $        154   

Gross operating expenses (excluding interest expense and commitment fee) (f)

     3.30     3.52     3.30     3.14     6.86     15.35

Interest expense and commitment fee

     (g)       (g)                              

Waiver/reimbursement

                   (0.36 )%      (1.19 )%      (0.91 )%      (1.62 )% 

Net operating expenses (including interest expense and commitment fee) (f)(h)

     3.30     3.52     2.94     1.95     5.95     13.73

Dividends and fees on securities sold short

     1.13     1.03     1.09     0.53     0.03       

Net operating expenses (excluding dividends and fees on securities sold short)

     2.17     2.49     1.85     1.42     5.92     13.73

Net investment loss

     (2.37 )%      (2.48 )%      (2.31 )%      (1.26 )%      (5.69 )%      (13.29 )% 

Portfolio turnover rate

     313 % (d)       1,035     1,336     1,553     262 % (d)       23

 

(a) Per share data was calculated using average shares outstanding during the period.
(b) Represents less than $0.005 per share.
(c) Total return is at net asset value assuming all distributions are reinvested and no initial sales charge or CDSC. For periods with waivers/reimbursements, had the Fund’s investment adviser not waived or reimbursed a portion of expenses, total return would have been reduced.
(d) Not annualized.
(e) All ratios for the period have been annualized, unless otherwise indicated.
(f) Includes dividends and fees on securities sold short.
(g) Represents less than 0.005%.
(h) Net expense ratio has been calculated after applying any waiver/reimbursement, if applicable.
(i) The Net Asset Value per share and total return have been calculated based on net assets which include adjustments made in accordance with U.S. generally accepted accounting principles required at period end for financial reporting purposes. These figures do not necessarily reflect the Net Asset Value per share or total return experienced by the shareholder at period end.

 

34       See accompanying Notes to Financial Statements.


Table of Contents

FINANCIAL HIGHLIGHTS

 

 

 

  Highland Long/Short Healthcare Fund, Class C

 

Selected data for a share outstanding throughout each period is as follows:

 

     For the
Six  Months
Ended
12/31/13
(unaudited)
    For the Years Ended June 30,     For the
Ten Months
Ended
06/30/10
    For the
Year

Ended
08/31/09
 
       2013     2012     2011      

Net Asset Value, Beginning of Period

   $ 10.68      $ 10.59      $ 13.54      $ 11.04      $ 9.33      $ 10.28   

Income from Investment Operations:

  

   

Net investment (loss) (a)

     (0.18     (0.31     (0.34     (0.23     (0.55     (1.43

Redemption fees added to paid-in capital

     (a)(b)       (a)(b)       0.01 (a)       (a)(b)              0.02   

Capital contributions (Note 1)

            (0.03 ) (a)                              

Net realized and unrealized gain/(loss) (a)

     2.31        0.43        (1.37     3.08        2.26        0.81   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total from investment operations

     2.13        0.09        (1.70     2.85        1.71        (0.60

Less Distributions Declared to Shareholders:

  

   

From net realized gains

                   (1.25     (0.35            (0.35
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions declared to shareholders

                   (1.25     (0.35            (0.35

Net Asset Value, End of Period (i)

   $ 12.81      $ 10.68      $ 10.59      $ 13.54      $ 11.04      $ 9.33   

Total return (c)(i)

     19.94 % (d)       0.85     (13.04 )%      26.35     18.33 % (d)       (6.32 )% 

Ratios to Average Net Assets (e) /Supplemental Data:

  

   

Net assets, end of period (in 000’s)

   $   11,860      $     5,460      $     9,181      $     6,075      $        338      $        145   

Gross operating expenses (excluding interest expense and commitment fee) (f)

     3.95     4.20     3.95     3.79     7.51     16.00

Interest expense and commitment fee

     (g)       (g)                              

Waiver/reimbursement

                   (0.36 )%      (1.19 )%      (0.91 )%      (1.62 )% 

Net operating expenses (including interest expense and commitment fee) (f)(h)

     3.95     4.20     3.59     2.60     6.60     14.38

Dividends and fees on securities sold short

     1.13     1.07     1.09     0.53     0.03       

Net operating expenses (excluding dividends and fees on securities sold short)

     2.82     3.13     2.50     2.07     6.57     14.38

Net investment (loss)

     (3.01 )%      (3.05 )%      (2.96 )%      (1.91 )%      (6.34 )%      (13.94 )% 

Portfolio turnover rate

     313 % (d)       1,035     1,336     1,553     262 % (d)       23

 

(a) Per share data was calculated using average shares outstanding during the period.
(b) Represents less than $0.005 per share.
(c) Total return is at net asset value assuming all distributions are reinvested and no initial sales charge or CDSC. For periods with waivers/reimbursements, had the Fund’s investment adviser not waived or reimbursed a portion of expenses, total return would have been reduced.
(d) Not annualized.
(e) All ratios for the period have been annualized, unless otherwise indicated.
(f) Includes dividends and fees on securities sold short.
(g) Represents less than 0.005%.
(h) Net expense ratio has been calculated after applying any waiver/reimbursement, if applicable.
(i) The Net Asset Value per share and total return have been calculated based on net assets which include adjustments made in accordance with U.S. generally accepted accounting principles required at period end for financial reporting purposes. These figures do not necessarily reflect the Net Asset Value per share or total return experienced by the shareholder at period end.

 

See accompanying Notes to Financial Statements.       35


Table of Contents

FINANCIAL HIGHLIGHTS

 

 

 

  Highland Long/Short Healthcare Fund, Class Z

 

Selected data for a share outstanding throughout each period is as follows:

 

     For the
Six  Months
Ended
12/31/13
(unaudited)
    For the Years Ended June 30,     For the
Ten Months
Ended
06/30/10
    For the
Year

Ended
08/31/09
 
       2013     2012     2011      

Net Asset Value, Beginning of Year

   $ 11.23      $ 11.03      $ 13.88      $ 11.26      $ 9.47      $ 10.31   

Income from Investment Operations:

  

   

Net investment (loss) (a)

     (0.13     (0.21     (0.24     (0.11     (0.49     (1.34

Redemption fees added to paid-in capital

     (a)(b)       (a)(b)       0.01 (a)       (a)(b)              0.02 (a)  

Capital contributions (Note 1)

            (0.03 ) (a)                              

Net realized and unrealized gain/(loss) (a)

     2.44        0.44        (1.37     3.08        2.28        0.84   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total from investment operations

     2.31        0.20        (1.60     2.97        1.79        (0.48

Less Distributions Declared to Shareholders:

  

   

From net investment income

                                        (0.01

From net realized gains

                   (1.25     (0.35            (0.35
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions declared to shareholders

                   (1.25     (0.35            (0.36

Net Asset Value, End of Year (i)

   $ 13.54      $ 11.23      $ 11.03      $ 13.88      $ 11.26      $ 9.47   

Total return (c)(i)

     20.57 % (d)       1.81     (11.95 )%      26.79     18.90 % (d)       (5.15 )% 

Ratios to Average Net Assets (e) /Supplemental Data:

  

   

Net assets, end of period (in 000’s)

   $   26,093      $   13,801      $   14,210      $   13,705      $     7,606      $     1,673   

Gross operating expenses (excluding interest expense and commitment fee) (f)

     2.94     3.24     2.95     2.79     6.51     15.00

Interest expense and commitment fee

     (g)       (g)                              

Waiver/reimbursement

            (g)       (0.36 )%      (1.19 )%      (0.91 )%      (1.62 )% 

Net operating expenses (including interest expense and commitment fee) (f)(h)

     2.94     3.24     2.59     1.60     5.60     13.38

Dividends and fees on securities sold short

     1.12     1.13     1.09     0.53     0.03       

Net operating expenses (excluding dividends and fees on securities sold short)

     1.82     2.11     1.50     1.07     5.57     13.38

Net investment (loss)

     (2.03 )%      (1.95 )%      (1.96 )%      (0.91 )%      (5.34 )%      (12.94 )% 

Portfolio turnover rate

     313 % (d)       1,035     1,336     1,553     262 % (d)       23

 

(a) Per share data was calculated using average shares outstanding during the period.
(b) Represents less than $0.005 per share.
(c) Total return is at net asset value assuming all distributions are reinvested and no initial sales charge or CDSC. For periods with waivers/reimbursements, had the Fund’s investment adviser not waived or reimbursed a portion of expenses, total return would have been reduced.
(d) Not annualized.
(e) All ratios for the period have been annualized, unless otherwise indicated.
(f) Includes dividends and fees on securities sold short.
(g) Represents less than 0.005%.
(h) Net expense ratio has been calculated after applying any waiver/reimbursement, if applicable.
(i) The Net Asset Value per share and total return have been calculated based on net assets which include adjustments made in accordance with U.S. generally accepted accounting principles required at period end for financial reporting purposes. These figures do not necessarily reflect the Net Asset Value per share or total return experienced by the shareholder at period end.

 

36       See accompanying Notes to Financial Statements.


Table of Contents

FINANCIAL HIGHLIGHTS

 

 

 

  Highland Floating Rate Opportunities Fund, Class A

 

Selected data for a share outstanding throughout each period is as follows:

 

    For the
Six  Months
Ended
12/31/13
(unaudited)
    For the Years Ended June 30,     For the
Ten Months
Ended

6/30/10 *
    For the
Year

Ended
08/31/09 *
 
      2013     2012     2011 *      

Net Asset Value, Beginning of Period

  $ 7.74      $ 6.85      $ 6.96      $ 6.55      $ 5.98      $ 9.70   

Income from Investment Operations:

  

   

Net investment income (a)

    0.11        0.30        0.26        0.27        0.18        0.51   

Redemption fees added to paid-in capital (a)

    (b)       (b)       (b)                       

Net realized and unrealized gain/(loss) (a)

    0.46        0.98        (0.07     0.46        0.57        (3.50
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total from investment operations

    0.57        1.28        0.19        0.73        0.75        (2.99

Less Distributions Declared to Shareholders:

  

     

From net investment income

    (0.14     (0.30 ) (i)       (0.30     (0.32     (0.06     (0.73

From return of capital

           (0.09 ) (i)                     (0.12       
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions declared to shareholders

    (0.14     (0.39     (0.30     (0.32     (0.18     (0.73

Net Asset Value, End of Period (h)

  $ 8.17      $ 7.74      $ 6.85      $ 6.96      $ 6.55      $ 5.98   

Total Return (c)(h)

    7.40 % (d)       19.16     2.52     11.73     12.68 % (d)       (30.25 )% 

Ratios to Average Net Assets (e) /Supplemental Data:

  

 

Net assets, end of period (in 000’s)

  $ 642,584      $ 249,450      $ 203,684      $ 264,385      $ 191,925      $ 219,010   

Gross operating expenses (excluding interest expense and commitment fee)

    1.39 % (f)       1.65     2.11     2.18     2.27     1.87

Interest expense and commitment fee

    0.03     0.14     0.42     0.47     0.61     1.08

Waiver/reimbursement

    (0.11 )%      (0.21 )%                           (0.01 )% 

Net operating expenses (including interest expense and commitment fee) (g)

    1.31 % (f)       1.58     2.53     2.65     2.88     2.94

Dividends and fees on securities sold short

    0.03                                   

Net operating expenses (excluding dividends and fees on securities sold short)

    1.28                                   

Net investment income

    2.73     4.06     3.91     3.97     3.29     8.09

Portfolio turnover rate

    7 % (d)       71     50     104     57 % (d)       21

 

* Historical data shown is that of the Highland Floating Rate Advantage Fund, which reorganized into the Highland Floating Rate Opportunities Fund on June 13, 2011 (See Note 13).
(a) Per share data was calculated using average shares outstanding during the period.
(b) Represents less than $0.005 per share.
(c) Total return is at net asset value assuming all distributions are reinvested and no initial sales charge or CDSC. For periods with waivers/reimbursements, had the Fund’s investment adviser not waived or reimbursed a portion of expenses, total return would have been reduced.
(d) Not annualized.
(e) All ratios for the period have been annualized, unless otherwise indicated.
(f) Includes dividends and fees on securities sold short.
(g) Net expense ratio has been calculated after applying any waiver/reimbursement, if applicable.
(h) The Net Asset Value per share and total return have been calculated based on net assets which include adjustments made in accordance with U.S. generally accepted accounting principles required at period end for financial reporting purposes. These figures do not necessarily reflect the Net Asset Value per share or total return experienced by the shareholder at period end.
(i) Changed from previously reported amounts of $(0.32) and $(0.07), respectively. See Note 5.

 

See accompanying Notes to Financial Statements.       37


Table of Contents

FINANCIAL HIGHLIGHTS

 

 

 

  Highland Floating Rate Opportunities Fund, Class B

 

Selected data for a share outstanding throughout each period is as follows:

 

     For the
Six  Months
Ended
12/31/13
(unaudited)
    For the Years Ended June 30,      For the
Ten Months
Ended
06/30/10 *
    For the
Year

Ended
08/31/09 *
 
       2013     2012      2011 *       

Net Asset Value, Beginning of Year

   $ 7.70      $ 6.84      $ 6.96       $ 6.55       $ 5.98      $ 9.70   

Income from Investment Operations:

              

Net investment income (a)

     0.10        0.31        0.24         0.25         0.16        0.49   

Redemption fees added to paid-in capital (a)

     (b)       (b)       (b)                         

Net realized and unrealized gain/(loss) (a)

     0.48        0.91        (0.08      0.45         0.58        (3.50
  

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total from investment operations

     0.58        1.22        0.16         0.70         0.74        (3.01

Less Distributions Declared to Shareholders:

  

           

From net investment income

     (0.12     (0.27 ) (i)       (0.28      (0.29      (0.06     (0.71

From return of capital

            (0.09 ) (i)                       (0.11       
  

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total distributions declared to shareholders

     (0.12     (0.36     (0.28      (0.29      (0.17     (0.71

Net Asset Value, End of Period (h)

   $ 8.16      $ 7.70      $ 6.84       $ 6.96       $ 6.55      $ 5.98   

Total return (c)(h)

     7.64 % (d)       18.30     2.01      11.34      12.36 % (d)       (30.50 )% 

Ratios to Average Net Assets (e) /Supplemental Data:

  

    

Net assets, end of period (in 000’s)

   $        135      $        154      $     4,073       $   18,575       $   16,063      $   20,660   

Gross operating expenses (excluding interest expense and commitment fee)

     1.75 % (f)       2.12     2.46      2.53      2.62     2.22

Interest expense and commitment fee

     0.04     0.18     0.42      0.47      0.61     1.08

Waiver/reimbursement

     (0.09 )%      (0.13 )%                             (0.01 )% 

Net operating expenses (including interest expense and commitment fee) (g)

     1.70 % (f)       2.17     2.88      3.00      3.23     3.29

Dividends and fees on securities sold short

     0.02                                     

Net operating expenses (excluding dividends and fees on securities sold short)

     1.68                                     

Net investment income

     2.43     4.30     3.56      3.62      2.94     7.74

Portfolio turnover rate

     7 % (d)       71     50      104      57 % (d)       21

 

* Historical data shown is that of the Highland Floating Rate Advantage Fund, which reorganized into the Highland Floating Rate Opportunities Fund on June 13, 2011 (See Note 13).
(a) Per share data was calculated using average shares outstanding during the period.
(b) Represents less than $0.005 per share.
(c) Total return is at net asset value assuming all distributions are reinvested and no initial sales charge or CDSC. For periods with waivers/reimbursements, had the Fund’s investment adviser not waived or reimbursed a portion of expenses, total return would have been reduced.
(d) Not annualized.
(e) All ratios for the period have been annualized, unless otherwise indicated.
(g) Net expense ratio has been calculated after applying any waiver/reimbursement, if applicable.
(h) The Net Asset Value per share and total return have been calculated based on net assets which include adjustments made in accordance with U.S. generally accepted accounting principles required at period end for financial reporting purposes. These figures do not necessarily reflect the Net Asset Value per share or total return experienced by the shareholder at period end.
(i) Changed from previously reported amounts of $(0.29) and $(0.07), respectively. See Note 5.

 

38       See accompanying Notes to Financial Statements.


Table of Contents

FINANCIAL HIGHLIGHTS

 

 

 

  Highland Floating Rate Opportunities Fund, Class C

 

Selected data for a share outstanding throughout each period is as follows:

 

     For the
Six  Months
Ended
12/31/13
(unaudited)
    For the Years Ended June 30,      For the
Ten Months
Ended
06/30/10 *
    For the
Year

Ended
08/31/09 *
 
       2013     2012      2011 *       

Net Asset Value, Beginning of Period

   $ 7.74      $ 6.85      $ 6.96       $ 6.55       $ 5.98      $ 9.70   

Income from Investment Operations:

              

Net investment income (a)

     0.09        0.26        0.23         0.24         0.15        0.48   

Redemption fees added to paid-in capital (a)

     (b)       (b)       (b)                         

Net realized and unrealized gain/(loss) (a)

     0.46        0.98        (0.07      0.45         0.58        (3.50
  

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total from investment operations

     0.55        1.24        0.16         0.69         0.73        (3.02

Less Distributions Declared to Shareholders:

  

           

From net investment income

     (0.12     (0.26 ) (i)       (0.27      (0.28      (0.06     (0.70

From return of capital

            (0.09 ) (i)                       (0.10       
  

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total distributions declared to shareholders

     (0.12     (0.35     (0.27      (0.28      (0.16     (0.70

Net Asset Value, End of Period (h)

   $ 8.17      $ 7.74      $ 6.85       $ 6.96       $ 6.55      $ 5.98   

Total return (c)(h)

     7.13 % (d)       18.58     2.01      11.16      12.22 % (d)       (30.60 )% 

Ratios to Average Net Assets (e) /Supplemental Data:

  

    

Net assets, end of period (in 000’s)

   $ 381,511      $ 326,476      $ 320,178       $ 437,220       $ 332,355      $ 359,579   

Gross operating expenses (excluding interest expense and commitment fee)

     1.90 % (f)       2.16     2.61      2.68      2.77     2.37

Interest expense and commitment fee

     0.04     0.14     0.42      0.47      0.61     1.08

Waiver/reimbursement

     (0.10 )%      (0.22 )%                             (0.01 )% 

Net operating expenses (including interest expense and commitment fee) (g)

     1.84 % (f)       2.08     3.03      3.15      3.38     3.44

Dividends and fees on securities sold short

     0.02                                     

Net operating expenses (excluding dividends and fees on securities sold short)

     1.82                                     

Net investment income

     2.27     3.56     3.41      3.47      2.79     7.59

Portfolio turnover rate

     7 % (d)       71     50      104      57 % (d)       21

 

* Historical data shown is that of the Highland Floating Rate Advantage Fund, which reorganized into the Highland Floating Rate Opportunities Fund on June 13, 2011 (See Note 13).
(a) Per share data was calculated using average shares outstanding during the period.
(b) Represents less than $0.005 per share.
(c) Total return is at net asset value assuming all distributions are reinvested and no initial sales charge or CDSC. For periods with waivers/reimbursements, had the Fund’s investment adviser not waived or reimbursed a portion of expenses, total return would have been reduced.
(d) Not annualized.
(e) All ratios for the period have been annualized, unless otherwise indicated.
(f) Includes dividends and fees on securities sold short.
(g) Net expense ratio has been calculated after applying any waiver/reimbursement, if applicable.
(h) The Net Asset Value per share and total return have been calculated based on net assets which include adjustments made in accordance with U.S. generally accepted accounting principles required at period end for financial reporting purposes. These figures do not necessarily reflect the Net Asset Value per share or total return experienced by the shareholder at period end.
(i) Changed from previously reported amounts of $(0.28) and $(0.07), respectively. See Note 5.

 

See accompanying Notes to Financial Statements.       39


Table of Contents

FINANCIAL HIGHLIGHTS

 

 

 

  Highland Floating Rate Opportunities Fund, Class Z

 

Selected data for a share outstanding throughout each period is as follows:

 

     For the
Six  Months
Ended
12/31/13
(unaudited)
    For the Years Ended June 30,      For the
Ten Months
Ended
06/30/10 *
    For the
Year

Ended
08/31/09 *
 
       2013     2012      2011 *       

Net Asset Value, Beginning of Year

   $ 7.74      $ 6.84      $ 6.96       $ 6.55       $ 5.97      $ 9.70   

Income from Investment Operations:

              

Net investment income (a)

     0.12        0.29        0.29         0.29         0.20        0.54   

Redemption fees added to paid-in capital (a)

     (b)       (b)       (b)                         

Net realized and unrealized gain/(loss) (a)

     0.46        1.03        (0.08      0.46         0.58        (3.52
  

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total from investment operations

     0.58        1.32        0.21         0.75         0.78        (2.98

Less Distributions Declared to Shareholders:

  

    

From net investment income

     (0.15     (0.33 ) (i)       (0.33      (0.34      (0.07     (0.75

From return of capital

            (0.09 ) (i)                       (0.13       
  

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total distributions declared to shareholders

     (0.15     (0.42     (0.33      (0.34      (0.20     (0.75

Net Asset Value, End of Year (h)

   $ 8.17      $ 7.74      $ 6.84       $ 6.96       $ 6.55      $ 5.97   

Total return (c)(h)

     7.59 % (d)       19.77     2.73      12.11      13.20 % (d)       (30.12 )% 

Ratios to Average Net Assets (e) /Supplemental Data:

  

    

Net assets, end of period (in 000’s)

   $ 585,444      $ 170,170      $   22,568       $   35,668       $   41,785      $   62,842   

Gross operating expenses (excluding interest expense and commitment fee)

     1.04 % (f)       1.21     1.76      1.83      1.92     1.52

Interest expense and commitment fee

     0.03     0.10     0.42      0.47      0.61     1.08

Waiver/reimbursement

     (0.11 )%      (0.27 )%                             (0.01 )% 

Net operating expenses (including interest expense and commitment fee) (g)

     0.96 % (f)       1.04     2.18      2.30      2.53     2.59

Dividends and fees on securities sold short

     0.03                                     

Net operating expenses (excluding dividends and fees on securities sold short)

     0.93                                     

Net investment income

     3.05     3.88     4.26      4.32      3.64     8.44

Portfolio turnover rate

     7 % (d)       71     50      104      57 % (d)       21

 

* Historical data shown is that of the Highland Floating Rate Advantage Fund, which reorganized into the Highland Floating Rate Opportunities Fund on June 13, 2011 (See Note 13).
(a) Per share data was calculated using average shares outstanding during the period.
(b) Represents less than $0.005 per share.
(c) Total return is at net asset value assuming all distributions are reinvested and no initial sales charge or CDSC. For periods with waivers/reimbursements, had the Fund’s investment adviser not waived or reimbursed a portion of expenses, total return would have been reduced.
(d) Not annualized.
(e) All ratios for the period have been annualized, unless otherwise indicated.
(f) Includes dividends and fees on securities sold short.
(g) Net expense ratio has been calculated after applying any waiver/reimbursement, if applicable.
(h) The Net Asset Value per share and total return have been calculated based on net assets which include adjustments made in accordance with U.S. generally accepted accounting principles required at period end for financial reporting purposes. These figures do not necessarily reflect the Net Asset Value per share or total return experienced by the shareholder at period end.
(i) Changed from previously reported amounts of $(0.34) and $(0.08), respectively. See Note 5.

 

40       See accompanying Notes to Financial Statements.


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited)

 

 

 

December 31, 2013   Highland Funds I

 

Note 1. Organization

Highland Funds I (the “Trust”) was organized as a Delaware statutory trust on February 28, 2006. The Trust is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company with four separate portfolios, each of which is non-diversified: Highland Long/Short Equity Fund (the “Long/Short Equity Fund”), Highland Long/Short Healthcare Fund (the “Long/Short Healthcare Fund”) and Highland Floating Rate Opportunities Fund (the “Floating Rate Opportunities Fund”) (each a “Fund” and, collectively, the “Funds”), and Highland/iBoxx Senior Loan ETF which is reported separately.

Fund Shares

Each Fund is authorized to issue an unlimited number of transferable shares of beneficial interest with a par value of $0.001 per share (each a “Share” and, collectively, the “Shares”). The Funds currently offer Class A, Class C and Class Z Shares. Class A Shares are sold with a front-end sales charge. Class A, Class B and Class C Shares may be subject to a contingent deferred sales charge. Class Z Shares are sold only to certain eligible investors. Certain share classes have their own sales charge and bear class specific expenses, which include distribution fees and service fees.

The Floating Rate Opportunities Fund does not sell Class B Shares to new and existing investors, except that existing Class B Share investors may still reinvest distributions in Class B Shares until such time as those shares are converted to Class A Shares. Class B Shares automatically convert to Class A Shares after eight years.

At December 31, 2013, Highland Capital Management, L.P., an affiliate of Highland Capital Management Fund Advisors, L.P. (the “Investment Advisor”) owned 14.83% of the total shares outstanding of the Long/Short Healthcare Fund.

Capital Contribution

On October 1, 2012, the Investment Advisor contributed $1,388 to Long/Short Healthcare Fund to mitigate the negative impact to shareholders from an incorrect amount recorded on a security.

Note 2. Significant Accounting Policies

The following summarizes the significant accounting policies consistently followed by the Funds in the preparation of their financial statements.

Use of Estimates

The Funds’ financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which require

management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially.

Determination of Class Net Asset Values

All income, expenses (other than distribution fees and service fees, which are class-specific expenses, as shown on the Statement of Operations) and realized and unrealized gains/(losses) are allocated to each class of shares of each Fund on a daily basis for purposes of determining the net asset value (“NAV”) of each class. Income and expenses are allocated to each class based on the settled shares method, while realized and unrealized gains/(losses) are allocated based on the relative net assets of each class.

Valuation of Investments

In computing the Funds’ net assets attributable to Shares, securities with readily available market quotations on the New York Stock Exchange, NASDAQ or other nationally recognized exchange use the closing quotations on the respective exchange for valuation of those securities. When portfolio securities are traded on the relevant day of valuation, the valuation will be the last reported sale price on that day. If there are no such sales on that day, the security will be valued at the mean between the most recently quoted bid and asked prices provided by the principal market makers. If there is more than one such principal market maker, the value shall be the average of such means. Securities without a sale price or quotations from principal market makers on the valuation day may be priced by an independent pricing service. Investments in mutual funds are valued at their respective net asset values as determined by those mutual funds each business day. Generally, the Funds’ loan and bond positions are not traded on exchanges and consequently are valued based on a mean of the bid and ask price from the third-party pricing services or broker-dealer sources that Highland Capital Management Fund Advisors, L.P. (the “Investment Adviser”) has determined generally have the capability to provide appropriate pricing services and have been approved by the Trustees.

Securities for which market quotations are not readily available for which the Funds have determined the price received from a pricing service or broker-dealer is “stale” or otherwise does not represent fair value (such as when events materially affecting the value of securities occur between the time when market price is determined and calculation of the Funds’ NAV), will be valued by the Funds

 

 

Semi-Annual Report       41


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

at fair value, as determined by the Funds’ Board of Trustees (the “Board”) or its designee in good faith in accordance with procedures approved by the Board, taking into account factors reasonably determined to be relevant, including: (i) the fundamental analytical data relating to the investment; (ii) the nature and duration of restrictions on disposition of the securities; and (iii) an evaluation of the forces that influence the market in which these securities are purchased and sold. In these cases, the Funds’ NAV will reflect the affected portfolio securities’ fair value as determined in the judgment of the Board or its designee instead of being determined by the market. Using a fair value pricing methodology to value securities may result in a value that is different from a security’s most recent sale price and from the prices used by other investment companies to calculate their NAV. Determination of fair value is uncertain because it involves subjective judgments and estimates.

There can be no assurance that the Funds’ valuation of a security will not differ from the amount that it realizes upon the sale of such security. Those differences could have a material impact to the Funds. Short-term debt investments, that is, those with a remaining maturity of 60 days or less, are valued at cost adjusted for amortization of premiums and accretion of discounts. Foreign price quotations are converted to U.S. dollar equivalents using the 4:00 PM London Time Spot Rate.

Fair Value Measurements

The Funds have performed an analysis of all existing investments and derivative instruments to determine the significance and character of all inputs to their fair value determination. The levels of fair value inputs used to measure the Funds’ investments are characterized into a fair value hierarchy. Where inputs for an asset or liability fall into more than one level in the fair value hierarchy, the investment is classified in its entirety based on the lowest level input that is significant to that investment’s valuation. The three levels of the fair value hierarchy are described below:

 

Level 1  Quoted unadjusted prices for identical instruments in active markets to which the Fund has access at the date of measurement;

 

Level 2  Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active, but are valued based on executed trades; broker quotations that constitute an executable price; and alternative pricing sources supported by observable inputs are classified within Level 2. Level 2 inputs are either directly or indirectly
  observable for the asset in connection with market data at the measurement date; and

 

Level 3  Model derived valuations in which one or more significant inputs or significant value drivers are unobservable. In certain cases, investments classified within Level 3 may include securities for which the Fund has obtained indicative quotes from broker-dealers that do not necessarily represent prices the broker may be willing to trade on, as such quotes can be subject to material management judgment. Unobservable inputs are those inputs that reflect the Fund’s own assumptions that market participants would use to price the asset or liability based on the best available information.

The Investment Adviser has established policies, as described above and approved by the Board, to ensure that valuation methodologies for investments and financial instruments that are categorized within all levels of the fair value hierarchy are fair and consistent. A Pricing Committee has been established to provide oversight of the valuation policies, processes and procedures, and is comprised of personnel from the Investment Adviser. The Pricing Committee meets monthly to review the proposed valuations for investments and financial instruments and is responsible for evaluating the overall fairness and consistent application of those policies.

As of December 31, 2013, the Funds’ investments consisted of senior loans, asset-backed securities, corporate bonds and notes, common stocks, preferred stocks, exchange-traded funds, rights, warrants, securities sold short and options. The fair value of the Funds’ loans, bonds and asset-backed securities are generally based on quotes received from brokers or independent pricing services. Loans, bonds and asset-backed securities with quotes that are based on actual trades with a sufficient level of activity on or near the measurement date are classified as Level 2 assets. Loans, bonds and asset-backed securities that are priced using quotes derived from implied values, indicative bids, or a limited number of actual trades are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable.

The fair value of the Funds’ common stocks, preferred stocks, exchange-traded funds, rights, warrants and options that are not actively traded on national exchanges are generally priced using quotes derived from implied values, indicative bids, or a limited amount of actual trades and are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable.

 

 

42       Semi-Annual Report


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

 

At the end of each calendar quarter, management evaluates the Level 2 and 3 assets and liabilities for changes in liquidity, including but not limited to: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges.

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Funds’ investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values the Funds may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise less liquid than publicly traded securities.

 

 

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. Transfers in and out of the levels are recognized at the value at the end of the period. A summary of the inputs used to value each Fund’s assets as of December 31, 2013 is as follows:

 

         Total value at
December 31, 2013
       Level 1
Quoted
Price
       Level 2
Significant
Observable
Inputs
       Level 3
Significant
Unobservable
Inputs
 

Long/Short Equity Fund

                   

Assets

                   

Common Stocks & Exchange-Traded Funds (1)

     $ 966,396,781         $ 966,396,781         $     —         $     —   

Master Limited Partnerships (1)

       9,772,962           9,772,962                       

Investment Companies

       68,431,932           68,431,932                       
    

 

 

      

 

 

      

 

 

      

 

 

 

Total Assets

       1,044,601,675           1,044,601,675                       
    

 

 

      

 

 

      

 

 

      

 

 

 

Liabilities

                   

Securities Sold Short (1)

       (239,425,243        (239,425,243                    

Other Financial Instruments

                   

Commodity Contracts—Futures

       (77,076        (77,076                    

Equity Contracts—Futures

       (1,599,634        (1,599,634                    

Foreign Currency Contracts—Futures

       (24,443        (24,443                    

Written Options Contracts Equity Contracts

       (753,600        (753,600                    
    

 

 

      

 

 

      

 

 

      

 

 

 

Total Liabilities

       (241,879,996        (241,879,996                    
    

 

 

      

 

 

      

 

 

      

 

 

 

Total

     $ 802,721,679         $ 802,721,679         $         $   
    

 

 

      

 

 

      

 

 

      

 

 

 

(1) See Investment Portfolio detail for industry breakout.

 

Semi-Annual Report       43


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

 

         Total value at
December 31, 2013
       Level 1
Quoted
Price
       Level 2
Significant
Observable
Inputs
       Level 3
Significant
Unobservable
Inputs
 

Long/Short Healthcare Fund

                   

Assets

                   

Common Stocks

                   

Consumer Discretionary

     $ 657,303         $ 657,303         $         $   

Financial

       2,447,971           2,447,971                       

Healthcare

                   

Biotechnology

       12,960,712           12,960,712                       

Healthcare Distributors

       1,670,250           1,670,250                       

Healthcare Equipment

       8,731,513           8,108,825                     622,688   

Healthcare Facilities

       1,980,861           1,980,861                       

Healthcare Services

       4,954,212           4,019,871                     934,341   

Healthcare Supplies

       1,027,437           1,027,437                       

Healthcare Technology

       1,632,346           1,632,346                       

Life Sciences Tools & Services

       3,869,018           3,869,018                       

Managed Healthcare

       456,593           456,593                       

Pharmaceuticals

       5,127,579           5,127,579                       

Information Technology

       602,454           602,454                       

Rights (1)

                   

Equity Contracts

       22,392           22,392                       

Warrants (1)

                   

Equity Contracts

       2,395,039                     1,307,092           1,087,947   

Purchased Options (1)

                   

Equity Contracts

       9,813           9,813                       

Investment Companies

       9,908,413           9,908,413                       
    

 

 

      

 

 

      

 

 

      

 

 

 

Total Assets

       58,453,906           54,501,838           1,307,092           2,644,976   
    

 

 

      

 

 

      

 

 

      

 

 

 

Liabilities

                   

Securities Sold Short (1)

       (21,322,736        (21,322,736                    
    

 

 

      

 

 

      

 

 

      

 

 

 

Total Liabilities

       (21,322,736        (21,322,736                    
    

 

 

      

 

 

      

 

 

      

 

 

 

Total

     $ 37,131,170         $ 33,179,102         $ 1,307,092         $ 2,644,976   
    

 

 

      

 

 

      

 

 

      

 

 

 

(1) See Investment Portfolio detail for industry breakout.

 

44       Semi-Annual Report


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

 

        

Total

value at
December 31, 2013

      

Level 1
Quoted

Price

       Level 2
Significant
Observable
Inputs
       Level 3
Significant
Unobservable
Inputs
 

Floating Rate Opportunities Fund

                   

Assets

                   

U.S. Senior Loans (1)

     $ 1,106,291,075         $         $ 1,030,108,758         $ 76,182,317 (2)  

Foreign Denominated or Domiciled Senior Loans (1)

       94,602,950                     85,480,936           9,122,014   

Collateralized Loan Obligations

       115,673,875                     111,029,175           4,644,700   

Corporate Bonds & Notes (1)

       55,280,969                     55,280,969             

Foreign Corporate Bonds & Notes

       15,526,294                     15,526,294             

Claims (1)

       1,143,780                     1,143,780             

Common Stocks & Exchange-Traded Funds

                   

Broadcasting

       2,437,808                               2,437,808   

Energy

       1,677,429                               1,677,429   

Gaming & Leisure

                                     (2)  

Healthcare

       12,465,336                               12,465,336   

Housing

       6,283,250                     1,239,299           5,043,951 (2)  

Media & Telecommunications

       119,091,979           85,350,233           33,741,746           (2)  

Other

       22,919,500           22,919,500                       

Real Estate Investment Trust

       10,826,782           10,826,782                       

Telecommunications

       2,041,911           2,041,911                       

Transportation

                                     (2)  

Utility

       28,616                     28,616             

Preferred Stocks (1)

                                     (2)  

Rights (1)

                   

Equity Contracts

       10,488,715                     10,488,715             

Warrants (1)

                   

Equity Contracts

                                     (2)  

Investment Companies

       24,801,660           24,801,660                       

Other Financial Instruments

                   

Foreign Currency Contracts —Foreign Currency Exchange Contracts

       28,951           28,951                       
    

 

 

      

 

 

      

 

 

      

 

 

 

Total Assets

       1,601,610,880           145,969,037           1,344,068,288           111,573,555   
    

 

 

      

 

 

      

 

 

      

 

 

 

Liabilities

                   

Securities Sold Short (1)

       (42,365,850        (42,365,850                    

Other Financial Instruments

                   

Foreign Currency Contracts —Foreign Currency Exchange Contracts

       (495,302        (495,302                    
    

 

 

      

 

 

      

 

 

      

 

 

 

Total Liabilities

       (42,861,152        (42,861,152                    
    

 

 

      

 

 

      

 

 

      

 

 

 

Total

     $ 1,558,749,728         $ 103,107,885         $ 1,344,068,288         $ 111,573,555   
    

 

 

      

 

 

      

 

 

      

 

 

 

(1) See Investment Portfolio detail for industry breakout.

(2) This category includes securities with a value of zero.

 

Semi-Annual Report       45


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

The tables below set forth a summary of changes in the Long/Short Healthcare Fund’s and the Floating Rate Opportunities Fund’s assets measured at fair value using significant unobservable inputs (Level 3) for the period ended December 31, 2013. The Long/Short Equity Fund had no Level 3 assets as of June 30, 2013 or December 31, 2013.

 

      Balance
as of
June 30,
2013
    Transfers into
Level 3
    Transfers
Out
of Level  3
    Net
Amortization
(Accretion)  of
Premium/
(Discount)
    Net
Realized
Gains/
(Losses)
    Net
Unrealized
Gains/
(Losses)
   

Net

Purchases

    Net
(Sales)
    Balance
as of
December 31,
2013
    Change in
Unrealized
Gain/(Loss)
on Level 3
securities
still held at
period end
 

Highland Long/Short Healthcare Fund

  

           

U.S. Senior Loans

  $ 320,000      $      $     —      $     —      $ (480,000   $ 480,000      $      $ (320,000          $   

Common Stock

                   

Healthcare Equipment & Services

    674,917        934,341                             (52,229                   1,557,029        (52,229

Warrants — Equity Price Risk

    2,582,227        91,919                             (1,586,199                   1,087,947        (184,824
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 3,577,144      $ 1,026,260      $      $      $ (480,000   $ (1,158,428   $      $ (320,000   $ 2,644,976      $ (237,053
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

      Balance
as of
June 30,
2013
    Transfers
into
Level 3
    Transfers
Out
of Level 3
    Net
Amortization
(Accretion)
of Premium/
(Discount)
    Net
Realized
Gains/
(Losses)
    Net
Unrealized
Gains/
(Losses)
   

Net

Purchases

    Net
(Sales)
    Balance
as of
December 31,
2013
    Change in
Unrealized
Gain/(Loss)
on Level 3
securities
still held at
period end
 

Highland Floating Rate Opportunities Fund

  

           

U.S. Senior Loans

  $ 46,040,249      $      $ (23,454,468   $ (7,204   $ (346,738   $ (1,459,973   $ 62,442,448      $ (7,031,997     76,182,317      $ (1,477,489

Foreign Denominated or Domiciled Senior Loans

    6,248,247               (1,508,196     5,753        (37,173     623,002        4,170,220        (379,839     9,122,014        660,811   

Collateralized Loan Obligations

    4,479,510                      56,694        .        108,496                      4,644,700        108,496   

Claims

                           (2,260,867     2,260,867                               

Common Stocks & Exchange-Traded Funds

                   

Broadcasting

    1,542,310                                    895,498                      2,437,808        895,498   

Energy

    1,677,429                                                         1,677,429          

Gaming & Leisure (1)

                                       8,551               (8,551            8,551   

Healthcare

    12,479,828                                    (14,492                   12,465,336        (14,492

Housing (1)

    4,714,281                                    329,670                      5,043,951        329,670   

Media & Telecommuni-cations

               —                                                           

Transportation

                                                                     

Preferred Stocks

                   

Real Esatate

                                       (247,732     247,732                      (247,732

Warrants

                   

Equity Contracts

    66,600                               (47,766            (18,834              
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 77,248,454      $      $ (24,962,664   $ 55,243      $ (2,644,778   $ 2,456,121      $ 66,860,400      $ (7,439,221   $ 111,573,555      $ 263,313   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(1) Balance as of June 30, 2013 reflects an industry reclassification for Nevada Land Group, LLC from Gaming & Leisure to Housing.

 

46       Semi-Annual Report


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

Investments designated as Level 3 may include assets valued using quotes or indications furnished by brokers which are based on models or estimates and may not be executable prices. In light of the developing market conditions, the Investment Adviser continues to search for observable data points and evaluate broker quotes and indications received for portfolio investments. As a result, for the period ended December 31, 2013, a net amount of $1,026,260 and $24,962,664 of the Long/Short Healthcare Fund and the Floating Rate Opportunities Fund’s portfolio investments, respectively, was transferred between Level 2 and Level 3. Determination of fair values is uncertain

because it involves subjective judgments and estimates that are unobservable. Transfers between level three and two were due to management’s assessment of the observable and unobservable inputs for valuing the assets.

For the period ended December 31, 2013, there were no transfers between Level 1 and Level 2.

The table below sets forth a summary of changes in the Funds’ Level 3 assets (assets measured at fair value using significant unobservable inputs) for the year ended December 31, 2013.

 

 

The following is a summary of significant unobservable inputs used in the fair valuations of assets and liabilities categorized within Level 3 of the fair value hierarchy:

 

Fund and
Category
  Ending
Balance at
12/31/13
    Valuation Technique   Unobservable Inputs   Input Value(s)

Highland Long/Short Healthcare Fund

  

     

Common Stocks

    1,557,029      Fair Valuation-Multiple Scenarios   Discount Rate   22%
      Scenario Probabilities   Various

Warrants

    1,087,947      Option Pricing Model   Custom Volatility   75%
 

 

 

       

Total

  $ 2,644,976         

Highland Floating Rate Opportunities Fund

  

     

Debt

  $ 89,949,031      Third-Party Pricing Vendor   N/A   N/A
    Multiple Analysis   Discount Rate   10%
      Asset Specific Discount   75% - 90%
      Liquidity Discount   10% - 30%
    Liquidation Analysis   Discount Rate   15%
    Debt-Loan Spread   Weighting of Comparables   Equal Weights
      Weighted Avg DM   5%
      Liquidity Discount   20%
      Multiple Discount   10%
      Scenario Probabilities   Various
    Recovery Analysis   Scenario Probabilities   Various
    Discounted Cash Flows   Liquidity Discount   25%
      Discount Rate   30%

Common Stocks

    21,624,524      Third-Party Pricing Vendor   N/A   N/A
    Multiples Analysis   Liquidity Discount   20%
      Minority Discount   20%
      Discount Rate   15%
 

 

 

       

Total

  $ 111,573,555         

 

The significant unobservable inputs used in the fair value measurement of the Funds’ debt investments are discount rates, scenario probabilities, weighted comparables and liquidity discounts. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement.

The significant unobservable inputs used in the fair value measurement of the reporting entity’s common stock investments are discount rates and scenario probabilities. Significant changes in either of those inputs in isolation would result in a significantly lower or higher fair value measurement.

 

 

Semi-Annual Report       47


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

Security Transactions

Security transactions are accounted for on the trade date. Realized gains/(losses) on investments sold are recorded on the basis of specific identification method for both financial statement and U.S. federal income tax purposes.

Income Recognition

Dividend income is recorded on the ex-dividend date. Interest income is recorded on the accrual basis and includes accretion of discounts and amortization of premiums of debt instruments.

U.S. Federal Income Tax Status

Each Fund is treated as a separate taxpayer for U.S. federal income tax purposes. The Funds intend to qualify each year as a “regulated investment company” under Subchapter M of the Internal Revenue Code of 1986, as amended, and will distribute substantially all of its taxable income and gains, if any, for the tax year, and as such will not be subject to U.S. federal income taxes. In addition, the Funds intend to distribute, in each calendar year, all of their net investment income, capital gains and certain other amounts, if any, such that the Funds should not be subject to U.S. federal excise tax. Therefore, no U.S. federal income or excise tax provisions are recorded.

Management has analyzed the Funds’ tax positions taken on U.S. federal income tax returns for all open tax years (current and prior three tax years), and has concluded that no provision for U.S. federal income tax is required in the Funds’ financial statements. The Funds’ U.S. federal and state income and U.S. federal excise tax returns for tax years for which the applicable statutes of limitations have not expired are subject to examination by the Internal Revenue Service and state departments of revenue. Furthermore, management of the Fund, is also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next 12 months.

Distributions to Shareholders

The Funds intend to pay distributions from net investment income, if any, on a monthly basis. The Funds intend to pay net realized capital gains, if any, on an annual basis.

Statement of Cash Flows

Information on financial transactions which have been settled through the receipt or disbursement of cash is presented in the Statement of Cash Flows. The cash amount shown in the Statement of Cash Flows is the amount included within each Fund’s Statement of Assets and Liabilities and includes cash on hand at its custodian bank and sub-custodian bank, respectively, and does not

include cash posted as collateral in the segregated account or with the broker-dealers.

Cash & Cash Equivalents

The Funds consider liquid assets deposited with a bank and certain short term debt instruments with original maturities of 3 months or less to be cash equivalents. These investments represent amounts held with financial institutions that are readily accessible to pay Fund expenses or purchase investments. Cash and cash equivalents are valued at cost plus accrued interest, which approximates market value. The value of cash equivalents denominated in foreign currencies is determined by converting to U.S. dollars on the date of the Statement of Assets and Liabilities.

Foreign Currency

Accounting records of the Funds are maintained in U.S. dollars. Foreign currencies, investments and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars at the exchange rates using the current 4:00 PM London Time Spot Rate. Fluctuations in the value of the foreign currencies and other assets and liabilities resulting from changes in exchange rates, between trade and settlement dates on securities transactions and between the accrual and payment dates on dividends, interest income and foreign withholding taxes, are recorded as unrealized foreign currency gains/(losses). Realized gains/(losses) and unrealized appreciation/(depreciation) on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not segregated in the Statement of Operations from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.

Investments in Foreign Markets

Investments in foreign markets involve special risks and considerations not typically associated with investing in the United States. These risks include revaluation of currencies, high rates of inflation, restrictions on repatriation of income and capital, and adverse political and economic developments. Moreover, securities issued in these markets may be less liquid, subject to government ownership controls, tariffs and taxes, subject to delays in settlements, and their prices may be more volatile.

The Funds may be subject to capital gains and repatriation taxes imposed by certain countries in which they invest. Such taxes are generally based on income and/or capital gains earned or repatriated. Taxes are accrued based upon net investment income, net realized gains and net unrealized appreciation as income and/or capital gains are earned.

 

 

48       Semi-Annual Report


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

Securities Sold Short

The Funds may sell securities short. A security sold short is a transaction in which the Funds sell a security it does not own in anticipation that the market price of that security will decline. When the Funds sell a security short, it must borrow the security sold short from a broker-dealer and deliver it to the buyer upon conclusion of the transaction. The Funds may have to pay a fee to borrow particular securities and is often obligated to pay over any dividends or other payments received on such borrowed securities. Cash held as collateral for securities sold short is classified as restricted cash on Long/Short Equity Fund’s and Long/Short Healthcare Fund’s Statement of Assets and Liabilities. Restricted cash in the amounts of $154,731,920, $21,038,845 and $58,983,363 were held with the broker for the Long/Short Equity Fund, the Long/Short Healthcare Fund and the Floating Rate Opportunities Fund, respectively. Additionally, securities valued at $328,634,465 and $19,005,618 were posted in the Long/Short Equity Fund and Long/Short Healthcare Fund’s segregated accounts as collateral.

Note 3. Derivative Transactions

The Funds are subject to equity price risk, interest rate risk, and foreign currency exchange rate risk in the normal course of pursuing their investment objectives. The Funds enter into derivative transactions for the purpose of hedging against the effects of changes in the value of portfolio securities due to anticipated changes in market conditions, to gain market exposure for residual and accumulating cash positions, and for managing the duration of fixed income investments.

Forward Foreign Currency Exchange Contracts

The Funds enters into forward foreign currency exchange contracts to facilitate transactions in foreign denominated securities and to manage the Funds’ currency exposure. Forward foreign currency exchange contracts are valued at the mean between the bid and the offered forward rates as last quoted by a recognized dealer. The aggregate principal amounts of the contracts are not recorded in the Fund’s financial statements. Such amounts appear under the caption Forward Foreign Currency Exchange Contracts in the Investment Portfolio. Fluctuations in the value of the contracts are recorded in the Statement of Assets and Liabilities as an asset (or liability) and in the Statement of Operations as unrealized appreciation (depreciation) until the contracts are closed, when they are recorded as realized gains or losses on foreign currency related transactions. The Fund’s risks in using these contracts include changes in the value of foreign currency or the possibility that the counterparties do not perform under the contracts’ terms. When the Fund enters into a forward foreign

currency exchange contract, it is required to segregate cash or liquid securities with its custodian in an amount equal to the value of the Fund’s total assets committed to the consummation of the forward contract. If the value of the segregated securities declines, additional cash or securities is segregated so that the value of the account will equal the amount of the Fund’s commitment with respect to the contract. For the period ended December 31, 2013, the open values of the Floating Rate Opportunities Fund’s forward foreign currency exchange contracts were EUR 1,485,000 and GBP 4,020,000.

For the period ended December 31, 2013, the Long/Short Equity Fund and the Long/Short Healthcare Fund did not invest in forward foreign currency exchange contracts.

Futures Contracts

A futures contract represents a commitment for the future purchase or sale of an asset at a specified price on a specified date. The Funds may invest in interest rate, financial and stock or bond index futures contracts subject to certain limitations. The Funds invest in futures contracts to manage their exposure to the stock and bond markets and fluctuations in currency values. Buying futures tends to increase a Fund’s exposure to the underlying instrument while selling futures tends to decrease a Fund’s exposure to the underlying instrument, or economically hedge other Fund investments. With futures contracts, there is minimal counterparty credit risk to the Funds since futures contracts are exchange-traded and the exchange’s clearinghouse, as counterparty to all traded futures, guarantees the futures against default. A Fund’s risks in using these contracts include changes in the value of the underlying instruments, non-performance of the counterparties under the contracts’ terms and changes in the liquidity of the secondary market for the contracts. Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they principally trade. Upon entering into a financial futures contract, the Funds are required to pledge to the broker an amount of cash and/or other assets equal to a certain percentage of the contract amount, known as initial margin deposit. Subsequent payments, known as variation margins, are made or received by the Funds each day, depending on the daily fluctuation in the fair value of the underlying security. The Funds record an unrealized gain/(loss) equal to the daily variation margin. Should market conditions move unexpectedly, the Funds may not achieve the anticipated benefits of the futures contracts and may incur a loss. The Funds recognize a realized gain/(loss) on the expiration or closing of a futures contract. During the period ended December 31, 2013, the Long/Short Equity Fund entered into futures transactions for the purpose of hedging against the effects of changes in the value of

 

 

Semi-Annual Report       49


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

portfolio securities due to anticipated changes in market conditions, to gain market exposure for residual and accumulating cash positions, and for managing the duration of fixed-income investments.

During the period ended December 31, 2013, the Long/Short Healthcare Fund and the Floating Rate Opportunities Fund did not invest in futures contracts.

Options

The Funds may utilize options on securities or indexes to varying degrees as part of their principal investment strategy. An option on a security is a contract that gives the holder of the option, in return for a premium, the right to buy from (in the case of a call) or sell to (in the case of a put) the writer of the option the security underlying the option at a specified exercise or “strike” price. The writer of an option on a security has the obligation upon exercise of the option to deliver the underlying security upon payment of the exercise price or to pay the exercise price upon delivery of the underlying security. The Funds may hold options, write option contracts, or both.

If an option written by a Fund expires unexercised, the Fund realizes on the expiration date a capital gain equal to the premium received by the Fund at the time the option was written. If an option purchased by a Fund expires unexercised, the Fund realizes a capital loss equal to the premium paid. Prior to the earlier of exercise or expiration, an exchange-traded option may be closed out by an offsetting purchase or sale of an option of the same series (type, underlying security, exercise price and expiration). There can be no assurance, however, that a closing purchase or sale transaction can be effected when the Fund desires. A Fund will realize a capital gain from a closing purchase transaction if the cost of the closing option is less than the premium received from writing the option, or, if it is more, the Fund will realize a capital loss.

During the period ended December 31, 2013, the Long/Short Equity Fund and the Long/Short Healthcare Fund had written options to provide leveraged short exposure, and purchased options to provide leveraged long exposure, to the underlying equity, which is consistent with the investment strategies of these Funds.

Transactions in written options for the period ended December 31, 2013 were as follows:

 

Long/Short Equity Fund   Number of
Contracts
    Premium  

Outstanding, June 30, 2013

    2,500      $ 188,490   

Call Options Written

    30,575        11,159,180   

Put Options Written

    600        296,279   

Call Options Exercised

    (9,948     (5,551,064

Call Options Expired

    (10,250     (1,460,024

Put Options Expired

    (2,500     (188,490

Call Options Closed

    (9,177     (3,440,885

Put Options Closed

    (600     (465,216
 

 

 

   

 

 

 

Outstanding, December 31, 2013

    1,200      $ 538,270   

 

Long/Short Healthcare Fund   Number of
Contracts
    Premium  

Outstanding, June 30, 2013

    662      $ 30,609   

Call Options Written

    165        24,326   

Call Options Expired

    (662     (30,609

Put Options Expired

    (165     (24,326
 

 

 

   

 

 

 

Outstanding, December 31, 2013

         $   

During the period ended December 31, 2013, the Floating Rate Opportunities Fund did not invest in options.

Additional Derivative Information

The Funds adopted amendments to authoritative guidance on disclosures about derivative instruments and hedging activities which require that the Funds disclose: a) how and why an entity uses derivative instruments, b) how derivative instruments and related hedged items are accounted for and c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance and cash flows.

The fair value of derivative instruments on the Statement of Assets and Liabilities have the following risk exposure at December 31, 2013.

 

   

Fair Value

 
Risk Exposure   Asset
Derivative
    Liability
Derivative
 

Long/Short Equity Fund

   

Equity Price Risk

  $      $ 753,600 (1)  

Foreign Exchange Risk

           1,701,153 (2)  

Floating Rate Opportunities Fund

   

Foreign Exchange Risk

    28,951 (3)       495,302 (4)3)  

 

(1)  

Statement of Assets and Liabilities location: Written options contracts, at value.

(2)

Amounts, or a portion thereof, reflect cumulative appreciation/depreciation of futures as disclosed on the Fund’s Investment Portfolio. The period end variation margin is separately disclosed on the Fund’s Statement of Assets and Liabilities.

(3)  

Statement of Assets and Liabilities location: Unrealized appreciation on forward foreign currency exchange contracts.

(4)  

Statement of Assets and Liabilities location: Unrealized depreciation on forward foreign currency exchange contracts.

 

 

50       Semi-Annual Report


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

 

To reduce counterparty credit risk with respect to OTC transactions, the Funds have entered into master netting arrangements, established within the Funds’ International Swap and Derivatives Association, Inc. (“ISDA”) master agreements, which allows the Funds to make (or to have an entitlement to receive) a single net payment in the event of default (close-out netting) for outstanding payables and receivables with respect to certain OTC derivative positions in forward currency exchange contracts for each individual counterparty. In addition, the Funds may require that certain counterparties post cash and/or securities in collateral accounts to cover their net payment obligations for those derivative contracts subject to ISDA master agreements. If the counterparty fails to perform under these contracts and agreements, the cash and/or securities will be made available to the Funds.

Certain ISDA master agreements include credit related contingent features which allow counterparties to OTC derivatives to terminate derivative contracts prior to maturity in the event the Funds’ net assets decline by a stated percentage or the Funds fail to meet the terms of its ISDA master agreements, which would cause the Funds to accelerate payment of any net liability owed to the counterparty.

 

For financial reporting purposes, the Funds do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statement of Assets and Liabilities. Bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against the right of offset in bankruptcy, insolvency or other events.

Collateral terms are contract specific for OTC derivatives. For derivatives traded under an ISDA master agreement, the collateral requirements are typically calculated by netting the mark to market amount for each transaction under such agreement and comparing that to the value of any collateral currently pledged by the Fund or the Counterparty.

For financial reporting purposes, cash collateral that has been pledged to cover obligations of the Funds, if any, is reported in restricted cash on the Statement of Assets and Liabilities. Generally, the amount of collateral due from or to a party must exceed a minimum transfer amount threshold before a transfer has to be made. To the extent amounts due to the Funds from its counterparties are not fully collateralized, contractually or otherwise, the Funds bear the risk of loss from counterparty non-performance.

 

 

The following tables present derivative instruments that are subject to enforceable netting arrangements as of December 31, 2013:

 

Gross Amounts Not Offset in the Statement of Assets and Liabilities  
Fund   Counterparty     Gross Amounts
of Assets
Presented in
Statement of
Assets &
Liabilities
    Financial
Instrument
    Collateral
Received
    Net Amount
(not  less
than 0)
 

Floating Rate Opportunities Fund

    PNC Capital Markets LLC      $ 28,951      $ (28,951   $      $   

 

Gross Amounts Not Offset in the Statement of Assets and Liabilities  
Fund    Counterparty     

Gross Amounts
of Liabilities
Presented in
Statement of
Assets &

Liabilities

    Financial
Instrument
    Collateral
Pledged
    Net Amount
(not less
than 0)
 

Floating Rate Opportunities Fund

     Credit Suisse First Boston       $ 417,961      $      $      $ 417,961   

Floating Rate Opportunities Fund

     PNC Capital Markets LLC         77,341        (28,951          $ 48,390   

 

Semi-Annual Report       51


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

The effect of derivative instruments on the Statement of Operations for the period ended December 31, 2013, is as follows:

 

Fund   Net
Realized
Gain/(Loss)
on
Derivatives
    Net Change  in
Unrealized
Appreciation/
(Depreciation)
on Derivatives
 

Long/Short Equity Fund

   

Equity Price Risk

  $ (7,445,378 ) (1)     $ (1,993,519 ) (3)  

Commodity Risk

    574,426 (1)       (77,076 ) (3)  

Foreign Currency Risk

    1,070,089 (1)       (24,443 ) (3)  

Long/Short Healthcare Fund

   

Equity Price Risk

    (1,333,816 ) (1)       138,657 (3)  

Floating Rate Opportunities Fund

   

Foreign Currency Risk

    261,571 (2)       (858,075 ) (4)  

 

(1)  

Statement of Operations location: Net realized gain/(loss) on written options contracts, futures contracts, and/or investments.

(2)  

Statement of Operations location: Net realized gain/(loss) on foreign currency related transactions.

(3)  

Statement of Operations location: Net change in unrealized appreciation/(depreciation) on written options contracts, futures contracts and/or investments.

(4)  

Statement of Operations location: Net change in unrealized appreciation/(depreciation) on foreign currency related translations.

For the period ended December 31, 2013, each Fund’s average volume of derivatives is as follows:

 

Fund   Units/
Contracts
    Appreciation/
(Depreciation)
 

Long/Short Equity Fund

   

Purchased Options Contracts

    3,333      $   

Futures Contracts

           (513,864

Written Options Contracts

    2,275          

Long/Short Healthcare Fund

   

Purchased Options Contracts

    41,525          

Written Options Contracts

    221          

Floating Rate Opportunities Fund

   

Forward Foreign Currency Exchange Contracts

           (134,920

Note 4. Securities Lending

Each Fund may make secured loans of its portfolio securities amounting to not more than one-third of the value of its total assets, thereby realizing additional income. The risks in lending portfolio securities, as with other extensions of credit, consist of possible delays in recovery of the securities or possible loss of rights in the collateral should the borrower fail financially and possible investment losses in the investment of collateral. Pursuant to the Fund’s securities lending policies, securities loans are made to unaffiliated broker-dealers pursuant to agreements requiring that loans be continuously secured by collateral in cash or short-term debt obligations at least equal at all

times to the value of the securities subject to the loan. The borrower pays to a Fund an amount equal to any interest or dividends received on securities subject to the loan. The Fund retains all or a portion of the interest received on investment of the cash collateral or receives a fee from the borrower.

Securities lending transactions are entered into Securities Lending Authorization Agreements (“SLAA”), which provides the right, in the event of default (including bankruptcy or insolvency) for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the Fund, as lender, would offset the market value of the collateral received against the market value of the securities loaned. The value of the collateral is typically greater than that of the market value of the securities loaned, leaving the lender with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of a SLAA counterparty’s bankruptcy or insolvency. Under the SLAA, the Fund can reinvest cash collateral, or, upon an event of default, resell or repledge the collateral, and the borrower can resell or repledge the loaned securities. The risks of securities lending also include the risk that the borrower may not provide additional collateral when required or may not return the securities when due. To mitigate this risk, the Fund benefits from a borrower default indemnity provided by State Street Bank and Trust Company (“State Street”). State Street’s indemnity allows for full replacement of securities lent.

The following table presents financial instruments that are subject to enforceable netting arrangements as of December 31, 2013:

 

Gross Amounts Not Offset in the Statement of Assets and Liabilities  
     

Gross
Amounts of
Liabilities

Presented
in
Statement
of Assets &
Liabilities
(1)

    Financial
Instrument
(2)(3)
    Collateral
Received
    Net
Amount
(not less
than 0)
 

Long/Short Equity Fund

  $ 68,431,932      $ (67,673,953   $ —        $ 757,979   

Long/Short Healthcare Fund

    9,908,413        (9,744,486     —          163,927   

Floating Rate Opportunities Fund

    24,801,660        (24,286,219     —          515,441   

 

(1)

Represents market value of securities on loan at year end.

(2)

For the year ended December 31, 2013, the market value of securities loaned by the Funds was $67,673,953, 9,744,486 and 24,286,219, respectively. The loaned securities were secured with cash collateral of $68,431,932, 9,908,413 and 24,801,660, respectively, which was invested in the State Street Navigator Prime Securities Lending Portfolio.

(3)  

In some instances, the actual collateral received and/or pledged may be more than the amount shown here due to overcollateralization.

 

 

52       Semi-Annual Report


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

Note 5. U.S. Federal Income Tax Information

The character of income and gains to be distributed is determined in accordance with income tax regulations which may differ from U.S. GAAP. These differences include (but are not limited to) investments organized as partnerships for tax purposes, foreign taxes, investments in futures, losses deferred to off-setting positions, tax treatment of organizational start-up costs, losses deferred due to wash sale transactions, tax treatment of net investment loss and distributions in excess of net investment income, dividends deemed paid upon shareholder redemption of fund shares and tax attributes from fund reorganizations. Reclassifications are made to the Funds’ capital accounts to reflect income and gains available for distribution (or available capital loss carryovers) under income tax regulations. These reclassifications have no impact on net investment income, realized gains or losses, or net asset value of the Funds. The calculation of net investment

income per share in the Financial Highlights table excludes these adjustments.

For the year ended June 30, 2013, permanent differences chiefly resulting from net investment losses, dividends on short sales, foreign currency gains and losses, equalization, short sale holding period reclass and REITs were identified and reclassified among the components of the Funds’ net assets as follows:

 

Fund   Undistributed
Net
Investment
Income
    Accumulated
Net Realized
Gain (Loss)
    Paid-in
Capital
 

Long/Short Equity Fund

  $ 10,073,645      $ (10,940,072   $ 866,427   

Long/Short Healthcare Fund

    1,614,767        (9,115     (1,605,652

Floating Rate Opportunities Fund

    (34,312     6,891,640        (6,857,328
 

 

At June 30, 2013, the Funds’ tax year end, components of distributable earnings on a tax basis is as follows:

 

Fund   Undistributed
Ordinary
Income
    Undistributed
Long-Term
Capital Gains
    Undistributed
Tax-Exempt
Income
    Accumulated
Capital and
Other Losses
    Net Tax
Appreciation/
(Depreciation)
(1)
 

Long/Short Equity Fund

  $ 18,806,481      $ —        $ —        $      $ 12,292,968   

Long/Short Healthcare Fund

           —          —          (9,368,194     2,620,444   

Floating Rate Opportunities Fund

           —          —          (884,992,058     (469,802,752

 

(1)  

Any differences between book-basis and tax-basis net unrealized appreciation/(depreciation) are primarily due to deferral of losses from wash sale, and other adjustments.

At June 30, 2013, the Floating Rate Opportunities Fund and the Long/Short Healthcare Fund had capital loss carryovers as indicated below. The capital loss carryovers are available to offset future realized capital gains to the extent provided in the Code and regulations promulgated thereunder. To the extent that these carryover losses are used to offset future capital gains, it is probable that the gains so offset will not be distributed to shareholders because they would be taxable as ordinary income.

 

Fund   2015     2016     2017     2018     2019    

No
Expiration

Short-
Term
(1)

    No
Expiration
Long-
Term
(1)
    Total  

Long/Short Healthcare Fund

  $      $      $      $      $      $ 8,493,043      $ 388,417      $ 8,881,460   

Floating Rate Opportunities Fund

    8,394,093 (2)       232,159,979 (2)       450,912,670 (2)       143,999,490 (2)                     57,108,843        892,575,075   
(1)  

On December 22, 2010, the Regulated Investment Company Modernization Act of 2010 (the “Modernization Act”) was signed into law. The Modernization Act modifies several of the Federal income and excise tax provisions related to RICs. Under the Modernization Act, new capital losses may now be carried forward indefinitely, and retain the character of the original loss as compared with pre-enactment law where capital losses could be carried forward for eight years, and carried forward as short-term capital losses, irrespective of the character of the original loss.

(2)  

These capital loss carryforward amounts were acquired in a reorganization and are available to offset future capital gains of Floating Rate Opportunities Fund. The Fund’s ability to utilize the capital loss carryforwards is limited under Internal Revenue Service regulations.

 

Semi-Annual Report       53


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

For the year ended June 30, 2013 there were no capital loss carryforwards for the Long/Short Equity Fund.

The tax character of distributions paid during the years ended June 30, 2013 and June 30, 2012 (unless otherwise indicated) were as follows:

 

   

Distributions Paid From:

 
Fund   Ordinary
Income
(1)
    Long-
Term
Capital
Gains
    Return of
Capital
 

Long/Short Equity Fund

     

2013

  $ 24,088,101      $ —        $   

2012

    3,482,889        —            

Long/Short Healthcare Fund

     

2013

           —            

2012

    6,785,881        —            

Floating Rate Opportunities Fund

     

2013

    21,786,709        —          6,857,328   

2012

    26,165,656        —            
(1)  

For tax purposes, short-term capital gains distributions, if any, are considered ordinary income distributions.

Unrealized appreciation and depreciation at December 31, 2013, based on cost of investments for U.S. federal income tax purposes was:

 

Fund   Gross
Appreciation
    Gross
Depreciation
    Net
Appreciation/
(Depreciation)
(1)
    Cost  

Long/Short Equity Fund

  $ 109,033,048      $ 24,467,295      $ 84,566,653      $ 720,609,779   

Long/Short Healthcare Fund

    8,111,509        2,578,205        5,533,304        31,597,866   

Floating Rate Opportunities Fund

    149,633,710        550,268,426        (400,634,716     1,959,850,795   
(1)  

Any differences between book-basis and tax-basis net unrealized appreciation/(depreciation) are primarily due to deferral of losses from wash sale, premium amortization, and other adjustments

 

In the first quarter of the 2014 fiscal year, the Trust identified a book-tax difference related to foreign-currency losses that were recorded as a capital loss in Floating Rate Opportunities Fund for fiscal year 2013, which should have been reported as a reduction of income in the financial statements for the fiscal year ended June 30, 2013. This resulted in a reclassification from “Distributions to shareholders from: Net Investment Income” to “Distributions to shareholders from: Return of Capital” on the Statement of Changes in Net Assets in the amount of $6,857,328. The reclassification also affects the components of Net Assets on the Statement of Asset and Liabilities, the character of distributions represent on the Financial Highlights, and the

tax character of earnings and distributions represented in Note 4, U.S. Federal Income Tax Information. Management evaluated the impact of the adjustment and determined the impact was not material to the prior period financial statements; however management has revised the June 30, 2013 financial statements as presented herein. The correction has no effect on Net Asset Value, total Net Assets, Fund returns, or total increase in net assets resulting from operations. The error also impacted previously reported financial highlights. See the Financial Highlights statement for the impact to financial highlights as reported at June 30, 2013.

 

 

54       Semi-Annual Report


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

The following tables illustrate the effect of the adjustment in the Statement of Assets and Liabilities, Statements of Changes in Net Assets, and related footnote disclosures for the period and year ended June 30, 2013, to allow a reader to roll the components of the Fund Net Assets for Floating Rate Opportunities Fund.

 

       Corrected
Amount
     Previous
Published
Amount
     Adjustment  

Statement of Assets and Liabilities:

Net Assets Consist of:

        

Par Value

   $ 96,419       $ 96,419       $   

Paid-in capital

     2,101,640,498         2,108,497,826         (6,857,328

Accumulated net investment loss

     (24,729,109      (24,003,420      (725,689

Accumulated net realized gain (loss)

     (883,237,412      (890,820,429      7,583,017   

Net unrealized appreciation (depreciation)

     (447,520,300      (447,520,300        
  

 

 

    

 

 

    

 

 

 

Net Assets

   $ 746,250,096       $ 746,250,096           
  

 

 

    

 

 

    

 

 

 
        
      

Corrected

Amount

     Previous
Published
Amount
     Adjustment  

Statement of Changes in Net Assets

        

Distributions to shareholders from:

        

Net investment income

        

Class A

   $ (8,158,527    $ (10,545,249    $ 2,386,722   

Class B

     (71,663      (91,537      19,874   

Class C

     (11,460,980      (15,271,797      3,810,817   

Class Z

     (2,095,539      (2,735,454      639,915   

Return of Capital

     

Class A

     (2,386,722              (2,386,722

Class B

     (19,874              (19,874

Class C

     (3,810,817              (3,810,817

Class Z

     (639,915              (639,915
  

 

 

    

 

 

    

 

 

 

Total distributions

     (28,644,037      (28,644,037        
  

 

 

    

 

 

    

 

 

 

Accumulated net investment loss

     (24,729,109      (24,003,420      (725,689
  

 

 

    

 

 

    

 

 

 
        
       Corrected
Amount
     Previous
Published
Amount
     Adjustment  

U.S. Federal Income Tax Information

        

Tax Reclassifications:

        

Undistributed Net Investment Income

   $ (34,312    $ 691,377       $ (725,689

Accumulated Net Realized Gain(Loss)

     6,891,640         (691,377      7,583,017   

Paid-in Capital

     (6,857,328              (6,857,328

Components of Distributable Earnings

     

Undistributed Ordinary Income

             725,689         (725,689

Undistributed Long-Term Capital Gains

                       

Undistributed Tax-Exempt Income

                       

Accumulated Capital and Other Losses

     (884,992,058      (892,575,075      7,583,017   

Net Tax Appreciation/(Depreciation)

     (469,802,752      (469,802,752        

Tax Character of Distributions

     

Distributions paid from:

     

Ordinary Income

     21,786,709         28,644,037         (6,857,328

Long-Term Capital Gains

                       

Return of Capital

     6,857,328                 6,857,328   

 

Semi-Annual Report       55


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

Note 6. Credit Agreement

Effective June 13, 2012, the Floating Rate Opportunities Fund entered into a $300,000,000 credit agreement (the “Credit Agreement”) with State Street Bank and Trust Company with an expiration of June 10, 2013. On October 29, 2012, the Credit Agreement was amended, reducing the facility from $300,000,000 to $250,000,000. At December 31, 2013, the Floating Rate Opportunities Fund had no borrowings under the Credit Agreement. For the period June 13, 2012 to June 9, 2013, interest was charged at a rate equal to the adjusted London Interbank Offered Rate (“LIBOR”) plus 1.10% per annum based on the outstanding borrowings. On June 10, 2013, the Credit Agreement was amended to reduce the interest rate to the adjusted LIBOR plus 0.95% per annum based on the outstanding borrowings. In addition, a commitment fee of 0.15% per annum is charged on the unutilized commitment amount. Included in the Statement of Operations is $0 of interest expense related to the Credit Agreement and $191,708 of commitment fees. On June 10, 2013, the Credit Agreement expiration date was extended to June 10, 2014.

The Floating Rate Opportunities Fund is required to maintain 300% asset coverage with respect to amounts outstanding under the Credit Agreement, as amended, and the Fund is required to maintain 300% asset coverage under Section 18(a) of the 1940 Act. Asset coverage is calculated by subtracting the Fund’s total liabilities, not including any amount representing bank loans and senior securities, from the Fund’s total assets and dividing the result by the principal amount of the borrowings outstanding. As of the dates indicated below, the Floating Rate Opportunities Fund’s debt outstanding and asset coverage was as follows:

 

Date    Total Amount
Outstanding
     % of Asset
Coverage of
Indebtedness
 

12/31/2013

     N/A         N/A   

06/30/2013

     N/A         N/A   

06/30/2012

   $ 89,000,000         718.4

06/30/2011

     135,000,000         659.9   

06/30/2010

     115,000,000         606.0   

08/31/2009

     181,000,000         465.8   

08/31/2008

     511,000,000         409.3   

08/31/2007

     960,000,000         400.5   

Effective May 24, 2013, the Long/Short Equity Fund and the Long/Short Healthcare Fund entered into a $25,000,000 unsecured credit agreement with State Street Bank and Trust Company (the “Unsecured Credit Agreement”) to be used for temporary purposes to facilitate portfolio liquidity. The Funds have access to the facility, but aggregate borrowings cannot exceed

$25,000,000. Interest is charged to the Funds based on their borrowings at a rate equal to the greater of the Federal Funds Effective Rate plus 1.25% or the LIBOR plus 1.25%. In addition, the Funds agree to pay commitment fee expenses of 0.10% on the undrawn amounts, which are included in “Other” on the Statement of Operations. The Unsecured Credit Agreement is set to expire May 23, 2014. During the period ended December 31, 2013, the Funds did not have any outstanding borrowings.

Note 7. Advisory, Administration, Service and Distribution, Trustee, and Other Fees

Investment Advisory Fees and Sub-advisory Fees

The Investment Adviser receives from the Long/Short Equity Fund and the Long/Short Healthcare Fund monthly investment advisory fees, computed and accrued daily based on the Average Daily Managed Assets of each Fund, at the annual rate of 2.25% and 1.00%, respectively.

The Long/Short Healthcare Fund and the Investment Adviser have entered into a sub-advisory agreement with Cummings Bay Capital Management, L.P. The Fund pays sub-advisory fees to Cummings Bay Capital Management, L.P. at an annual rate of 0.50% of the Average Daily Managed Assets of the Fund.

The Investment Adviser receives from the Floating Rate Opportunities Fund monthly investment advisory fees, computed and accrued daily, based on an annual rate of 0.65% of the Fund’s Average Daily Managed Assets for the first $1 billion, 0.60% of the Fund’s Average Daily Managed Assets for the next $1 billion and 0.55% of the Fund’s Average Daily Managed Assets over $2 billion.

“Average Daily Managed Assets” of a Fund means the average daily value of the total assets of the Fund less all accrued liabilities of the Fund (other than the aggregate amount of any outstanding borrowings constituting financial leverage).

Administration Fees

The Investment Adviser provides administrative services to each Fund. For its services, the Investment Adviser receives a monthly administration fee, computed and accrued daily, at the annual rate of 0.20% of each Fund’s Average Daily managed net assets.

Service and Distribution Fees

Foreside Funds Distributors LLC (the “Underwriter”), serves as the principal underwriter and distributor of each Fund’s shares. The Underwriter receives the front-end sales charge imposed on the sale of Class A Shares and the

 

 

56       Semi-Annual Report


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

contingent deferred sales charge (“CDSC”) imposed on certain redemptions of Class A and Class C Shares. For the period ended December 31, 2013, the Underwriter received $113,317, $131,666 and $468,942 of front end sales charges for Class A Shares of the Long/Short Equity Fund, the Long/Short Healthcare Fund and the Floating Rate Opportunities Fund, respectively. The Underwriter also received $5,925 and $15,920 of CDSC for Class C Shares of the Long/Short Equity Fund and the Floating Rate Opportunities Fund, respectively.

The Funds have adopted a plan pursuant to Rule 12b-1 under the 1940 Act (the “Plan”) for Class A Shares, Class B Shares and Class C Shares of the Funds, which requires the payment of a monthly fee to the Underwriter at an annual rate of the average daily net assets of each class as follows:

 

Fund   Class A
Shares
    Class B
Shares
    Class C
Shares
 

Long/Short Equity Fund

    0.35     N/A        1.00

Long/Short Healthcare Fund

    0.35     N/A        1.00

Floating Rate Opportunities Fund

    0.35     0.70     0.85

For the period ended December 31, 2013, the Distribution and Service fees, which are included on the Statement of Operations for each class, were as follows:

 

Fund   Class A
Fees
    Class B
Fees
    Class C
Fees
 

Long/Short Equity Fund

  $ 278,197      $ —        $ 241,671   

Long/Short Healthcare Fund

    25,704        —          33,888   

Floating Rate Opportunities Fund

    753,995        509        1,528,865   

Expense Limits and Fee Reimbursements

For the Long/Short Equity Fund, the Investment Adviser contractually agreed to waive a portion of its advisory fee in an amount equal to 1.25% of the Fund’s Average Daily Managed Assets. This waiver will continue through at least October 31, 2014 and may not be terminated prior to this date without the action or consent of the Board of Trustees.

For the Floating Rate Opportunities Fund, effective November 1, 2012, the Investment Adviser contractually agreed to limit the total annual operating expenses of the Floating Rate Opportunities Fund (exclusive of fees paid by the Fund pursuant to its distribution plan under Rule 12b-1 under the Investment company Act of 1940, taxes, interest (including interest incurred in connection with bank and custody overdrafts), brokerage commissions and other transaction costs, acquired fund fees and expenses, and extraordinary expenses) of the Fund to 0.95% of average daily net assets of the fund. The Expense Cap will continue through at least October 31, 2014, and may not be

terminated prior to this date without the action or consent of the Board of Trustees.

The Trust, on behalf of the Fund, has contractually agreed to pay the Adviser all amounts previously paid, waived or reimbursed by the Adviser with respect to the Fund pursuant to the Expense Cap, provided that the amount of such additional payment in any year, together with all other expenses of the Fund, in the aggregate, would not cause the Fund’s total annual operating expenses in any such year to exceed the amount of the Expense Cap, and provided further that no additional payments by the Trust will be made with respect to amounts paid, waived or reimbursed by the Adviser more than 36 months after the date the Fund accrues a liability with respect to such amounts paid, waived or reimbursed by the Adviser. The recoupment amount for the Floating Rate Fund was $584,315, which will expire in November 1, 2015.

For the period ended December 31, 2013, the Investment Adviser waived $6,235,607 for the Long/Short Equity Fund, and reimbursed $584,315 for the Floating Rate Opportunities Fund.

Fees Paid to Officers and Trustees

Each Trustee who is not an “interested person” of the Funds as defined in the 1940 Act (the “Independent Trustees”) receives an annual retainer of $150,000 payable in quarterly installments and allocated among each portfolio in the Highland Fund Complex based on relative net assets. The “Highland Fund Complex” consists of all of the registered investment companies advised by the Investment Adviser as of the date of this report.

The Funds pay no compensation to their one interested Trustee or any of their officers, all of whom are employees of the Investment Adviser.

Note 8. Redemption Fees

The Funds impose a 2.00% redemption fee on some Class A, Class B, Class C and Class Z Shares that are redeemed or exchanged within two months or less after the date of purchase, unless otherwise waived by a Fund. The fee is calculated based on the shares’ aggregate net asset value on the date of redemption, is allocated back to each class based on relative net assets and is deducted from the redemption proceeds on the Statement of Changes in Net Assets. The redemption fee is not a sales charge and is retained by the Funds. For the period ended

 

 

Semi-Annual Report       57


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

December 31, 2013, the Funds collected the following redemption fees:

 

   

Redemption Fee Amount

 
Fund   Class A     Class B     Class C     Class Z  

Long/Short Equity Fund

  $ 3,475      $ —        $ 1,082      $ 17,014   

Long/Short Healthcare Fund

    36        —          16        10   

Floating Rate Opportunities Fund

    42,023        17        37,964        28,585   

Note 9. Disclosure of Significant Risks and Contingencies

The primary risks of investing in the Funds are described below in alphabetical order:

Concentration Risk

The Funds may focus their investments in instruments of only a few companies. The concentration of each Fund’s portfolios in any one obligor would subject the Funds to a greater degree of risk with respect to defaults by such obligor, and the concentration of the portfolio in any one industry would subject the Funds to a greater degree of risk with respect to economic downturns relating to such industry.

Counterparty Credit Risk

Counterparty credit risk is the potential loss the Funds may incur as a result of the failure of a counterparty or an issuer to make payments according to the terms of a contract. Counterparty credit risk is measured as the loss the Funds would record if its counterparties failed to perform pursuant to the terms of their obligations to the Funds. Because the Funds may enter into over-the-counter forwards, options, swaps and other derivative financial instruments, the Funds may be exposed to the credit risk of its counterparties. To limit the counterparty credit risk associated with such transactions, the Funds conduct business only with financial institutions judged by the Investment Adviser to present acceptable credit risk.

Credit Risk

Investments rated below investment grade are commonly referred to as high-yield, high risk or “junk debt.” They are regarded as predominantly speculative with respect to the issuing company’s continuing ability to meet principal and/ or interest payments. Investments in high yield debt and high yield Senior Loans may result in greater net asset value fluctuation than if the Fund did not make such investments.

Corporate debt obligations, including Senior Loans, are subject to the risk of non-payment of scheduled interest and/or principal. Non-payment would result in a reduction of income to the Fund, a reduction in the value of the

corporate debt obligation experiencing non-payment and a potential decrease in the NAV of the Fund.

Currency Risk

A portion of the Fund’s assets may be quoted or denominated in non-U.S. currencies. These securities may be adversely affected by fluctuations in relative currency exchange rates and by exchange control regulations. The Fund’s investment performance may be negatively affected by a devaluation of a currency in which the Fund’s investments are quoted or denominated. Further, the Fund’s investment performance may be significantly affected, either positively or negatively, by currency exchange rates because the U.S. dollar value of securities quoted or denominated in another currency will increase or decrease in response to changes in the value of such currency in relation to the U.S. dollar.

Emerging Markets Risk

Any investments in Emerging Market Countries (countries in which the capital markets are developing) may involve greater risks than investments in more developed markets and the prices of such investments may be more volatile. The consequences of political, social or economic changes in these markets may have disruptive effects on the market prices of the Fund’s investments and the income they generate, as well as the Fund’s ability to repatriate such amounts.

Foreign Securities Risk

Investments in foreign securities involve certain factors not typically associated with investing in U.S. securities, such as risks relating to (i) currency exchange matters, including fluctuations in the rate of exchange between the U.S. dollar (the currency in which the books of the Fund are maintained) and the various foreign currencies in which the Fund’s portfolio securities will be denominated and costs associated with conversion of investment principal and income from one currency into another; (ii) differences between the U.S. and foreign securities markets, including the absence of uniform accounting, auditing and financial reporting standards and practices and disclosure requirements, and less government supervision and regulation; (iii) political, social or economic instability; and (iv) the extension of credit, especially in the case of sovereign debt.

Forward Foreign Currency Exchange Contracts Risk

The Funds are subject to foreign currency exchange rate risk in the normal course of pursuing its investment objectives. The Funds may use forward contracts to gain exposure to, or hedge against changes in the value of foreign currencies. A forward contract represents a commitment for the future purchase or sale of an asset at

 

 

58       Semi-Annual Report


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

a specified price on a specified date. Upon entering into such contracts, daily fluctuations in the value of the contract are recorded for financial statement purposes as unrealized gains or losses by the Funds. At the expiration of the contracts the Funds realize the gain or loss. Upon entering into such contracts, the Funds bear the risk of exchange rates moving unexpectedly, in which case, the Funds may not achieve the anticipated benefits of the forward contracts and may realize a loss. With forwards, there is counterparty credit risk to the Funds because the forwards are not exchange-traded, and there is no clearinghouse to guarantee the forwards against default.

Futures Contracts Risk

The risks of entering into futures contracts include the possibilities that their markets may become illiquid and/or changes in the values of the contracts may not correlate to changes in the values of the underlying instruments.

Hedging Transactions Risk

Each Fund may engage in “hedging,” the practice of attempting to offset a potential loss in one position by establishing an opposite position in another investment. Hedging strategies in general are usually intended to limit or reduce investment risk, but can also be expected to limit or reduce the potential for profit. For example, if the Funds have taken a defensive posture by hedging its portfolio, and stock prices advance, the return to investors will be lower than if the portfolio had not been hedged. No assurance can be given that any particular hedging strategy will be successful, or that the Investment Adviser will elect to use a hedging strategy at a time when it is advisable.

Illiquid Securities Risk

The investments made by the Fund may be illiquid, and consequently the Fund may not be able to sell such investments at prices that reflect the Investment Adviser’s assessment of their value or the amount originally paid for such investments by the Fund. Illiquidity may result from the absence of an established market for the investments as well as legal, contractual or other restrictions on their resale and other factors. Furthermore, the nature of the Fund’s investments, especially those in financially distressed companies, may require a long holding period prior to profitability.

Indemnification Risk

The Funds have a variety of indemnification obligations under contracts with their service providers. The Funds’ maximum exposure under these arrangements is unknown. However, the Funds have not had prior claims or losses pursuant to these contracts and expect the risk of loss to be remote.

Industry Concentration Risk

The Long/Short Healthcare Fund has a policy of investing primarily in securities issued by healthcare companies, which makes the Fund susceptible to economic, political or regulatory risks or other occurrences associated with the healthcare industry.

Leverage Risk

Each of the Funds may use leverage in their investment program, including the use of borrowed funds and investments in certain types of options, such as puts, calls and warrants, which may be purchased for a fraction of the price of the underlying securities. While such strategies and techniques increase the opportunity to achieve higher returns on the amounts invested, they also increase the risk of loss. To the extent the Funds purchase securities with borrowed funds, their net assets will tend to increase or decrease at a greater rate than if borrowed funds are not used. If the interest expense on borrowings were to exceed the net return on the portfolio securities purchased with borrowed funds, the Funds’ use of leverage would result in a lower rate of return than if the Funds were not leveraged.

Options Risk

There are several risks associated with transactions in options on securities. For example, there are significant differences between the securities and options markets that could result in an imperfect correlation between these markets, causing a given transaction not to achieve its objectives. A transaction in options or securities may be unsuccessful to some degree because of market behavior or unexpected events.

When the Funds write a covered call option, the Fund forgoes, during the option’s life, the opportunity to profit from increases in the market value of the security covering the call option above the sum of the premium and the strike price of the call, but retains the risk of loss should the price of the underlying security decline. The writer of an option has no control over the time when it may be required to fulfill its obligation and once an option writer has received an exercise notice, it must deliver the underlying security in exchange for the strike price.

When the Funds write a covered put option, the Fund bears the risk of loss if the value of the underlying stock declines below the exercise price minus the put premium. If the option is exercised, the Fund could incur a loss if it is required to purchase the stock underlying the put option at a price greater than the market price of the stock at the time of exercise plus the put premium the Fund received when it wrote the option. While the Fund’s potential gain in writing a covered put option is limited to distributions

 

 

Semi-Annual Report       59


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

earned on the liquid assets securing the put option plus the premium received from the purchaser of the put option, the Fund risks a loss equal to the entire exercise price of the option minus the put premium.

Short-Selling Risk

Short sales by the Funds that are not made where there is an offsetting long position in the asset that it is being sold short theoretically involve unlimited loss potential since the market price of securities sold short may continuously increase. Short selling allows the Funds to profit from declines in market prices to the extent such decline exceeds the transaction costs and costs of borrowing the securities. However, since the borrowed securities must be replaced by purchases at market prices in order to close out the short position, any appreciation in the price of the borrowed securities would result in a loss. Purchasing securities to close out the short position can itself cause the price of securities to rise further, thereby exacerbating the loss. The Funds may mitigate such losses by replacing the securities sold short before the market price has increased significantly. Under adverse market conditions, the Funds might have difficulty purchasing securities to meet margin calls on its short sale delivery obligations, and might have to sell portfolio securities to raise the capital necessary to meet its short sale obligations at a time when fundamental investment considerations would not favor such sales.

Troubled, Distressed or Bankrupt Companies Risk

The Fund invests in companies that are troubled, in distress or bankrupt. As such, they are subject to a multitude of

legal, industry, market, environmental and governmental forces that make analysis of these companies inherently difficult. Further, the Investment Adviser relies on company management, outside experts, market participants and personal experience to analyze potential investments for the Fund. There can be no assurance that any of these sources will prove credible, or that the resulting analysis will produce accurate conclusions.

Note 10. Investment Transactions

Purchases & Sales of Securities

The cost of purchases and the proceeds from sales of investments, other than short-term securities and short-term options, for the period ended December 31, 2013, were as follows:

 

   

U.S. Government
Securities
(1)

   

Other Securities

 
Fund   Purchases     Sales     Purchases     Sales  

Long/Short Equity Fund

  $ —        $ —        $ 1,305,237,268      $ 1,319,052,675   

Long/Short Healthcare Fund

    —          —          121,996,073        128,963,211   

Floating Rate Opportunities Fund

    —          —          497,474,803        77,425,626   

 

(1)  

The Funds did not have any purchases or sales of U.S. Government Securities for the period ended December 31, 2013.

 

 

Note 11. Affiliated Issuers

Under Section 2(a)(3) of the 1940 Act, a portfolio company is defined as “affiliated” if a Fund owns five percent or more of its outstanding voting securities.

The Long/Short Equity Fund held at least five percent of the outstanding voting securities of the following company as of December 31, 2013:

 

                Market Value                    
Issuer   Shares at
June  30,
2013
    Shares at
December  31,
2013
    June 30,
2013
    December 31,
2013
    Affiliated
Income
    Purchases     Sales  

Highland/iBoxx Senior Loan, ETF (Common Stocks & Exchange–Traded Funds)

    750,000        480,654      $ 14,970,000      $ 9,579,434      $ 393,880      $      $ 5,382,216   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

60       Semi-Annual Report


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

The Floating Rate Opportunities Fund held at least five percent of the outstanding voting securities of the following companies as of December 31, 2013:

 

                Market Value                    
Issuer   Shares at
June  30,
2013
    Shares at
December  31,
2013
    June 30,
2013
    December 31,
2013
    Affiliated
Income
    Purchases     Sales  

CCD Equity Partners, LLC (Common Stocks & Exchange–Traded Funds)

    1,648,350        1,648,350      $ 4,714,281      $ 5,043,951      $      $      $   

CCS Medical, Inc. (Common Stocks & Exchange–Traded Funds)

    207,031        207,031        12,479,828        12,465,336                        

Endurance Business Media, Inc. (Common Stocks & Exchange–Traded Funds)

    4,921        4,921                                      

Highland/iBoxx Senior Loan, ETF (Common Stocks & Exchange–Traded Funds)

    1,150,000        1,150,000        22,954,000        22,919,500        610,482                 

LLV Holdco, LLC (Common Stocks & Exchange–Traded Funds)    

    37,375        34,992                                      

Nevada Land Group LLC (Common Stocks & Exchange–Traded Funds)

    8        8                                      
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    3,047,685        3,045,302      $ 40,148,109      $ 40,428,787      $ 610,482      $      $   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

Note 12. Legal Matters

Matters Relating to Floating Rate Opportunities Fund’s Investment in TOUSA, Inc.

Floating Rate Opportunities Fund (“FRO”) is one of numerous defendants (“Lenders”) that have been named in an adversary proceeding pending in the Bankruptcy Court of the Southern District of Florida (the “Court”). The action, entitled In re Tousa Inc., et al., was filed on July 15, 2008, by the Official Committee of Unsecured Creditors of TOUSA, Inc. and its affiliates (the “Plaintiff”), which are home building companies to which the Lenders loaned money through different lending facilities. Plaintiff alleges that monies used to repay the Lenders should be voided as fraudulent and preferential transfers under the bankruptcy laws. More specifically, Plaintiff alleges that subsidiaries of the home building companies were forced to become co-borrowers and guarantors of the monies used to repay the Lenders, and that the subsidiaries did not receive fair consideration or reasonably equivalent value when they transferred the proceeds to repay the Lenders.

Plaintiff seeks to void the transfers and other equitable relief. FRO and other Funds and accounts managed by the Investment Adviser and the other Lenders are named as defendants in two separate lending capacities; first, as lenders in a credit agreement (the “Credit Lenders”); and second, as lenders in a term loan (the “Term Loan Lenders”). The case went to trial, which concluded in August 2009. On October 13, 2009, the Bankruptcy Court ruled for the Plaintiff in the action and ordered the Defendants to return the proceeds received from the pay-off of the term loan at par on July 31, 2007. The proceeds received by FRO totaled $4,000,000. Additionally, the court

ordered the Defendants to pay simple interest on the amount returned at an annual rate of 9%. In November 2009, FRO and other Defendants filed appealed the decision from the Bankruptcy Court to the District Court. On December 22, 2009, FRO posted $5,310,479 (“Security”) with the Court. This amount was recorded in the Statement of Assets and Liabilities and the Statement of Operations. On February 11, 2011, the District Court entered an order quashing all liability of the Lenders and declaring the remedies against the Lenders null and void. On May 15, 2012, the Eleventh Circuit Court of Appeal (“Eleventh Circuit”) issued its decision reversing the judgment of the District Court, affirming the liability findings of the Bankruptcy Court, and remanding to the District Court for further proceedings consistent with their opinion. Briefing has been completed at the District Court, but the case has been stayed pending the outcome of a related US Supreme Court case which could have a significant effect on the Tousa action. The US Supreme Court case was heard on January 14, 2014, and the Parties are waiting the decision. FRO’s posted Security will be released upon a final appellate ruling.

Note 13. Reorganization of Floating Rate Fund and Floating Rate Advantage Fund into Floating Rate Opportunities Fund

On February 21, 2011, the Board of Trustees approved an agreement and plan of reorganization (the “Agreement”) which provided for the transfer of all of the assets and liabilities of the Floating Rate Advantage Fund and the Floating Rate Fund (collectively, the “Acquired Funds”) into the Floating Rate Opportunities Fund (the “Reorganization”). The Floating Rate Opportunities Fund

 

 

Semi-Annual Report       61


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

was created in anticipation of the Reorganization. Shareholders of each of the Acquired Funds approved the Reorganization at a joint meeting held on May 23, 2011. The primary purpose of the Reorganization was to provide greater liquidity to the shareholders of the Acquired Funds. The tax-free Reorganization was completed on June 13, 2011. The cost of the reorganization was $641,470, of which 57% and 43% was paid by the Floating Rate Advantage Fund and the Floating Rate Fund, respectively. For financial reporting purposes, assets received and shares issued by the Floating Rate Opportunities Fund were recorded at fair value; however, for tax purposes, the cost basis of the investments received from the Acquired Funds was carried forward to align ongoing reporting of the Floating Rate Opportunities Fund’s realized and unrealized gains and losses with amounts distributable to shareholders for tax purposes. Using the facts and circumstances of the Reorganization, it was determined that the Floating Rate Advantage Fund would be the accounting survivor. The financial statements and historical information contained in the Financial Highlights and footnotes for Floating Rate Opportunities Fund reflect this determination.

The shares outstanding and net assets for each Share class of the Floating Rate Advantage Fund immediately before the Reorganization were:

 

Highland Floating Rate
Advantage Fund
  Net Assets     Shares
Outstanding
    Conversion
Ratio
 

Class A

  $ 152,005,518        21,683,600        1.0000   

Class B

    10,590,972        1,511,544        1.0000   

Class C

    260,755,064        37,203,278        1.0000   

Class Z

    18,149,806        2,591,311        1.0000   

The shares outstanding for each Share class of the Floating Rate Fund immediately before the Reorganization and shares of the Floating Rate Opportunities Fund issued to Floating Rate Fund shareholders were:

 

Merged Fund
Highland
Floating
Rate Fund
  Shares
Exchanged
    Highland
Floating  Rate
Opportunities
Fund
  Shares
Issued
    Net
Asset
Value
    Conversion
Ratio

Class A

    18,720,164      Class A     17,615,566      $ 7.01      0.9410

Class B

    1,354,869      Class B     1,273,780      $ 7.01      0.9402

Class C

    30,496,942      Class C     28,687,427      $ 7.01      0.9407

Class Z

    3,030,909      Class Z     2,852,666      $ 7.00      0.9412

The net assets and net unrealized appreciation/(depreciation) of Floating Rate Fund and Floating Rate Opportunities Fund immediately before the Reorganization were:

 

Merged Fund
Highland
Floating
Rate Fund

  Shares
Exchanged
  Unrealized
Appreciation
(Depreciation)
    Acquiring
Fund
  Net Asset
Value
 

Highland Floating Rate Fund

  353,461,456   $ 233,892,251      Highland
Floating Rate
Opportunities
Fund
  $ 441,501,360   

The net assets and shares outstanding of the Floating Rate Opportunities Fund upon the completion of the Reorganization were:

 

Highland Floating Rate Opportunities Fund   Net Assets     Shares
Outstanding
 

Class A

  $ 275,493,444        39,299,166   

Class B

    19,516,010        2,785,324   

Class C

    461,823,197        65,890,705   

Class Z

    38,130,164        5,443,977   

Assuming the reorganization had been completed on July 1, 2010 the Floating Rate Opportunities Fund results of operations for the year ended June 30, 2011 would have been as follows:

 

Net investment income (loss)

  $ 33,880,318   

Net realized and unrealized gain (loss) on investments

  $ (178,621,241

Net increase (decrease) in assets from operations

  $ (144,364,864

Note 14. New Accounting Pronouncements

ASU 2013-08

In June 2013, FASB issued an update (“ASU 2013-08”) to ASC Topic 946, Financial Services — Investment Companies  (“Topic 946”). ASU 2013-08 amends the guidance in Topic 946 for determining whether an entity qualifies as an investment company and requires certain additional disclosures. ASU 2013-08 is effective for interim and annual reporting periods in fiscal years that begin after December 15, 2013. Management is currently evaluating the impact, if any, of ASU 2013-08 on the Fund’s financial statements.

Note 15. Subsequent Events

Management has evaluated the impact of all subsequent events on the Funds through the date the financial statements were issued, and has determined that there were no subsequent events.

 

 

62       Semi-Annual Report


Table of Contents

ADDITIONAL INFORMATION (unaudited)

 

 

 

December 31, 2013   Highland Funds I

 

Additional Portfolio Information

The Investment Adviser and its affiliates manage other accounts, including registered and private funds and individual accounts. Although investment decisions for the Funds are made independently from those of such other accounts, the Investment Adviser may, consistent with applicable law, make investment recommendations to other clients or accounts that may be the same or different from those made to the Funds, including investments in different levels of the capital structure of a company, such as equity versus senior loans, or that involve taking contradictory positions in multiple levels of the capital structure. The Investment Adviser has adopted policies and procedures that address the allocation of investment opportunities, execution of portfolio transactions, personal trading by employees and other potential conflicts of interest that are designed to ensure that all client accounts are treated equitably over time. Nevertheless, this may create situations where a client could be disadvantaged because of the investment activities conducted by the Investment Adviser for other client accounts. When the Funds and one or more of such other accounts are prepared to invest in, or desire to dispose of, the same security, available investments or opportunities for each will be allocated in a manner believed by the Investment Adviser to be equitable to the Funds and such other accounts. The Investment Adviser also may aggregate orders to purchase and sell securities for the Funds and such other accounts. Although the Investment Adviser believes that, over time, the potential benefits of participating in volume transactions and negotiating lower transaction costs should benefit all accounts including the Funds, in some cases these activities may adversely affect the price paid or received by the Funds or the size of the position obtained or disposed of by the Funds.

Disclosure of Fund Expenses

As a shareholder of a Fund, you incur two types of costs: (1) transaction costs, including sales charges (loads) on purchases and redemption fees; and (2) ongoing costs, including management fees; distribution (12b-1) and service fees; and other Fund expenses. This example is intended to help you understand the ongoing costs (in dollars) of investing in your Fund and to compare these costs with the ongoing costs of investing in other mutual funds. The example is based on an investment of $1,000 invested at the beginning of the period and held for the six-month period July 1, 2013 through December 31, 2013, unless otherwise indicated.

This table illustrates your Fund’s costs in two ways:

Actual Expenses: The first part of the table provides information about actual account values and actual

expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading entitled “Expenses Paid During Period” to estimate the expenses you paid on your account during this period.

Hypothetical Example for Comparison Purposes: The second part of the table provides information about hypothetical account values and hypothetical expenses based on your Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not your Fund’s actual return. The actual expense ratio includes voluntary fee waivers or expense reimbursements by the Fund’s investment adviser. The expense ratio would be higher had the fee waivers or expense reimbursements not been in effect. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in your Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as sales charges (loads) or redemption fees. Therefore, the second part of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

 

 

Semi-Annual Report       63


Table of Contents

ADDITIONAL INFORMATION (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

 

      Beginning
Account
Value
7/1/2013
    Ending
Account
Value
12/31/2013
    Annualized
Expense
Ratio
(1)
    Annualized
Expense
Ratio
(2)
    Expenses
Paid
During  the
Period
(3)
    Expenses
Paid
During  the
Period
(4)
    Actual
Returns
for
Period
 

Long/Short Equity Fund

  

       

Actual Fund Return

  

           

Class A

  $ 1,000.00      $ 1,159.80        2.41     1.87   $ 13.07      $ 10.18        15.98

Class C

    1,000.00        1,155.90        3.05     2.52     16.57        13.69        15.59

Class Z

    1,000.00        1,162.50        2.05     1.52     11.17        8.29        16.25

Hypothetical

  

           

Class A

  $ 1,000.00      $ 1,015.78        2.41     1.87   $ 12.18      $ 9.50        5.00

Class C

    1,000.00        1,012.50        3.05     2.52     15.45        12.78        5.00

Class Z

    1,000.00        1,017.54        2.05     1.52     10.41        7.73        5.00

Long/Short Healthcare Fund

  

     

Actual Fund Return

  

           

Class A

    1,000.00      $ 1,203.10        3.30     2.17   $ 18.32      $ 12.05        20.31

Class C

    1,000.00        1,199.40        3.95     2.82     21.95        15.69        19.94

Class Z

    1,000.00        1,205.70        2.94     1.82     16.35        10.12        20.57

Hypothetical

  

           

Class A

    1,000.00        1,014.27        3.30     2.17   $ 16.71      $ 11.02        5.00

Class C

    1,000.00        1,010.94        3.95     2.82     20.02        14.34        5.00

Class Z

    1,000.00        1,016.03        2.94     1.82     14.90        9.25        5.00

Floating Rate Opportunities Fund

  

     

Actual Fund Return

  

           

Class A

  $ 1,000.00      $ 1,074.00        1.31     1.28   $ 6.90      $ 6.74        7.40

Class B

    1,000.00        1,076.40        1.70     1.68     8.84        8.74        7.64

Class C

    1,000.00        1,071.30        1.84     1.82     9.61        9.50        7.13

Class Z

    1,000.00        1,075.90        0.96     0.93     5.08        4.92        7.59

Hypothetical

  

           

Class A

  $ 1,000.00      $ 1,018.70        1.31     1.28   $ 6.72      $ 6.56        5.00

Class B

    1,000.00        1,016.79        1.70     1.68     8.59        8.49        5.00

Class C

    1,000.00        1,016.03        1.84     1.82     9.35        9.25        5.00

Class Z

    1,000.00        1,020.47        0.96     0.93     4.94        4.79        5.00

 

(1) Annualized, based on the Fund’s most recent fiscal half-year expenses, including dividends on short positions and interest expenses, if any.
(2) Annualized, based on the Fund’s most recent fiscal half-year expenses, excluding dividends on short positions and interest expenses, if any.
(3) Expenses are equal to the Fund’s annualized expense ratio including interest expense and dividends on short positions, if any, multiplied by the average account value over the period, multiplied by the number of days in the fiscal half-year, then divided by 365.
(4) Expenses are equal to the Fund’s annualized expense ratio excluding interest expense and dividends on short positions, if any, multiplied by the average account value over the period, multiplied by the number of days in the fiscal half-year, then divided by 365.

 

Approval of Highland Funds I Advisory and Sub-Advisory Agreements

The Trust has retained the Investment Adviser to manage the assets of each of Highland Floating Rate Opportunities Fund, Highland Long/Short Equity Fund and Highland Long/Short Healthcare Fund (for purposes of this section, each a “Fund”) pursuant to investment advisory agreements between the Investment Adviser and each such Fund (the “Advisory Agreements”). The Trust has also retained Cummings Bay Capital Management, L.P. (the “Sub-Adviser” and, together with the Investment Adviser, the “Advisers”) to serve as sub-adviser to Highland Funds I, on behalf of Highland Long/Short Healthcare Fund (“Long/Short Healthcare Fund”), pursuant to a subadvisory

agreement (the “Sub-Advisory Agreement” and, together with the Advisory Agreements, the “Agreements”) by and among the Investment Adviser, the Sub-Adviser and Highland Funds I. The Agreements have been approved by the Funds’ Board of Trustees, including a majority of the Independent Trustees.

Following an initial two-year term, each of the Agreements continues in effect from year-to-year, provided such continuance is specifically approved at least annually by the vote of holders of at least a majority of the outstanding shares of the Fund or by the Board of Trustees and, in either event, by a majority of the Independent Trustees of the Fund casting votes in person at a meeting called for such purpose.

 

 

64       Semi-Annual Report


Table of Contents

ADDITIONAL INFORMATION (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

The Board of Trustees held a meeting of the board on August 29, 2013, at which meeting they gave preliminary consideration to information bearing on the continuation of each Advisory Agreement for a one-year period commencing December 31, 2013. The primary purpose of the meeting was to ensure that the Trustees had ample opportunity to consider matters they deemed relevant in considering the continuation of the Agreements, and to request any additional information they considered reasonably necessary to their deliberations, without undue time constraints.

At a meeting held on September 12-13, 2013, the Board of Trustees, including the Independent Trustees, approved the continuance of the Agreements with respect to each Fund. As part of its review process, the Board of Trustees requested, through Fund counsel and its independent legal counsel, and received from the Advisers, various information and written materials in connection with meetings of the Board of Trustees held on August 29, 2013 and September 12-13, 2013, including: (1) information regarding the financial soundness of the Advisers and the profitability of the Agreements to the Advisers; (2) information on the advisory and compliance personnel of the Advisers, including compensation arrangements; (3) information on the internal compliance procedures of the Advisers; (4) comparative information showing how the Funds’ proposed and actual fees and anticipated and actual operating expenses compare to those of other registered investment companies and private funds that follow investment strategies similar to those of the Funds; (5) information on the investment performance of the Funds, including comparisons of the Funds’ performance against that of other registered investment companies and private funds that follow investment strategies similar to those of the Funds; (6) information regarding brokerage and portfolio transactions; and (7) information on any legal proceedings or regulatory audits or investigations affecting the Advisers. The Trustees also relied on information provided in connection with the initial approval of the Agreements, as well as new information specifically relating to changes from such time, and information provided at periodic meetings of the Trustees over the course of the year. In addition, the Trustees received an independent report from Keil Fiduciary Strategies (“KFS”), an independent source of investment company data, relating to each Fund’s performance, volatility and expenses compared to the performance, volatility and expenses of a relatively small peer group determined by Keil Fiduciary Strategies to be comparable. The Trustees also reviewed various factors discussed in independent counsel’s legal memorandum, the detailed information provided by the Investment Adviser and Sub-Adviser and other relevant

information and factors. The Trustees’ conclusions as to the approval of the Agreements were based on a comprehensive consideration of all information provided to the Trustees without any single factor being dispositive in and of itself. Some of the factors that figured particularly in the Trustees’ deliberations are described below, although individual Trustees may have evaluated the information presented differently from one another, giving different weights to various factors.

The nature, extent, and quality of the services to be provided by the Advisers

The Board of Trustees considered the portfolio management services to be provided by the Advisers under the Agreements and the activities related to portfolio management, including use of technology, research capabilities, and investment management staff. The Board of Trustees discussed the relevant experience and qualifications of the personnel providing advisory services, including the background and experience of the members of each Fund’s portfolio management team. The Trustees reviewed the management structure, assets under management and investment philosophies and processes of the Advisers. The Trustees also reviewed and discussed information regarding the Advisers’ compliance policies, procedures and personnel, including compensation arrangements. With regard to Long/Short Healthcare Fund, for which the Investment Adviser has retained the Sub-Adviser, the Trustees considered the services provided by the Investment Adviser with respect to the supervision of the Sub-Adviser, including the performance of periodic detailed analysis and review of the performance by the Sub-Adviser of its obligations to the Fund, including, without limitation, a review of the Sub-Adviser’s investment performance in respect of the Fund; preparation and presentation of periodic reports to the Trustees regarding the investment performance of the Sub-Adviser and other information regarding the Sub-Adviser; review and consideration of any changes in the personnel of the Sub-Adviser responsible for performing the Sub-Adviser’s obligations and making appropriate reports to the Trustees; review and consideration of any changes in the ownership or senior management of the Sub-Adviser and making appropriate reports to the Trustees; performing periodic in-person or telephonic diligence meetings with representatives of the Sub-Adviser; and preparing recommendations with respect to the continued retention of the Sub-Adviser or the replacement of the Sub-Adviser. The Trustees concluded that the Advisers had the quality and depth of personnel and investment methods essential to performing their duties under the Agreements, and that the nature and the quality of such advisory services were satisfactory.

 

 

Semi-Annual Report       65


Table of Contents

ADDITIONAL INFORMATION (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

The Advisers’ Historical Performance in Managing the Funds

The Board of Trustees reviewed the historical performance of the Advisers and the Funds’ portfolio management teams in managing the Funds over various time periods and reflected on previous discussions regarding matters bearing on the Advisers’ performance at their meetings throughout the year. With respect to the Funds, the Trustees discussed relative performance and contrasted the performance of the Funds and their respective portfolio management teams versus that of the Funds’ peers, as represented by certain other registered investment companies that follow investment strategies similar to the Funds as well as comparable indices. With respect to each Fund, the Trustees concluded that the Fund’s performance or other relevant factors supported the renewal of the Agreement(s) relating to that Fund. In the case of each Fund that had performance that lagged that of a relevant peer group for certain (although not necessarily all) periods, the Trustees concluded that other factors relevant to performance supported renewal of the Agreements. These factors included one or more of the following: (1) that underperformance was attributable, to a significant extent, to investment decisions (such as security selection or sector allocation) by the Advisers that were reasonable and consistent with the Fund’s investment objective and policies; and (2) that the Fund’s more recent performance was competitive when compared to relevant performance benchmarks or peer groups.

The costs of the services to be provided by the Investment Adviser and the profits to be realized by the Investment Adviser and its affiliates from the relationship with the Funds

The Board of Trustees also gave substantial consideration to the fees payable under the Agreements, the expenses the Advisers incur in providing advisory services and the profitability to the Advisers of managing the Funds, including: (1) information regarding the financial condition of the Advisers; (2) information regarding the total fees and payments received by the Advisers for their services and whether such fees are appropriate given economies of scale and other considerations; (3) comparative information showing (a) the fees payable under the Agreements and the actual fees paid by the Funds to the Investment Adviser versus the investment advisory fees of certain registered investment companies and private pooled vehicles that follow investment strategies similar to those of the Funds and (b) the expense ratios of the Funds versus the expense ratios of certain registered investment companies and private pooled vehicles that follow investment strategies similar to those of the Funds;

(4) information regarding the total fees and payments received and the related amounts waived and/or reimbursed by the Investment Adviser for providing administrative services to the Funds under separate agreements and whether such fees are appropriate; and, (5) with respect to the Advisory Agreement for Long/Short Healthcare Fund, the fact that the fees payable to the Investment Adviser would be reduced by amounts payable to the Sub-Adviser for a given period. The Trustees also considered the so-called “fall-out benefits” to the Advisers with respect to the Funds, such as the reputational value of serving as Adviser or Sub-Adviser to the relevant Funds, potential fees paid to the Advisers’ affiliates by a Fund or portfolio companies for services provided, including administrative services provided to the Funds by the Investment Adviser pursuant to separate agreements, and the benefits of research made available to the Advisers by reason of brokerage commissions (if any) generated by the Funds’ securities transactions. With respect to Long/Short Equity Fund and Long/Short Healthcare Fund, the Board of Trustees considered that the Funds’ actual management fees and total expense ratios were competitive as compared to their respective peer groups. With respect to Floating Rate Opportunities Fund, the Board of Trustees considered that, while the Fund’s relative management fee and total expenses exceeded the KFS peer group, the Adviser had agreed to limit total annual operating expenses through at least October 31, 2014. After such review, the Trustees determined that the anticipated profitability rates to the Investment Adviser and Sub-Adviser with respect to the Agreements were fair and reasonable. The Trustees also took into consideration the amounts waived and/or reimbursed, if any, where expense caps or advisory fee waivers had been implemented.

The extent to which economies of scale would be realized as the Fund grows and whether fee levels reflect these economies of scale for the benefit of shareholders

The Board of Trustees considered the respective asset levels of the Funds, the information provided by the Advisers relating to their costs and information comparing the fee rates charged by the Advisers with fee rates charged by other unaffiliated investment advisers to their clients. The Trustees concluded that the fee structures are reasonable, and appropriately should result in a sharing of economies of scale in view of the information provided by the Advisers. The Board determined to continue to review ways, and the extent to which, economies of scale might be shared between the applicable Adviser and/or Sub-Adviser on the one hand and shareholders of the Funds on the other.

 

 

66       Semi-Annual Report


Table of Contents

ADDITIONAL INFORMATION (unaudited) (continued)

 

 

 

December 31, 2013   Highland Funds I

 

Following a further discussion of the factors above and the merits of the Agreements and their various provisions, it was noted that in considering the approval of the Agreements, no single factor was determinative to the decision of the Board of Trustees. Rather, after weighing all of the factors and reasons discussed above, the Trustees, includ-

ing the Independent Trustees, unanimously agreed that the Agreements, including the advisory and sub-advisory fees to be paid to the Advisers are fair and reasonable to the Funds in light of the services that the Advisers provide, the expenses that they incur and the reasonably foreseeable asset levels of the Funds.

 

 

Semi-Annual Report       67


Table of Contents

IMPORTANT INFORMATION ABOUT THIS REPORT

 

 

 

Investment Adviser

Highland Capital Management Fund Advisors, L.P.

200 Crescent Court, Suite 700

Dallas, TX 75201

Subadviser

(for Highland Long/Short Healthcare Fund)

Cummings Bay Capital Management, L.P.

200 Crescent Court, Suite 700

Dallas, TX 75201

Transfer Agent

Boston Financial Data Services, Inc.

30 Dan Road

Canton, MA 02021-2809

Underwriter

Foreside Funds Distributors LLC

400 Berwyn Park

899 Cassatt Road, 1st Floor

Berwyn, PA 19312

Custodian

State Street Bank and Trust Company

One Lincoln Street

Boston, Massachusetts 02111

Independent Registered Public Accounting Firm

PricewaterhouseCoopers LLP

2001 Ross Avenue, Suite 1800

Dallas, TX 75201

Fund Counsel

Ropes & Gray LLP

Prudential Tower

800 Boylston Street

Boston, MA 02199

This report has been prepared for shareholders of Highland Long/Short Equity Fund, Highland Long/Short Healthcare Fund and Highland Floating Rate Opportunities Fund (collectively, the “Funds”). The Funds mail one shareholder report to each shareholder address. If you would like more than one report, please call shareholder services at 1-877-665-1287 to request that additional reports be sent to you.

A description of the policies and procedures that the Funds use to determine how to vote proxies relating to their portfolio securities, and the Funds’ proxy voting records for the most recent 12-month period ended June 30, are available (i) without charge, upon request, by calling 1-877-665-1287 and (ii) on the Securities and Exchange Commission’s website at http://www.sec.gov.

The Funds file their complete schedules of portfolio holdings with the Securities and Exchange Commission for the first and third quarters of each fiscal year on Form N-Q. The Funds’ Forms N-Q are available on the Commission’s website at http://www.sec.gov and also may be reviewed and copied at the Commission’s Public Reference Room in Washington, DC. Information on the Public Reference Room may be obtained by calling 1-800-SEC-0330. Shareholders may also obtain the Form N-Q by visiting the Funds’ website at www.highlandfunds.com.

The Statements of Additional Information include additional information about the Funds’ Trustees and are available upon request without charge by calling 1-877-665-1287.

 

 

68       Semi-Annual Report


Table of Contents

LOGO

Highland Funds

c/o BFDS

30 Dan Road

Canton, MA 02021-2809

 

LOGO

 

Highland Funds I    Semi-Annual Report, December 31, 2013

 

www.highlandfunds.com    HLC-HFI-SEMI-12/13


Table of Contents

LOGO

 

Highland/iBoxx Senior Loan ETF

 

 

Semi-Annual Report

December 31, 2013

 

 


Table of Contents

Highland/iBoxx Senior Loan ETF

 

TABLE OF CONTENTS

 

Fund Profile

     1   

Financial Statements

     2   

Investment Portfolio

     3   

Statement of Assets and Liabilities

     8   

Statement of Operations

     9   

Statement of Changes in Net Assets

     10   

Financial Highlights

     11   

Notes to Financial Statements

     12   

Additional Information

     18   

Disclosure of Fund Expenses

     18   

Important Information About This Report

     20   

Economic and market conditions change frequently.

There is no assurance that the trends described in this report will continue or commence.

 

A prospectus must precede or accompany this report. Please read the prospectus carefully before you invest.


Table of Contents

FUND PROFILE (unaudited)

 

 

 

December 31, 2013   Highland/iBoxx Senior Loan ETF

 

Objective

Highland/iBoxx Senior Loan ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Markit iBoxx USD Liquid Leveraged Loan Index (the “Underlying Index”).

 

Net Assets as of December 31, 2013

$127.8 million

 

Portfolio Data as of December 31, 2013

The information below provides a snapshot of Highland/iBoxx Senior Loan ETF at the end of the reporting period.

 

Quality Breakdown as of 12/31/13 (%)*  

BBB

       3.7   

BB

       33.5   

B

       53.6   

CCC

       7.2   

D

       0.8   

Not Rated

       1.2   
Top 5 Sectors as of 12/31/13 (%)*  

Media/Telecommunications

       14.7   

Service

       9.6   

Information Technology

       9.4   

Healthcare

       8.6   

Food/Tobacco

       6.9   
 

 

Top 10 Holdings as of 12/31/13 (%)*  

Caesars Entertainment Operating Co., Inc. (Term B-6 Loan)

       2.5   

Dell International (Term B Loan)

       2.0   

Clear Channel Communications, Inc. (Tranche D Term Loan)

       2.0   

Texas Competitive Electric Holdings Co., LLC (2017 Term Loan (Extending))

       1.9   

Asurion, LLC (Incremental Tranche B-1 Term Loan)

       1.9   

First Data Corporation (2018 Dollar Term Loan)

       1.8   

HJ Heinz Company (Term B-2 Loan)

       1.8   

Clear Channel Communications, Inc. (Tranche B Term Loan)

       1.6   

BMC Software Finance (Initial US Term Loan)

       1.6   

The Fund is non-diversified and may invest a larger portion of its assets in the securities of fewer issuers than if the Fund was diversified.

Please refer to Note 7, Disclosure of Significant Risks and Contingencies, for more information.

 

* Quality is calculated as a percentage of total senior loans. Sectors and holdings are calculated as a percentage of total net assets. The quality ratings reflected were issued by Standard & Poor’s, a nationally recognized statistical rating organization. Ratings are measured on a scale that generally ranges from AAA (highest) to D (lowest). Quality ratings reflect the credit quality of the underlying bonds in the Fund’s portfolio and not that of the Fund itself. Quality Ratings are subject to change.

 

Semi-Annual Report       1


Table of Contents

FINANCIAL STATEMENTS

 

 

 

December 31, 2013   Highland/iBoxx Senior Loan ETF

 

A guide to understanding the Fund’s financial statements

 

Investment Portfolio      The Investment Portfolio details each of the Fund’s holdings and their market value as of the last day of the reporting period. Portfolio holdings are organized by type of asset and industry to demonstrate areas of concentration and diversification.
Statement of Assets and Liabilities      This statement details the Fund’s assets, liabilities, net assets and share price for each share class as of the last day of the reporting period. Net assets are calculated by subtracting all of a Fund’s liabilities (including any unpaid expenses) from the total of the Fund’s investment and non-investment assets. The net asset value per share for each class is calculated by dividing net assets allocated to that share class by the number of shares outstanding in that class as of the last day of the reporting period.
Statement of Operations      This statement reports income earned by the Fund and the expenses incurred by the Fund during the reporting period. The Statement of Operations also shows any net gain or loss the Fund realized on the sales of its holdings during the period as well as any unrealized gains or losses recognized over the period. The total of these results represents the Fund’s net increase or decrease in net assets from operations.
Statement of Changes in Net Assets      This statement details how the Fund’s net assets were affected by its operating results, distributions to shareholders and shareholder transactions (e.g., subscriptions, redemptions and distribution reinvestments) during the reporting period. The Statement of Changes in Net Assets also details changes in the number of shares outstanding.
Financial Highlights      The Financial Highlights demonstrate how the Fund’s net asset value per share was affected by the Fund’s operating results. The Financial Highlights also disclose the class’ performance and certain key ratios (e.g., net expenses and net investment income as a percentage of average net assets).
Notes to Financial Statements      These notes disclose the organizational background of the Fund, certain of its significant accounting policies (including those surrounding security valuation, income recognition and distributions to shareholders), federal tax information, fees and compensation paid to affiliates and significant risks and contingencies.

 

2       Semi-Annual Report


Table of Contents

INVESTMENT PORTFOLIO (unaudited)

 

 

 

As of December 31, 2013   Highland/iBoxx Senior Loan ETF

 

    Principal Amount ($)    

 

    Value ($)    

 

 

US Senior Loans (a) - 94.2%

  

  AEROSPACE - 2.0%   
  743,120     

Sequa Corp.
Initial Term Loan,
5.250%, 06/19/17

    727,857  
  1,815,397     

TransDigm, Inc.
Tranche C Term Loan,
3.750%, 02/28/20 (b)

    1,822,622  
   

 

 

 
      2,550,479  
   

 

 

 
  BROADCASTING - 4.9%   
  995,000     

Charter Communications Operating, LLC Term E Loan,
3.000%, 07/01/20

    990,339  
  730,309     

Charter Communications Operating, LLC Term F Loan,
3.000%, 12/31/20

    726,088  
  2,129,788     

Clear Channel Communications, Inc. Tranche B Term Loan,
3.814%, 01/29/16 (b)

    2,066,927  
  2,620,212     

Clear Channel Communications, Inc.
Tranche D Term Loan,
6.914%, 01/30/19 (b)

    2,507,215  
   

 

 

 
      6,290,569  
   

 

 

 
  CABLE/WIRELESS VIDEO - 0.9%   
  1,093,368     

WideOpenWest Finance, LLC
Term B Loan,
4.750%, 04/01/19 (b)

    1,100,748  
   

 

 

 
  CHEMICALS - 4.5%   
  1,478,087     

Axalta Coating Systems
Initial Term B Loan,
4.750%, 02/01/20

    1,490,946  
  1,637,324     

Ineos US Finance, LLC
Cash Dollar Term Loan,
4.000%, 05/04/18

    1,645,854  
  645,113     

PQ Corporation
2013 Term Loan,
4.500%, 08/07/17

    650,677  
  1,932,169     

Univar, Inc.
Term B Loan,
5.000%, 06/30/17

    1,920,229  
   

 

 

 
      5,707,706  
   

 

 

 
  CONSUMER NON-DURABLES - 0.1%   
  92,143     

Spectrum Brands, Inc.
Tranche C Term Loan,
3.500%, 09/04/19

    92,453  
   

 

 

 
  CONSUMER PRODUCTS - 0.8%   
  214,150     

Revlon Consumer Products Corp.
Replacement Term Loan,
4.000%, 11/20/17

    215,823  
  776,897     

Serta Simmons Super Holdings, LLC
Term Loan,
5.000%, 10/01/19

    782,530  
   

 

 

 
      998,353  
   

 

 

 

    Principal Amount ($)    

 

    Value ($)    

 
  DIVERSIFIED MEDIA - 0.2%   
  468,008     

R.H. Donnelley, Inc.
Loan,
9.750%, 12/31/16

    287,158  
   

 

 

 
  ENERGY - 1.9%   
  1,400,000     

Chesapeake Energy Corp.
Loan,
5.750%, 12/02/17

    1,431,402  
  250,000     

Energy Transfer Equity, LP
Loan,
3.250%, 12/02/19

    249,562  
  700,000     

FTS International, Inc.
Term Loan,
8.500%, 05/06/16

    704,669  
   

 

 

 
      2,385,633  
   

 

 

 
  FINANCIAL - 1.8%   
  1,750,000     

Nuveen Investments, Inc.
Tranche B First-Lien Term Loan,
4.164%, 05/13/17

    1,745,625  
  496,250     

Ocwen Loan Servicing
Initial Term Loan,
5.000%, 02/15/18

    503,260  
   

 

 

 
      2,248,885  
   

 

 

 
  FOOD & DRUG - 1.1%   
  309,541     

Roundy’s Supermarkets, Inc.
Tranche B Term Loan,
5.750%, 02/13/19

    310,025  
  1,040,980     

Supervalu, Inc.
New Term Loan,
5.000%, 03/21/19 (b)

    1,052,363  
   

 

 

 
      1,362,388  
   

 

 

 
  FOOD/TOBACCO - 6.8%   
  246,875     

Burger King Corporation
Tranche B Term Loan (2012),
3.750%, 09/28/19

    248,349  
  1,358,315     

Del Monte Foods Company
Initial Term Loan,
4.000%, 03/08/18

    1,365,100  
  1,282,606     

Dunkin Brands, Inc.
Term B-3 Loan,
3.750%, 02/14/20

    1,288,615  
  1,741,250     

HJ Heinz Company
Term B-1 Loan,
3.250%, 06/07/19

    1,754,214  
  2,239,373     

HJ Heinz Company
Term B-2 Loan,
3.500%, 06/05/20

    2,259,864  
  467,500     

OSI Restaurant Partners, LLC
2013 Replacement Term Loan,
3.500%, 10/28/19

    468,610  
  894,245     

Pinnacle Foods Finance, LLC
New Term Loan G,
3.250%, 04/29/20

    894,639  
  249,375     

Pinnacle Foods Finance, LLC
Tranche H Term Loan,
3.250%, 04/29/20 (b)

    249,462  
 

 

See accompanying Notes to Financial Statements.       3


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland/iBoxx Senior Loan ETF

 

    Principal Amount ($)    

 

    Value ($)    

 

 

US Senior Loans (continued)

  

  FOOD/TOBACCO (continued)   
  341,087     

Wendy’s International, Inc
Term B Loan,
3.250%, 05/15/19

    342,032  
   

 

 

 
      8,870,885  
   

 

 

 
  FOREST PRODUCTS/CONTAINERS - 2.3%   
  593,901     

Berry Plastics Corp.
Term C Loan,
2.164%, 04/03/15

    594,230  
  997,487     

Berry Plastics Corp.
Term D Loan,
3.500%, 02/08/20 (b)

    996,241  
  1,392,351     

Reynolds Group Holdings Inc.
Incremental U.S. Term Loan,
4.000%, 12/31/18 (b)

    1,407,061  
   

 

 

 
      2,997,532  
   

 

 

 
  GAMING/LEISURE - 5.1%   
  750,000     

Caesars Entertainment
Operating Co., Inc.
Term B-5 Loan,
4.488%, 01/28/18

    711,562  
  3,316,535     

Caesars Entertainment
Operating Co., Inc.
Term B-6 Loan,
5.488%, 01/28/18

    3,176,445  
  1,120,000     

Hilton Worldwide Finance
Initial Term Loan,
3.750%, 10/25/20(b)

    1,131,402  
  495,000     

MGM Resorts International
(MGM Grand Detroit, LLC)
Term Loan B,
3.500%, 12/20/19

    496,703  
  739,115     

Seaworld Parks & Entertainment, Inc.
Term B-2 Loan,
3.000%, 05/14/20

    731,724  
  247,500     

Six Flags Theme Parks, Inc.
Tranche B Term Loan,
5.250%, 12/20/18

    248,626  
   

 

 

 
      6,496,462  
   

 

 

 
  HEALTHCARE - 8.5%   
  1,187,773     

Biomet
Dollar Term B-2 Loan,
3.665%, 07/25/17

    1,196,805  
  1,750,000     

CHS/Community Health Systems, Inc.
Extended Term Loan,
3.748%, 01/25/17

    1,766,266  
  792,509     

Envision Healthcare Corporation
Initial Term Loan,
4.000%, 05/25/18

    796,360  
  988,539     

Grifols, Inc.
New U.S. Tranche B Term Loan,
4.250%, 06/01/17(b)

    996,308  
  1,246,875     

HCA, Inc.
Tranche B-4 Term Loan,
2.914%, 05/01/18

    1,249,082  

    Principal Amount ($)    

 

    Value ($)    

 
  HEALTHCARE (continued)   
  1,047,375     

HCA, Inc.
Tranche B-5 Term Loan,
2.998%, 03/31/17

    1,049,119  
  784,450     

Health Management Associates, Inc. Replacement Term B Loan,
3.500%, 11/16/18

    785,572  
  643,738     

Hologic, Inc. Refinancing
Tranche B Term Loan,
3.750%, 08/01/19

    648,634  
  998,788     

IMS Health Incorporated
Tranche B-1 Dollar Term Loan,
3.750%, 09/01/17

    1,004,252  
  438,234     

MultiPlan, Inc.
Term B-1 Loan,
4.000%, 08/26/17

    441,795  
  996,237     

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)
2013 Term Loan,
4.250%, 12/05/18 (b)

    1,004,432  
   

 

 

 
      10,938,625  
   

 

 

 
  HOUSING - 0.4%   
  496,222     

HD Supply, Inc.
Term Loan,
4.500%, 10/12/17

    501,581  
  30,081     

Realogy Group, LLC
Extended Synthetic Commitment,
4.400%, 10/10/16

    30,452  
   

 

 

 
      532,033  
   

 

 

 
  INFORMATION TECHNOLOGY - 9.4%   
  990,744     

Alcatel-Lucent USA, Inc.
U.S. Term Loan,
5.750%, 01/30/19

    996,877  
  1,484,318     

Avaya, Inc.
Term B-3 Loan,
4.736%, 10/26/17

    1,456,116  
  729,593     

Avaya, Inc.
Term B-5 Loan,
8.000%, 03/31/18

    741,631  
  2,000,000     

BMC Software Finance
Initial US Term Loan,
5.000%, 09/10/20

    2,014,070  
  986,339     

CDW LLC
Term Loan,
3.250%, 04/29/20

    985,195  
  2,500,000     

Dell International
Term B Loan,
4.500%, 04/29/20 (b)

    2,511,612  
  1,489,997     

Freescale Semiconductor, Inc.
Tranche B-4 Term Loan,
5.000%, 02/28/20

    1,508,220  
  1,767,106     

Infor (US), Inc.
Tranche B-2 Term Loan,
5.250%, 04/05/18 (b)

    1,775,756  
   

 

 

 
      11,989,477  
   

 

 

 
 

 

4       See accompanying Notes to Financial Statements.


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland/iBoxx Senior Loan ETF

 

    Principal Amount ($)    

 

    Value ($)    

 

 

US Senior Loans (continued)

  

  MANUFACTURING - 2.1%   
  398,000     

Apex Tool Group, LLC
Term Loan,
4.500%, 01/31/20

    400,563  
  1,246,875     

Gardner Denver, Inc.
Initial Dollar Term Loan,
4.250%, 07/30/20 (b)

    1,249,606  
  997,500     

Rexnord LLC/RBS Global, Inc
Term B Loan,
4.000%, 08/21/20 (b)

    1,001,759  
   

 

 

 
      2,651,928  
   

 

 

 
  MEDIA/TELECOMMUNICATIONS - 13.7%   
  744,864     

Affinion Group, Inc.
Tranche B Term Loan,
6.750%, 10/09/16

    735,766  
  546,443     

Cengage Learning Acquisitions, Inc. (Thomson Learning)
Original Term Loan,
4.750%, 07/03/14 (c)

    428,138  
  744,080     

Cengage Learning Acquisitions, Inc. (Thomson Learning)
Tranche B Term Loan (Extending),
7.750%, 07/05/17 (c)

    583,757  
  1,585,398     

Cequel Communications, LLC
Term Loan,
3.500%, 02/14/19

    1,590,519  
  1,490,616     

Crown Castle Operating Company
New Tranche B Term Loan,
3.250%, 01/31/19

    1,495,818  
  217,391     

Crown Castle Operating Company
Term Loan B2,
0.070%, 01/31/21 (b)

    218,292  
  1,364,302     

Getty Images, Inc.
Initial Term Loan,
4.750%, 10/18/19 (b)

    1,276,236  
  1,925,923     

Intelsat Jackson Holdings
Tranche B-2 Term Loan,
3.750%, 06/30/19

    1,943,979  
  500,000     

Level 3 Financing
Tranche B-III 2019 Term Loan,
4.000%, 08/01/19

    503,697  
  1,493,089     

Nielsen Finance, LLC
Class E Dollar Term Loan,
2.918%, 05/01/16

    1,499,435  
  547,056     

Regal Cinemas Corp.
Term Loan,
2.748%, 08/23/17

    550,034  
  731,888     

SuperMedia Inc.
Loan,
11.600%, 12/30/16

    548,462  
  849,460     

TWCC Holding Corp.
Term Loan,
3.500%, 02/13/17

    853,903  
  1,390,747     

Univision Communications, Inc.
2013 Converted Extended First-Lien
Term Loan,
4.500%, 03/01/20

    1,399,550  

    Principal Amount ($)    

 

    Value ($)    

 
  MEDIA/TELECOMMUNICATIONS (continued)   
  994,987     

Univision Communications, Inc.
2013 Incremental Term Loan,
4.000%, 03/01/20

    1,000,997  
  1,750,000     

Virgin Media Investment Holdings
Limited B Facility,
3.500%, 06/07/20

    1,756,125  
  1,134,884     

West Corporation
Term B-8 Loan,
3.750%, 06/30/18

    1,141,653  
   

 

 

 
      17,526,361  
   

 

 

 
  METALS/MINERALS - 1.5%   
  1,239,327     

Arch Coal, Inc.
Term Loan,
6.250%, 05/16/18

    1,225,130  
  692,052     

Walter Energy, Inc.
B Term Loan,
6.750%, 04/02/18

    680,083  
   

 

 

 
      1,905,213  
   

 

 

 
  RETAIL - 5.8%   
  495,609     

Academy, Ltd.
Initial Term Loan (2012),
4.500%, 08/03/18

    499,676  
  498,750     

American Builders & Contractors Supply Co.
Term B Loan,
3.500%, 04/16/20 (b)

    500,481  
  746,241     

BJ’s Wholesale Club
New 2013 (November) Replacement Loan (First Lien),
4.500%, 09/26/19

    751,729  
  500,000     

Gymboree Corporation
Term Loan,
5.000%, 02/23/18

    468,750  
  818,671     

J. Crew Group, Inc.
Term B-1 Loan,
4.000%, 03/07/18 (b)

    824,807  
  1,493,123     

J.C. Penney Corporation, Inc.
Loan,
6.000%, 05/22/18

    1,463,261  
  1,250,000     

Neiman Marcus Group Inc.
Term Loan,
5.000%, 10/25/20 (b)

    1,267,450  
  594,250     

Party City Holdings, Inc.
2013 Replacement
Term Loan,
4.250%, 07/27/19

    597,732  
  598,906     

PVH Corp.
Tranche B Term Loan,
3.250%, 02/13/20

    603,164  
  486,506     

Toys ‘R’ Us - Delaware, Inc.
Initial Loan,
6.000%, 09/01/16

    441,329  
   

 

 

 
      7,418,379  
   

 

 

 
  SERVICE - 9.6%   
  1,246,851     

ADS Waste Holdings, Inc.
Tranche B Term Loan,
4.250%, 10/09/19 (b)

    1,255,423  
 

 

See accompanying Notes to Financial Statements.       5


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland/iBoxx Senior Loan ETF

 

    Principal Amount ($)    

 

    Value ($)    

 

 

US Senior Loans (continued)

  

  SERVICE (continued)   
  2,408,396     

Asurion, LLC
Incremental Tranche B-1 Term Loan,
4.500%, 05/24/19 (b)

    2,412,250  
  598,687     

Ceridian Corporation
2013 New Replacement US Term Loan,
4.415%, 05/09/17

    602,054  
  570,764     

Education Management, LLC
Tranche C-2 Term Loan,
4.250%, 06/01/16 (b)

    549,420  
  1,500,000     

First Data Corporation
2017 New Term Loan,
4.166%, 03/24/17

    1,504,973  
  2,300,000     

First Data Corporation
2018 Dollar Term Loan,
4.166%, 03/23/18

    2,307,498  
  500,000     

First Data Corporation
2018B New Term Loan,
4.166%, 09/24/18

    501,320  
  1,288,922     

Sabre, Inc.
Term B Loan,
5.250%, 02/19/19

    1,300,606  
  545,220     

ServiceMaster Company
Tranche B Term Loan,
4.420%, 01/31/17 (b)

    542,666  
  1,467,668     

Weight Watchers International, Inc.
Initial Tranche B-2 Term Loan,
3.750%, 04/02/20

    1,313,013  
   

 

 

 
      12,289,223  
   

 

 

 
  TELECOMMUNICATIONS - 2.0%   
  997,494     

Cricket Communications, Inc.
C Term Loan,
4.750%, 03/08/20

    1,003,000  
  397,000     

Fairpoint Communications, Inc.
Term Loan,
7.500%, 02/14/19

    411,193  
  1,093,103     

Zayo Group, LLC
Term Loan,
4.500%, 07/02/19

    1,095,650  
   

 

 

 
      2,509,843  
   

 

 

 
  TRANSPORTATION - 2.8%   
  495,006     

Allison Transmission, Inc.
Term B-3 Loan,
3.750%, 08/23/19

    498,565  
  1,496,164     

Chrysler Group, LLC
Term Loan B,
4.250%, 05/24/17

    1,508,941  
  1,047,196     

Federal-Mogul Corporation
Tranche B Term Loan,
2.108%, 12/29/14 (b)

    1,036,562  
  603,083     

Federal-Mogul Corporation
Tranche C Term Loan,
2.108%, 12/28/15 (b)

    596,959  
   

 

 

 
      3,641,027  
   

 

 

 

    Principal Amount ($)    

 

    Value ($)    

 
  UTILITY - 6.0%   
  441,149     

AES Corporation
2013 Other Term Loan,
3.750%, 06/01/18

    444,643  
  893,125     

Calpine Corporation
Term Loan (3/11),
4.000%, 04/01/18

    900,855  
  745,603     

Calpine Corporation
Term Loan,
4.000%, 10/09/19

    752,000  
  1,240,603     

NRG Energy, Inc.
Term Loan (2013),
2.750%, 07/01/18

    1,239,412  
  2,650,000     

Texas Competitive Electric Holdings Co., LLC
2014 Term Loan (Non-Extending),
3.739%, 10/10/14

    1,883,487  
  3,500,000     

Texas Competitive Electric Holdings Co., LLC
2017 Term Loan (Extending),
4.739%, 10/10/17

    2,429,595  
   

 

 

 
      7,649,992  
   

 

 

 
 

Total US Senior Loans (Cost $120,991,786)

    120,441,352   
   

 

 

 

 

Foreign Domiciled Senior Loans (a) - 5.4%

  

  AUSTRALIA - 1.6%   
  USD       
  1,983,116     

FMG Resources (August 2006) (FMG America Finance, Inc.)
Loan,
4.250%, 06/30/19

    2,011,623  
   

 

 

 
  CANADA - 1.1%   
  USD       
  377,143     

Bombardier Recreational Products Inc.
Term B Loan,
4.000%, 01/30/19

    378,961  
  1,000,000     

Hudson’s Bay Company
Initial Term Loan (First Lien),
4.750%, 11/04/20 (b)

    1,017,690  
   

 

 

 
      1,396,651  
   

 

 

 
  GERMANY - 1.0%   
  USD       
  250,000     

Ina Beteiligungsegesellschaft
Mit Beschrankter Haftung
Facility C (USD),
4.250%, 01/27/17

    252,551  
  997,500     

Springer SBM Two GmbMBH
Initial Term B2 Loan,
5.000%, 08/15/20 (b)

    1,003,420  
   

 

 

 
      1,255,971  
   

 

 

 
 

 

6       See accompanying Notes to Financial Statements.


Table of Contents

INVESTMENT PORTFOLIO (unaudited) (continued)

 

 

 

As of December 31, 2013   Highland/iBoxx Senior Loan ETF

 

    Principal Amount ($)    

 

    Value ($)    

 

 

Foreign Domiciled Senior Loans (continued)

  

  NETHERLANDS - 1.3%   
  USD       
  842,196     

Tronox Pigments BV
New Term Loan,
4.500%, 03/19/20

    854,619  
  750,000     

UPC Financing Partnership
Facility AH,
3.250%, 06/30/21 (b)

    749,813  
   

 

 

 
      1,604,432  
   

 

 

 
  UNITED KINGDOM - 0.4%   
  USD       
  498,744     

Alpha Topco Limited
New Facility B (USD),
6.000%, 04/30/19 (b)

    504,701  
   

 

 

 
 

Total Foreign Domiciled Senior Loans (Cost $6,735,150)

    6,773,378  
   

 

 

 

 

Total Investments - 99.6%

    127,214,730   
   

 

 

 

 

(Cost $127,726,936) (d)

 

 

Other Assets & Liabilities, Net - 0.4%

    563,182  
   

 

 

 

 

Net Assets - 100.0%

    127,777,912  
   

 

 

 

 

(a) Senior loans (also called bank loans, leveraged loans, or floating rate loans) in which the Highland/iBoxx Senior Loan ETF (the “Fund”) invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread. (Unless otherwise denoted as a fixed rate loan, all senior loans carry a variable rate interest.) These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by one or more European banks such as the London Inter-Bank Offered Rate (“LIBOR”) or (iii) the Certificate of Deposit rate. Rate shown represents the weighted average rate at December 31, 2013. Senior loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy less than the stated maturity shown.
(b) All or a portion of this position has not settled. Full contract rates do not take effect until settlement date.
(c) Security is in default on interest payments as of December 31, 2013.
(d) Cost for U.S. federal income tax purposes is $127,726,936.

 

LLC   Limited Liability Company
LP   Limited Partnership
Ltd.   Limited
USD   United States Dollar

Foreign Domiciled Senior Loans

Industry Concentration Table:

(% of Net Assets)

 

Chemicals

    0.8

Gaming/Leisure

    0.3

Media/Telecommunications

    1.0

Metals/Minerals

    1.5

Retail

    0.8

Technology

    0.8

Transportation

    0.2
 

 

 

 
    5.4
 

 

 

 
 

 

See accompanying Notes to Financial Statements.       7


Table of Contents

STATEMENT OF ASSETS AND LIABILITIES

 

 

 

As of December 31, 2013 (unaudited)   Highland/iBoxx Senior Loan ETF

 

       ($)  

Assets:

  

Total Investments, at value (cost $127,726,936)

     127,214,730  

Cash

     12,137,965  

Receivable for:

  

Investments sold

     4,737,566  

Dividends and interest

     302,304  

Prepaid expenses

     11,742  
  

 

 

 

Total assets

     144,404,307  
  

 

 

 

Liabilities:

  

Payables for:

  

Investments purchased

     16,480,217  

Audit fees

     53,892  

Investment advisory fees (Note 4)

     20,099  

Administration fees (Note 4)

     10,525  

Transfer agent fees

     5,991  

Trustees’ fees (Note 4)

     2,491  

Accrued expenses and other liabilities

     53,180  
  

 

 

 

Total liabilities

     16,626,395  
  

 

 

 

Net Assets

     127,777,912  
  

 

 

 

Composition of Net Assets:

  

Paid-in capital

     128,417,000  

Distributions in excess of net investment income

     (47,710

Accumulated net realized loss on investments

     (79,172

Net unrealized depreciation on investments

     (512,206
  

 

 

 

Net Assets

     127,777,912  
  

 

 

 

Shares outstanding (unlimited authorization — no par value)

     6,400,000  

Net asset value, offering and redemption price per share (Net assets/shares outstanding)

     19.97  

 

8       See accompanying Notes to Financial Statements.


Table of Contents

STATEMENT OF OPERATIONS

 

 

 

For the Six Months Ended December 31, 2013 (unaudited)   Highland/iBoxx Senior Loan ETF

 

       ($)  

Investment Income:

  

Interest income

     2,814,969  
  

 

 

 

Total investment income

     2,814,969  
  

 

 

 

Expenses:

  

Investment advisory fees (Note 4)

     246,217  

Administration fees (Note 4)

     54,715  

Trustees’ fees (Note 4)

     5,303  

Offering Costs

     146,707  

Licensing fees

     47,123  

Audit fees

     24,654  

Custodian fees

     17,311  

Printing fees

     15,017  

Legal fees

     12,998  

Registration fees

     7,342  

Transfer agent fees

     7,146  

Commitment fees (Note 8)

     503  

Other

     7,908  
  

 

 

 

Total operating expenses before waiver and reimbursement

     592,944  
  

 

 

 

Fees and expenses waived by Investment Adviser (Note 4)

     (246,217

Reimbursement of other operating expenses by Investment Adviser (Note 4)

     (45,793
  

 

 

 

Net operating expenses

     300,934  
  

 

 

 

Net investment income

     2,514,035  
  

 

 

 

Net Realized and Unrealized Gain/(Loss) on Investments:

  

Net realized loss on investments

     (95,656

Net change in unrealized appreciation/(depreciation) on investments

     628,307  
  

 

 

 

Net realized and unrealized gain on investments

     532,651  
  

 

 

 

Net increase in net assets resulting from operations

     3,046,686  
  

 

 

 

 

See accompanying Notes to Financial Statements.       9


Table of Contents

STATEMENT OF CHANGES IN NET ASSETS

 

 

 

  Highland/iBoxx Senior Loan ETF

 

     Six Months Ended
December 31,  2013
(unaudited)
($)
     Period Ended
June 30, 2013 (a)
($)
 

Increase/(Decrease) in Net Assets:

     

From Operations

     

Net investment income

     2,514,035        1,938,830  

Net realized gain/(loss) on investments

     (95,656      260,986  

Net change in unrealized appreciation/(depreciation) on investments

     628,307        (1,140,513
  

 

 

    

 

 

 

Net increase in net assets resulting from operations

     3,046,686        1,059,303  
  

 

 

    

 

 

 

Distributions Declared to Shareholders

     

From net investment income

     (2,586,190      (1,817,844

From net realized gains

     (341,043       
  

 

 

    

 

 

 

Total distributions declared to shareholders

     (2,927,233      (1,817,844
  

 

 

    

 

 

 

Share Transactions

     

Subscriptions

     37,986,000        90,431,000  
  

 

 

    

 

 

 

Net increase from share transactions

     37,986,000        90,431,000  
  

 

 

    

 

 

 

Total increase in net assets

     38,105,453        89,672,459  
  

 

 

    

 

 

 

Net Assets:

     

Beginning of period

     89,672,459         
  

 

 

    

 

 

 

End of period

     127,777,912        89,672,459  
  

 

 

    

 

 

 

Undistributed (Distributions in excess of) net investment income

     (47,710      24,445  
  

 

 

    

 

 

 

Changes in Shares

     

Subscriptions

     1,900,000        4,500,000  
  

 

 

    

 

 

 

Net increase

     1,900,000        4,500,000  
  

 

 

    

 

 

 

 

(a) The Highland/iBoxx Senior Loan ETF commenced operations on November 6, 2012.

 

10       See accompanying Notes to Financial Statements.


Table of Contents

FINANCIAL HIGHLIGHTS

 

 

 

  Highland/iBoxx Senior Loan ETF

 

Selected data for a share outstanding throughout each period is as follows:

 

     For Six
Months Ended
12/31/13
(unaudited)
    For the
Period
Ended
06/30/13 (a)
 

Net Asset Value, Beginning of Period

   $ 19.93      $ 20.00   

Income from Investment Operations:

    

Net Investment Income (b)

     0.46        0.73   

Net realized and unrealized gain /(loss)

     0.12        (0.13
  

 

 

   

 

 

 

Total from investment operations

     0.58        0.60   

Less Distributions Declared to Shareholders:

    

From net investment income

     (0.48     (0.67

From net realized gains

     (0.06       
  

 

 

   

 

 

 

Total distributions declared to shareholders

     (0.54     (0.67

Net Asset Value, End of Period

   $ 19.97      $ 19.93   

Total return (c)

     2.85 % (g)       3.04 % (g)  

Ratios to Average Net Assets/Supplemental Data:

    

Net assets, end of period (000s)

   $ 127,778     $   89,672  

Gross expenses

     1.08 % (d)       1.62 % (d)  

Waiver/reimbursement

     (0.53 )% (d)       (1.07 )% (d)  

Net expenses (f)

     0.55 % (d)       0.55 % (d)  

Net investment income

     4.59 % (d)       5.60 % (d)  

Portfolio turnover rate

     11 % (e)       38 % (e)  

 

(a) The Highland/iBoxx Senior Loan ETF commenced operations on November 6, 2012.
(b) Per share data was calculated using average shares outstanding for the period.
(c) Total return is at net asset value assuming all distributions are reinvested. For periods with waivers/reimbursements, had the Fund’s Investment Adviser not waived or reimbursed a portion of expenses, total return would have been reduced.
(d) Annualized.
(e) Not annualized.
(f) Net expense ratio has been calculated after applying any waiver/reimbursement, if applicable.
(g) Total return is for the period indicated and is not annualized.

 

See accompanying Notes to Financial Statements.       11


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited)

 

 

 

December 31, 2013   Highland/iBoxx Senior Loan ETF

 

Note 1. Organization

Highland Funds I (the “Trust”) was organized as a Delaware statutory trust on February 28, 2006. The Trust is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company with four separate portfolios. The financial statements herein are those of the Highland/iBoxx Senior Loan ETF (the “Fund”). The Fund is a non-diversified exchange-traded fund (“ETF”). The financial statements of the remaining funds of the Trust are presented separately. On November 6, 2012, the Fund issued 1,500,000 shares. The beginning net assets of the Fund on such date were $30,000,000.

Investment Objective

The investment objective of the Fund is to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Markit iBoxx USD Liquid Leveraged Loan Index (the “Underlying Index”).

Fund Shares

Shares of the Fund are listed and traded on the NYSE Arca, Inc. Market prices for the shares of the Fund may be different from their net asset value (“NAV”). The Fund issues and redeems shares on a continuous basis at NAV only to authorized participants who have entered into agreements with the Fund’s distributor (“Authorized Participants”) in exchange for the deposit or delivery of a basket of assets (securities and/or cash) in large blocks, known as Creation Units, each of which comprises 100,000 shares. Once created, shares will trade in a secondary market at market prices that change throughout the day in amounts less than a Creation Unit.

Note 2. Significant Accounting Policies

The following is a summary of significant accounting policies consistently followed by the Fund in the preparation of its financial statements.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Valuation of Investments

In computing the Fund’s net assets attributable to shares, securities with readily available market quotations use those quotations for valuation. When portfolio securities are traded on the relevant day of valuation, the valuation will be the last reported sale price on that day. If there are no such sales on that day, the security will be valued at the mean between the most recently quoted bid and ask prices provided by the principal market makers. If there is more than one such principal market maker, the value shall be the average of such means. Securities without a sale price or quotations from principal market makers on the valuation day may be priced by an independent pricing service. Investments in mutual funds are valued at their respective net asset values as determined by those mutual funds each business day. Generally, the Fund’s loan and bond positions are not traded on exchanges and consequently are valued based on a mean of the bid and ask price from the third-party pricing services or broker-dealer sources that Highland Capital Management Fund Advisors, L.P. (the “Investment Adviser”) has determined generally have the capability to provide appropriate pricing services and have been approved by the Fund’s Board of Trustees (the “Board”).

Securities for which market quotations are not readily available and for which the Fund has determined the price received from a pricing service or broker-dealer is “stale” or otherwise does not represent fair value (such as when events occur between the time when market price is determined and calculation of the Fund’s net asset value materially affect the value of securities), will be valued by the Fund at fair value, as determined by the Board or its designee in good faith in accordance with procedures approved by the Board, taking into account factors reasonably determined to be relevant, including: (i) the fundamental analytical data relating to the investment; (ii) the nature and duration of restrictions on disposition of the securities; and (iii) an evaluation of the forces that influence the market in which these securities are purchased and sold. In these cases, the Fund’s net asset value will reflect the affected portfolio securities’ fair value as determined in the judgment of the Board or its designee instead of being determined by the market. Using a fair value pricing methodology to value securities may result in a value that is different from a security’s most recent sale price and from the prices used by other investment companies to calculate their net asset values. Determination of fair value is uncertain because it involves subjective judgments and estimates not easily substantiated.

There can be no assurance that the Fund’s valuation of a security will not differ from the amount that it realizes

 

 

12       Semi-Annual Report


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland/iBoxx Senior Loan ETF

 

upon the sale of such security. Short-term debt investments, that is, those with a remaining maturity of 60 days or less, are valued at cost adjusted for amortization of premium and accretion of discounts, a method of valuation which approximates market values. Repurchase agreements are valued at cost plus accrued interest.

Fair Value Measurements

The Fund has performed an analysis of all existing investments to determine the significance and character of all inputs to their fair value determination. The levels of fair value inputs used to measure the Fund’s investments are characterized into a fair value hierarchy. Where inputs for an asset or liability fall into more than one level in the fair value hierarchy, the investment is classified in its entirety based on the lowest level input that is significant to that investment’s valuation. The three levels of the fair value hierarchy are described below:

 

Level 1  Quoted unadjusted prices for identical instruments in active markets to which the Fund has access at the date of measurement;

 

Level 2  — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active, but are valued based on executed trades; broker quotations that constitute an executable price; and alternative pricing sources supported by observable inputs are classified within Level 2. Level 2 inputs are either directly or indirectly observable for the asset in connection with market data at the measurement date; and

 

Level 3  — Model derived valuations in which one or more significant inputs or significant value drivers are unobservable. In certain cases, investments classified within Level 3 may include securities for which the Fund has obtained indicative quotes from broker-dealers that do not
  necessarily represent prices the broker may be willing to trade on, as such quotes can be subject to material management judgment. Unobservable inputs are those inputs that reflect the Fund’s own assumptions that market participants would use to price the asset or liability based on the best available information.

The fair value of the Fund’s loans are generally based on quotes received from brokers or independent pricing services. Loans and bonds with quotes that are based on actual trades with a sufficient level of activity on or near the measurement date are classified as Level 2 assets. Loans that are priced using quotes derived from implied values, indicative bids, or a limited number of actual trades are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable.

At the end of each calendar quarter, management evaluates the Level 2 and 3 assets and liabilities for changes in liquidity, including but not limited to: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges.

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Fund’s investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values the Fund may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise less liquid than publicly traded securities.

 

 

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. Transfers in and out of the levels are recognized at the value at the end of the period. A summary of the inputs used to value the Fund’s assets as of December 31, 2013 is as follows:

 

         Total Market
Value at
12/31/13
       Level 1
Quoted
Prices
       Level 2 Other
Significant
Observable
Inputs
       Level 3
Significant
Unobservable
Inputs
 

Highland/iBoxx Senior Loan ETF

                   

Assets

                   

US Senior Loans*

     $ 120,441,352        $         $ 120,441,352        $   

Foreign Domiciled Senior Loans*

       6,773,378                   6,773,378           
    

 

 

      

 

 

      

 

 

      

 

 

 

Total

     $ 127,214,730        $         $ 127,214,730        $   
    

 

 

      

 

 

      

 

 

      

 

 

 

* Please refer to the Investment Portfolio for industry/country breakout.

 

Semi-Annual Report       13


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland/iBoxx Senior Loan ETF

 

For the six months ended December 31, 2013, there were no transfers between Level 1 and Level 2. For the six months ended December 31, 2013, there were no Level 3 securities.

Security Transactions

Security transactions are accounted for on the trade date. Cost and gains/(losses) are determined based upon the specific identification method for both financial statement and U.S. federal income tax purposes.

Cash and Cash Equivalents

The Fund considers liquid assets deposited with a bank, and certain short term debt instruments with original maturities of 3 months or less, to be cash equivalents. These investments represent amounts held with financial institutions that are readily accessible to pay Fund expenses or investments. Cash and cash equivalents are valued at cost plus accrued interest, which approximates fair value.

Creation Units

Except when aggregated in Creation Units, shares are not redeemable securities of the Fund. Shares of the Fund may only be purchased or redeemed by Authorized Participants. An Authorized Participant is either (i) a broker-dealer or other participant in the clearing process through the Continuous Net Settlement System of the National Securities Clearing Corporation or (ii) a Depository Trust Company (“DTC”) participant and, in each case, must have executed an Authorized Participant Agreement with the Fund’s distributor. Most retail investors will not qualify as Authorized Participants or have the resources to buy and sell whole Creation Units. Therefore, they will be unable to purchase or redeem the shares directly from the Fund. Rather, most retail investors will purchase shares in the secondary market with the assistance of a broker and will be subject to customary brokerage commissions or fees.

Income Recognition

Dividend income is recorded on the ex-dividend date. Interest income is recorded on the accrual basis and includes accretion of discounts and amortization of premiums of debt instruments.

U.S. Federal Income Tax Status

The Fund intends to qualify each year as a “regulated investment company” under Subchapter M of the Internal Revenue Code of 1986, as amended, and will distribute substantially all of its taxable income and gains, if any, for the tax year, and as such will not be subject to U.S. federal income taxes. In addition, the Fund intends to distribute, in each calendar year, all of their net investment income, capital gains and certain other amounts, if any, such that

the Fund should not be subject to U.S. federal excise tax. Therefore, no U.S. federal income or excise tax provisions are recorded.

Management has analyzed the Fund’s tax positions taken on federal income tax returns for all open tax years (current tax year), and has concluded that no provision for federal income tax is required in the Fund’s financial statements. The Fund’s federal and state income and federal excise tax returns for tax years for which the applicable statutes of limitations have not expired are subject to examination by the Internal Revenue Service and state departments of revenue.

Offering Costs

Offering costs, including costs of printing initial prospectus, legal and registration fees, are amortized over twelve months from inception of the Fund. As of December 31, 2013, the Fund had fully amortized its offering costs.

Distributions to Shareholders

The Fund intends to pay distributions from net investment income, if any, on a monthly basis. The Fund intends to pay net realized capital gains, if any, on an annual basis.

Note 3. U.S. Federal Tax Information

The timing and character of income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. As a result, net investment income/(loss) and net realized gain/(loss) on investment transactions for a reporting period may differ significantly from distributions during such period.

Reclassifications are made to the Fund’s capital accounts for permanent tax differences to reflect income and gains available for distribution (or available capital loss carryforwards) under income tax regulations.

The tax character of distributions paid during the period ended June 30, 2013 was as follows:

 

      Ordinary
Income*
    Distributions
paid from:
Long-Term
Capital Gains
    Distributions
in  Excess
 

Highland/iBoxx Senior Loan ETF

     

2013

  $ 1,817,844      $      $   

 

* For tax purposes, short-term capital gains distributions, if any, are considered ordinary income distributions.
 

 

14       Semi-Annual Report


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland/iBoxx Senior Loan ETF

 

As of June 30, 2013, the Fund’s tax year end, the components of accumulated losses on a tax basis were as follows:

 

      Accumulated
Capital  and
Other Losses
    Undistributed
Ordinary
Income
    Undistributed
Long-Term
Capital Gains
    Net  Unrealized
Appreciation/
(Depreciation)
 

Highland/iBoxx Senior Loan ETF

  $      $ 365,483     $      $ (1,124,024 )

Unrealized appreciation and depreciation at December 31, 2013, based on cost of investments for U.S. federal income tax purposes, was:

 

      Gross
Appreciation
    Gross
Depreciation
    Net
Appreciation/
(Depreciation)
    Cost  

Highland/iBoxx Senior Loan ETF

  $ 765,222     $ (1,277,428 )   $ (512,206 )   $ 127,726,936  

Note 4. Advisory, Administration, Service and Distribution, Trustee, and Other Fees

Investment Advisory Fees

The Investment Adviser receives from the Fund monthly investment advisory fees, computed and accrued daily based on the Average Daily Managed Assets of each Fund, at the annual rate of 0.45%.

“Average Daily Managed Assets” of a Fund means the average daily value of the total assets of the Fund less all accrued liabilities of the Fund (other than the aggregate amount of any outstanding borrowings constituting financial leverage).

Administration Fees

SEI Investments Global Funds Services (the “Administrator”) serves as the Fund’s Administrator pursuant to an Administration Agreement. The Administrator receives a monthly administration fee from the Fund, calculated and assessed monthly in arrears based on the aggregate net assets of the Fund at an annual rate of 0.10% on the first $250 million of net assets, 0.09% on the next $750 million of net assets, and 0.08% on all net assets exceeding $1 billion, subject to an annual minimum fee of $85,000. The Fund will be charged the greater of the asset based fee or the annual minimum fee.

Service and Distribution Fees

SEI Investments Distribution Co. (the “Distributor) serves as the Fund’s underwriter and distributor of shares pursuant to a Distribution Agreement. Under the Distribution Agreement, the Distributor, as agent, receives orders to create and redeem shares in Creation Unit Aggregations

and transmits such orders to the Fund’s custodian and transfer agent. The Distributor has no obligation to sell any specific quantity of Fund shares. The Distributor bears the following costs and expenses relating to the distribution of shares: (i) the costs of processing and maintaining records of creations of Creation Units; (ii) all costs of maintaining the records required of a registered broker/dealer; (iii) the expenses of maintaining its registration or qualification as a dealer or broker under Federal or state laws; (iv) filing fees; and (v) all other expenses incurred in connection with the distribution services as contemplated in the Distribution Agreement. The Distributor receives $100 per Authorized Participant transaction for its distribution services under the Distribution Agreement. The Distributor does not maintain any secondary market in Fund shares.

Expense Limits and Fee Reimbursements

The Investment Adviser contractually agreed to limit total annual operating expenses to 0.55% of average daily net assets. The expense cap will continue through at least October 31, 2014, and may not be terminated prior to this date without the action or consent of the Board. For the six months ended December 31, 2013, the Investment Adviser waived $246,217 of investment advisory fees and reimbursed $45,793 of other operating expenses.

If at any point it becomes unnecessary for the Investment Adviser to reduce fees or make expense reimbursements, the Investment Adviser may retain the difference between the Fund’s total annual operating expenses and 0.55% to recapture all or a portion of its prior fee reductions or expense reimbursements made during the preceding three-year period during which this agreement was in place. As of December 31, 2013, pursuant to the above, fees which were previously waived and reimbursed by the Investment Adviser which may be subject to possible future reimbursement to the Investment Adviser were $371,764, expiring in 2016 and $292,010 expiring in 2017.

Fees Paid to Officers and Trustees

Each Trustee who is not an “interested person” of the Fund as defined in the 1940 Act (the “Independent Trustees”) receives an annual retainer of $150,000 payable in quarterly installments and allocated among each portfolio in the Highland Fund Complex based on relative net assets. The “Highland Fund Complex” consists of all of the registered investment companies advised by the Investment Adviser as of the date of this report. The Fund pays no compensation to their one interested Trustee or any of their officers, all of whom are employees of the Investment Adviser.

 

 

Semi-Annual Report       15


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland/iBoxx Senior Loan ETF

 

Note 5. Portfolio Information

For the six months ended December 31, 2013, the cost of purchases and the proceeds from sales of the Fund’s portfolio securities (excluding in-kind transactions, long-term U.S. government securities and short-term investments) amounted to the following:

 

   

Purchases

   

Sales

 
      U.S.
Government*
    Other     U.S.
Government*
    Other  

Highland/iBoxx Senior Loan ETF

  $      $ 58,738,375      $      $ 11,961,442   

 

* The Fund did not have any purchases or sales of U.S. government securities for the six months ended December 31, 2013.

Note 6. Indemnification

The Fund has a variety of indemnification obligations under contracts with their service providers. The Fund’s maximum exposure under these arrangements is unknown. However, the Fund has not had prior claims or losses pursuant to these contracts and expects the risk of loss to be remote.

Note 7. Disclosure of Significant Risks and Contingencies

Counterparty Risk

A counterparty (the other party to a transaction or an agreement or the party with whom the Fund executes transactions) to a transaction with the Fund may be unable or unwilling to make timely principal, interest or settlement payments, or otherwise honor its obligations.

Credit Risk

The Fund invests all or substantially all of its assets in senior loans of other securities that are rated below investment grade and unrated senior loans of comparable quality. Investments rated below investment grade are commonly referred to as “high yield securities” or “junk securities”. They are regarded as predominantly speculative with respect to the issuing company’s continuing ability to meet principal and interest payments. Investments in high-yield securities may result in greater NAV fluctuation than if the Fund did not make such investments.

Debt Securities and Leveraged Loans Risk

The market prices of debt securities generally fluctuate inversely with changes in interest rates so that the value of investments in such securities can be expected to decrease as interest rates rise and increase as interest rates fall. Such changes may be greater among debt securities with longer maturities. Leveraged loans are subject to

the same risks typically associated with debt securities. In addition, leveraged loans, which typically hold a senior position in the capital structure of a borrower, are subject to the risk that a court could subordinate such loans to presently existing or future indebtedness or take other action detrimental to the holders of leveraged loans. Leveraged loans are also especially subject to the risk that the value of the collateral, if any, securing a loan may decline, be insufficient to meet the obligations of the borrower or be difficult to liquidate.

Focused Investment Risk

The Fund’s investments in senior loans arranged through private negotiations between a borrower and several financial institutions may expose the Fund to risks associated with the financial services industry. The financial services industry is subject to extensive government regulation, which can limit both the amounts and types of loans and other financial commitments financial services companies can make and the interest rates and fees they can charge. Profitability is largely dependent on the availability and cost of capital funds, and can fluctuate significantly when interest rates change. Because financial services companies are highly dependent on short-term interest rates, they can be adversely affected by downturns in the U.S. and foreign economies or changes in banking regulations. Losses resulting from financial difficulties of borrowers can negatively affect financial services companies.

Lender Liability Risk

A number of judicial decisions have upheld the right of borrowers to sue lending institutions on the basis of various evolving legal theories founded upon the premise that an institutional lender has violated a duty of good faith and fair dealing owed to the borrower or has assumed a degree of control over the borrower resulting in a creation of a fiduciary duty owed to the borrower or its other creditors or shareholders. Because of the nature of certain of the Fund’s investments, the Fund or the Investments Adviser could be subject to such liability.

Market Risk

The Fund’s share price will fluctuate with changes in the market value of its portfolio securities. Many factors can affect this value and you may lose money by investing in the Fund.

Non-Diversification Risk

Due to the nature of the Fund’s investment strategy and its non-diversified status, it is possible that a material amount of the Fund’s portfolio could be invested in the securities of one or a few issuers. Investing a significant portion of the

 

 

16       Semi-Annual Report


Table of Contents

NOTES TO FINANCIAL STATEMENTS (unaudited) (continued)

 

 

 

December 31, 2013   Highland/iBoxx Senior Loan ETF

 

Fund’s portfolios in any one or a few issuers may result in the Fund’s shares being more sensitive to the economic results of those few issuers.

Regulatory Risk

To the extent that legislation or state or federal regulators impose additional requirements or restrictions with respect to the ability of financial institutions to make loans in connection with highly leveraged transactions, the availability of Senior Loan interests for investment by the Fund may be adversely affected.

Non-Payment Risk

Debt securities are subject to the risk of non-payment of scheduled interest and/or principal. Non-payment would result in a reduction of income to the Fund, a reduction in the value of the obligation experiencing non-payment and a potential decrease in the Fund’s NAV and the market price of the Fund’s shares.

Ongoing Monitoring Risk

On behalf of the several lenders, the agent generally will be required to administer and manage the senior loans and, with respect to collateralized senior loans, to service or monitor the collateral. Financial difficulties of agents can pose a risk to the Fund. Unless, under the terms of the loan, the Fund has direct recourse against the borrower, the Fund may have to rely on the agent or other financial intermediary to apply appropriate credit remedies against a borrower.

Note 8. Credit Agreement

Effective November 2, 2012, the Fund entered into a $25,000,000 credit agreement (the “Credit Agreement”) with State Street Bank, with an expiration date of November 1, 2013. On May 24, 2013, the Credit Agreement expiration date was extended to May 23, 2014. Interest is charged at a rate equal to the higher of the federal funds rate or adjusted LIBOR plus 1.25% per annum based on any outstanding borrowings. In addition, a commitment fee of 0.10% per annum is charged. Included in the Statement of Operations is $503 of Commitment fees.

During the six months ended December 31, 2013, the Fund did not have any outstanding borrowings.

Note 9. Recent Accounting Pronouncement

In June 2013, the Financial Accounting Standards Board issued an update (“ASU 2013-08”) to ASC Topic 946, Financial Services—Investment Companies (“Topic 946”). ASU 2013-08 amends the guidance in Topic 946 for determining whether an entity qualifies as an investment company and requires certain additional disclosures. ASU 2013-08 is effective for interim and annual reporting periods in fiscal years that begin after December 15, 2013. Management is currently evaluating the impact, if any, of ASU 2013-08 on the Fund’s financial statements.

Note 10. Subsequent Events

Management has evaluated the impact of all subsequent events on the Fund through the date the financial statements were issued, and has determined that there were no subsequent events requiring recognition or disclosure in the financial statements.

 

 

Semi-Annual Report       17


Table of Contents

ADDITIONAL INFORMATION (unaudited)

 

 

 

December 31, 2013   Highland/iBoxx Senior Loan ETF

 

Additional Portfolio Information

Net asset value, or “NAV,” is the price per share at which the Fund issues and redeems shares. It is calculated in accordance with the standard formula for valuing mutual fund shares. The “Market Price” of the Fund generally is determined using the midpoint between the highest bid and the lowest offer on the stock exchange on which the shares of the Fund are listed for trading, as of the time that the Fund’s NAV is calculated. The Fund’s Market Price may be at, above or below its NAV. The NAV of the Fund will fluctuate with changes in the market value of its holdings. The Market Price of the Fund will fluctuate in accordance with changes in its NAV, as well as market supply and demand. Premiums or discounts are the differences (expressed as a percentage) between the NAV and Market Price of the Fund on a given day, generally at the time NAV is calculated. A premium is the amount that the Fund is trading above the reported NAV, expressed as a percentage of the NAV. A discount is the amount that the Fund is trading below the reported NAV, expressed as a percentage of the NAV. Further information regarding premiums and discounts is available on the Fund’s website at www.highlandfunds.com.

The Investment Adviser and its affiliates manage other accounts, including registered and private funds and individual accounts. Although investment decisions for the Fund are made independently from those of such other accounts, the Investment Adviser may, consistent with applicable law, make investment recommendations to other clients or accounts that may be the same or different from those made to the Fund, including investments in different levels of the capital structure of a company, such as equity versus senior loans, or that involve taking contradictory positions in multiple levels of the capital structure. The Investment Adviser has adopted policies and procedures that address the allocation of investment opportunities, execution of portfolio transactions, personal trading by employees and other potential conflicts of interest that are designed to ensure that all client accounts are treated equitably over time. Nevertheless, this may create situations where a client could be disadvantaged because of the investment activities conducted by the Investment Adviser for other client accounts. When the Fund and one or more of such other accounts are prepared to invest in, or desire to dispose of, the same security, available investments or opportunities for each will be allocated in a manner believed by the Investment Adviser to be equitable to the Fund and such other accounts. The Investment Adviser also may aggregate orders to purchase and sell securities for the Fund and such other accounts. Although the Investment Adviser believes that, over time, the potential benefits of participating in volume transactions and negotiating lower transaction costs

should benefit all accounts including the Fund, in some cases these activities may adversely affect the price paid or received by the Fund or the size of the position obtained or disposed of by the Fund.

Disclosure of Fund Expenses

As a shareholder of a Fund, you incur two types of costs: (1) transaction costs and (2) ongoing costs, including management fees, and other Fund expenses. This example is intended to help you understand the ongoing costs (in dollars) of investing in your Fund and to compare these costs with the ongoing costs of investing in other mutual funds.

The example is based on an investment of $1,000 invested at the beginning of the period and held for the six-month period July 1, 2013 through December 31, 2013, unless otherwise indicated. This table illustrates your Fund’s costs in two ways:

Actual Expenses: The first part of the table provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading entitled “Expenses Paid During Period” to estimate the expenses you paid on your account during this period.

Hypothetical Example for Comparison Purposes: The second part of the table provides information about hypothetical account values and hypothetical expenses based on your Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not your Fund’s actual return. The actual expense ratio includes voluntary fee waivers or expense reimbursements by the Fund’s investment adviser. The expense ratio would be higher had the fee waivers or expense reimbursements not been in effect. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in your Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs. Therefore, the second part of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

 

 

18       Semi-Annual Report


Table of Contents

ADDITIONAL INFORMATION (unaudited) (continued)

 

 

 

December 31, 2013   Highland/iBoxx Senior Loan ETF

 

 

      Beginning
Account
Value
07/01/13
    Ending
Account
Value
12/31/13
    Annualized
Expense
Ratios
    Expenses
Paid
During
Period*
    Actual
Returns
for
Period
 

Highland/iBoxx Senior Loan ETF

  

     

Actual Fund Return

  $ 1,000.00      $ 1,028.50       0.55   $ 2.81       2.85

Hypothetical

  $ 1,000.00      $ 1,022.43       0.55   $ 2.80       2.24

 

* Expenses are equal to the Fund’s annualized expense ratio multiplied by the average account value over the hypothetical six-month period, multiplied by 184/365 (to reflect the one-half year period.)
 

 

Semi-Annual Report       19


Table of Contents

IMPORTANT INFORMATION ABOUT THIS REPORT

 

 

 

Investment Adviser

Highland Capital Management

Fund Advisors, L.P.

200 Crescent Court, Suite 700

Dallas, TX 75201

Transfer Agent

State Street Bank and Trust Company

200 Clarendon Street, 16 th Floor

Boston, MA 02116

Distributor

SEI Investments Distribution Co.

One Freedom Valley Drive

Oaks, PA 19456

Custodian

State Street Bank and Trust Company

200 Clarendon Street, 16 th Floor

Boston, MA 02116

Independent Registered Public

Accounting Firm

PricewaterhouseCoopers LLP

2001 Ross Avenue, Suite 1800

Dallas, TX 75201

Fund Counsel

Ropes & Gray LLP

Prudential Tower

800 Boylston Street

Boston, MA 02199

This report has been prepared for shareholders of the Highland/iBoxx Senior Loan ETF (the “Fund”). The Fund mails one shareholder report to each shareholder address. If you would like more than one report, please call shareholder services at 1-855-799-4757 to request that additional reports be sent to you.

A description of the policies and procedures that the Fund uses to determine how to vote proxies relating to its portfolio securities, and the Fund’s proxy voting records for the most recent 12-month period ended December 31, are available (i) without charge, upon request, by calling 1-855-799-4757 and (ii) on the Securities and Exchange Commission’s website at http://www.sec.gov.

The Fund files its complete schedule of portfolio holdings with the Securities and Exchange Commission (the “Commission”) for the first and third quarters of each fiscal year on Form N-Q. The Fund’s Forms N-Q are available on the Commission’s website at http://www.sec.gov and also may be reviewed and copied at the Commission’s Public Reference Room in Washington, DC. Information on the Public Reference Room may be obtained by calling 1-800-SEC-0330. Shareholders may also obtain the Form N-Q by visiting the Fund’s website at www.highlandfunds.com.

The Statement of Additional Information includes additional information about the Fund’s Trustees and are available upon request without charge by calling 1-855-799-4757.

 

 

20       Semi-Annual Report


Table of Contents

THIS PAGE LEFT BLANK INTENTIONALLY


Table of Contents

LOGO

 


Table of Contents

Item 2. Code of Ethics.

Not applicable.

Item 3. Audit Committee Financial Expert.

Not applicable.

Item 4. Principal Accountant Fees and Services.

Not applicable.

Item 5. Audit Committee of Listed Registrants.

Not applicable.

Item 6. Investments.

 

(a) Schedule of Investments in securities of unaffiliated issuers as of the close of the reporting period is included as part of the report to shareholders filed under Item 1 of this form.

 

(b) Not applicable.

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable.

Item 8. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable.

Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable.

Item 10. Submission of Matters to a Vote of Security Holders.

There have been no material changes to the procedures by which the shareholders may recommend nominees to the registrant’s board of directors.

Item 11. Controls and Procedures.

 

(a) The registrant’s principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”) (17 CFR 270.30a-3(c)) are effective, as of a date within 90 days of the filing date of the report that includes the disclosure required by this paragraph, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 240.15d-15(b)).

 

3


Table of Contents
(b) There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act (17 CFR 270.30a-3(d)) that occurred during the registrant’s second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 12. Exhibits.

 

(a)(1) Not applicable.

 

(a)(2) Certifications pursuant to Rule 30a-2(a) under the 1940 Act and Section 302 of the Sarbanes-Oxley Act of 2002 are attached hereto.

 

(a)(3) Not applicable.

 

(b) Certifications pursuant to Rule 30a-2(b) under the 1940 Act and Section 906 of the Sarbanes-Oxley Act of 2002 are attached hereto.

 

4


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

HIGHLAND FUNDS I

 

By (Signature and Title):

  

/s/ Ethan Powell

   Ethan Powell
   Executive Vice President and Principal Executive Officer
   (Principal Executive Officer)

Date: March 10, 2014

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By (Signature and Title):

  

/s/ Ethan Powell

   Ethan Powell
   Executive Vice President and Principal Executive Officer
   (Principal Executive Officer)

Date: March 10, 2014

 

By (Signature and Title):

  

/s/ Brian Mitts

   Brian Mitts
   Chief Financial Officer and Treasurer
   (Principal Financial Officer)

Date: March 10, 2014

 

5

FuelStream (CE) (USOTC:FLST)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025 Plus de graphiques de la Bourse FuelStream (CE)
FuelStream (CE) (USOTC:FLST)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025 Plus de graphiques de la Bourse FuelStream (CE)